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Abstract
Tumour blood flow plays a critical role in tumour growth and cancer therapies.
Computational fluid dynamics is an efficient method to study blood behaviour
by modelling fluid flow through numerical simulations. A mathematical model
is developed to study the blood flow through a three-dimensional permeable
vascular network embedded in a solid tumour, and its transvascular move-
ment and spread within tumour interior in context with cancer therapies. The
vasculature is described by the parametric equations in terms of vessel centre
lines. The flow through each tumour vessel is approximated with the lead-
ing component in the longitudinal direction of the vessel, and its governing
equation becomes an ordinary differential equation based on the parameter
of the parametric equation for the vessel centre line. The pressure continuity
and mass conservation conditions are imposed at every junction within tumour
vascular network. The interstitial flow is described by the Darcy’s law which
is converted into the Laplace equation. The coupling effect between the flows
through tumour vasculature and within tumour interstitial due to the vascu-
lar permeability is described by the Starling’s law. A coupling mathematical
model is then developed. Based on mass conservation, a differential equation
for pressures on both sides of vascular surface is obtained. Transforming the
Laplace equation into the boundary-integral form by using the Green’s func-
tion offers another equation linking the pressures inside and outside vessels.
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The numerical procedure is developed, and the discretised differential and in-
tegral equations are solved by finite difference method and boundary element
method respectively. The model is applied to investigate how different types of
physical parameters and special characters of tumour vasculature affect tumour
blood flow. Finally, an approximation model by ignoring the term with small
value of the fully coupling model is developed, and its validity and simulation
efficiency are examined.
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Nomenclature
a radius of tumour vessel cross section
cv drug concentration in tumour vessel
lv length of tumour vessel measured from
some reference point
p0 peripheral pressure on tumour surface
pa inlet vascular flow pressure
pc vascular flow pressure
pJc pressure at junction point J in vascular
network
pi interstitial flow pressure
pv outlet vascular flow pressure
qe transmission flux over unit length along cir-
cumference of vessel cross section
u interstitial flow velocity
As vascular surface area
D Dean number
Js flux of molecules
Lp permeability of tumour vessel
Continued on next page. . .
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Continued
Nw Womersley parameter
Qa inlet vascular flow flux
Qc flux through vessel
Qex overall amount of extravasation flux
Qv outlet vascular flow flux
Re Reynolds number
Rc curvature radius of vessel centre line
U0 peak velocity through vessel cross section
U1, U2, U3 components of vascular flow velocity U in
orthogonal curvilinear coordinate system
(q1, q2, q3)
Ux, Uy, Uz components of vascular flow velocity U in
Cartesian coordinate system o− xyz
Ur, Uθ, Ut components of vascular flow velocity U in
orthogonal curvilinear coordinate system
(r, θ, t)
U vascular flow velocity
Zg geometrical resistance of vascular flow
Zη viscous resistance of vascular flow
γ
Q
ratio of extravasation flux over inlet vascu-
lar flow flux
κ tumour tissue hydraulic conductivity
parameter
µ dynamic viscosity of blood
ω heart pumping frequency
πv oncotic pressure in vascular fluid
Continued on next page. . .
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Continued
πi oncotic pressure in interstitial fluid
ρ density of blood
σ oncotic reflection coefficient
σ
F
plasmadrag reflection coefficient
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Chapter 1
Introduction
Blood is a specialised bodily fluid flowing around human body through blood
vessels driven by the pumping actions of heart. Blood flow plays a key role
in maintaining body health. It delivers necessary nutrients and oxygen to
body organs and cells, and takes waste products of metabolism away from the
same organs or cells. Blood flow also signals tissue damages, maintains body
temperatures, and transports therapeutic agents.
One of the main medical motivations behind the study of blood flow is the
desire to process the fundamental understanding of pathology for blood flow
system and apply it to help improve the effectiveness of resource transportation
for life sustenance and/or disease treatment. Many methods can be adopted
to undertake the research on the behaviour of blood flow. Fluid dynamics sim-
ulation offers good options to study blood flow when it is hard or dangerous to
obtain in vivo measurement. Computational fluid dynamics (CFD) is a means
to model fluid flow through numerical tools. It solves governing equations for
mass and momentum conservations. It can make systematic analysis, and also
allow local detailed study on fluid behaviour in areas which are not easy to
access. With this kind of insightful information, one can ultimately deduce
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some importance in physiological implications.
The study on blood flow from fluid dynamics point of view not only has
the potential to bring medical benefit, but also poses many mathematical and
numerical challenges. Applying mathematics for the research on blood flow
has raised new types of problems, including an uncommon range of Reynolds
number, pulsatile flow conditions, and unusual multiplicity and configuration
of vascular networks [Lighthill (1972)]. In pursuit of meaningful results and
useful analysis with physiologists, this cross-disciplinary subject is very active
today.
In the work starting after this brief introduction, we will introduce and
approach a CFD study on the blood flow in tumour which goes through a
permeable vascular network embedded in tumour interstitium. Before that, it
is beneficial to understand the foundation of tumour growth, the therapeutic
effectiveness of cancer treatment and the special characters of tumour blood
flow environment.
1.1 Cancer — the malignant tumours
Cancer is a fatal disease which can affect everyone in any age. It has already
been one of the leading causes of world-wide death, and will be the most lethal
disease within next few years. Globally, based on the recent available incidence
and mortality data, it is estimated that there were more than 12 million new
cancer cases in 2007, and the corresponding estimate for total cancer deaths in
that year was 7.6 million [Garcia et al. (2007)]. This represents an increase of
around 20% in cancer incidence and 13.4% in cancer mortality relative to the
estimates in 2002, in which year, there were 10.9 million new cancer cases and
6.7 million deaths caused by cancer [Parkin et al. (2005)]. Fig.1.1a depicts the
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Figure 1.1: Estimated global cancer burn: (a) number of cancer incidence
per year; (b) number of cancer mortality per year [Boyle and
Levin (2008), Garcia et al. (2007), Parkin et al. (1984, 1988,
1993, 1999), Parkin (2001), Parkin et al. (2005)].
estimates of subsequent new cancer cases for 1975 to 2030, and Fig.1.1b shows
the cancer death cases estimated from 1985 to 2030. Adopting the current
trends of cancer incidence and mortality, and taking the growth and ageing
of world-wide population into account, it is predicted that there would be
15 million new cancer patients and 10 million cancer deaths in 2020 [Parkin
(2001)]. Much worse, in 2030, the data will jump to 26 million and 16 million
for cancer incidence and mortality respectively [Boyle and Levin (2008)]. This
critical situation alerts us that cancer is becoming a much more dangerous
global burden of disease and a major reason for losing lives.
Cancer is a disease beginning from somatic cells and their progeny. When
cells begin to divide uncontrollably, they form an abnormal mass of tissue
known as a tumour. A tumour can be either malignant or benign. Benign
tumours [Sarg and Gross (2007)] imply a kind of mild and non-progressive dis-
ease. Although a benign tumour may cause some healthy problems depending
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on its size and location, it does not infiltrate surrounding tissues or spread to
distant organs. Benign tumours are seldom life-threatening (although some
types of benign tumours are capable of becoming malignant). In fact, many
kinds of benign tumours are harmless to human health.
On the contrary, malignant tumours, which are characterised with in-
vasion and metastasis, are very harmful to human health [Sarg and Gross
(2007)]. These two special characters, invasion and metastasis, differentiate
malignant tumours from benign tumours. Invasion refers to a population of
cells which grow from previously healthy genomic intact cells. However, these
cells (malignant tumour cells) are different from normal cells as they disre-
gard the normal controls of proliferation. They divide rapidly to replace old
cells and damage normal cells without respect to normal limits, and multiply
constantly to invade and destroy adjacent tissues and organs. Furthermore,
malignant tumour cells can spread to distant anatomic sites along human body
through circulatory system (both bloodstream and lymphatic system). This
process is called metastasis. According to this peculiar character of metasta-
sis, Hippocrates assigned the name of cancer or crab to malignant tumours
because of their crab-like spreading behaviour within human bodies [Walter
(1977)]. Hanahan and Weinberg (2000) summarised the following six char-
acteristics of cancer: (1) ability to spontaneous proliferation; (2) discard of
external inhibitory signals; (3) malfunction of apoptosis — immortalization;
(4) capability to promote tumour angiogenesis; (5) unresponsiveness to the
signal of differentiate; and (6) invasion and metastasis.
Though heart disease (HTD) is still the high risk for human beings, deaths
from HTD have decreased significantly during the last three decades due to
the great development of the knowledge and treatment on HTD possessed by
us. In contrast, as shown in Fig.1.2, the overall death rate caused by cancer
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Figure 1.2: Death rate per year caused by cancer and heart disease [UCL
Cancer Institute (2007)].
has not changed very much, since there are a lot of unknowns about cancer
and its treatment. People can suffer with types of cancers at any age, and
the risk for the more common varieties tends to increase with age. Cancer is
now one of the major causes to lose lives, and very few patients with cancer
are currently curable. Its treatment has become one of the major missions of
science.
1.2 Therapeutic methods for cancer
1.2.1 Introduction on etiology of cancer and environ-
mental carcinogenic factors
There are still many questions needed to be answered, though, a lot of evidence
has been shown that the etiology of cancer is contributed to the variations in
key gene activity caused by a series of genetic and epigenetic changes in human
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bodies [Evan and Vousden (2001), Ponder (2001)]. Phrase “genetic changes”
means mutations, while term “epigenetic changes” is regarded as the damage
of DNA resulted from exogenous agents which can alter gene transcription
pattern [Nagy (2005)]. Such key gene variations are induced by two categories
of factors. One is the intrinsic influence, including the acquired and inherited
defects of DNA repair and the variations in metabolic polymorphism inside
and outside cells [Ponder (2001)]. The other is the extrinsic (exogenous) effect,
which refers to the environmental carcinogenic factors.
A large number of environmental factors have been confirmed with car-
cinogenic or mutagenic properties. The Monographs Program on the Evalu-
ation of Carcinogenic Risks to Humans of International Agency for Research
on Cancer (IARC Monographs) identifies environmental factors which can in-
crease the risk of human cancer. To date, this program has identified a total of
105 agents, mixtures and exposures classified in Group 1, or “carcinogenic to
humans” [IARC (2008)]. Basically, these agents can be catalogued as life-style
factors, radiation, virus, and pollution [Wogan et al. (2004)].
One of the leading life-style carcinogen factors is our daily diet. It has
been estimated that nearly one third of all cancer cases are related with diet
[Gabriel (2007)]. It causes 90% of colorectal cancer globally [Cartmel (1997)].
One main reason for this fact is that our diet becomes low in fibre, but high in
animal fats nowadays. It is also well recognised that some significant sources
from our diet can induce cancer. Through the application of well-validated
biomarker in molecular epidemiology, aflatoxin has been proven as a strong
liver carcinogen which is bloated contaminant of dietary staples in Asia and
Africa [Wogan et al. (2004)]. The heterocyclic amines represent another im-
portant class of carcinogens in food products when meat is over cooked for
a long period [Wogan et al. (2004)]. They are mutagens and carcinogens at
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numerous organ sites.
Another clear life-style involving carcinogen exposure factor is tobacco.
There are overwhelming proofs linking tobacco with many types of cancers
[IARC (2004)]. Taking cigarette increases the risk of all histological types
of lung cancers. It also induces cancers of oral cavity, especially when using
smokeless tobacco or smoking together with drinking alcohol [IARC (1998)].
Furthermore, cigarette smoking is connected with other cancers, such as la-
ryngeal, oropharyngeal, hypopharyngeal and nasopharyngeal cancers, as well
as stomach, liver, and bladder carcinomata [Wogan et al. (2004)]. It has been
confirmed that cigarettes and smokeless tobacco contain a mixture of carcino-
gens, tumour promoters and co-carcinogens. The coal tar in cigarette smoke
can damage DNA directly to induce cancer [Nagy (2005)]. There are over one
billion smokers and hundreds of millions of smokeless tobacco users all over
the world. By far, tobacco use is the most widespread link between known
carcinogens and death from cancer.
Radiation is another kind of carcinogenic sources. Ionising radiation re-
leases enough energy to damage DNA within cells, which can lead to malignant
changes taking place in later life. Exposure can be in the form of repeated
doses or one isolated incident, such as the nuclear accident at Chernobyl in
1986 [Walter (1977)].
Viruses, bacteria and chemical pollution can place a premium on cancer
as well. Chronic infection by hepatitis B (HBV) or hepatitis C (HVC) virus
is a big risk for the great majority of hepatocellular carcinoma [IARC (1994)].
Exposure to asbestos is known to be responsible for inducing mesothelioma
[Nagy (2005)].
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1.2.2 Cancer therapeutic methods
At present, cancer is usually treated by surgery, chemotherapy (non-specific
and/or targeted therapy such as monoclonal antibody therapy), radiotherapy,
hormonal therapy, and hyperthermia therapy. The choice of treatment depends
on the type, location and stage of cancer, as well as the general health of
patientsi.
Removing cancerous tissues completely, but minimising the damage on
the rest of body is the goal of cancer treatment. This can be accomplished by
surgery to some extent when cancer is localised at a specific organ. But the
propensity of cancer to invade adjacent tissues and/or metastasise to distant
sites can limit its effectiveness [Beardsley (1994)].
Chemotherapy [Sarg and Gross (2007)] is one of the most important meth-
ods to treat cancer. In general sense, chemotherapy is the treatment or control
of cancer by anti-cancer drugs, the highly toxic medications which can destroy
cancer cells by interfering with their growth or preventing their reproduction.
Chemotherapy works by interrupting cell cycle, preventing cells from repro-
ducing, and killing the cells which divide rapidly. However, it also means that
anti-cancer drugs may harm the cells that divide rapidly under normal circum-
stances, such as cells in bone marrow, digestive tract, and hair follicles, which
leads to the most common side effect of chemotherapy. Targeted therapy is
a developed form of chemotherapy. Unlike conventional chemotherapy, it tar-
gets specific processes and proteins unique to cancer cells, e.g. proteins which
cause cell proliferation or invasion, or proteins which induce angiogenesis. As a
result, target therapy usually has less adverse effects relative to the traditional
chemotherapy.
isome knowledge in this section is obtained from Cancer Research UK
(http://www.cancerresearchuk.org).
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Most types of malignant tumours can be treated by radiotherapy (radi-
ation therapy in North America) [Sarg and Gross (2007)] in some way. Ra-
diotherapy may be used as the primary therapy, but it is usually combined
with sugary, chemotherapy, hyperthermia therapy, or some mixture of them.
The mechanism of radiotherapy is to damage the DNA of cells in the target
cancerous tissues through the radiation beams ionising the atoms directly and
indirectly to the DNA chain. The main side effects caused by radiotherapy are
skin irritation which is like a mild to moderate sun burn, and physically ex-
hausting of patients (fatigue) which could make patients lose appetite, weaken
the immunologic system of patients to make them easily infected by some epi-
demic diseases, and even affect the mental health of patients. For example
some patients feel low or depressed during radiotherapy.
Hormonal therapy [Sarg and Gross (2007)] is another popular therapeutic
method for several types of cancers which derives from hormonally responsive
tissues. It involves the manipulation of the endocrine system through exoge-
nous administration of specific hormones or drugs which inhibit the production
or activity of such hormones (hormone antagonists). Because some kinds of
hormones are the powerful drivers of gene expression in certain cancer cells,
changing the levels or activity of certain hormones can cause certain cancers
to cease growing, or even undergo cell death.
Hyperthermia therapy [Sarg and Gross (2007)] is also a medical method
to treat cancer, in which body tissues are exposed to high temperature to dam-
age and kill cancer cells or make cancer cells more sensitive to the effects of
radiation and/or certain anti-cancer drugs. Hyperthermia alone is only useful
for certain kinds of cancers, and is not in widespread use. Most commonly,
as an adjuvant therapy, hyperthermia is applied alongside with other thera-
pies, such as surgery, radiation, chemotherapy, to increase the effectiveness of
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therapies.
1.3 Role of tumour blood flow in cancer treat-
ment
Most of conventional and novel cancer therapies, such as chemotherapy, ra-
diotherapy, hormonal therapy, hyperthermia therapy, immunotherapy, and
photodynamic therapy, are closely connected with the blood flow in tumour
[Jain (1987a,b, 1988)]. As illustrated in Fig.1.3, for chemotherapy, no matter
whether the anti-cancer drugs are taken orally (e.g. Glivec or Tarceva) or in-
jected intravenously (e.g. Avastin and Rituximab), they are intended to travel
by convection and diffusion along with blood circulation, across tumour vascu-
lar surface into surrounding cancerous tissues, and through tumour interstitial
space to kill cancer cells [Jain (1989, 1994, 1997, 1998a,b, 2001)]. All these
three major steps for the delivery of chemical anti-cancer drugs are closely
related with tumour blood flow. This indicates that tumour blood flow is the
key factor to determine the effectiveness of chemotherapy. In the meantime,
the distribution of temperature within cancerous and surrounding normal tis-
sues is affected by the convective heat transfer between blood and tissue media
[Jain and Ward-Hartley (1984)]. As a result, in the process of hyperthermia,
the ability to reach the desired temperature depends on the local perfusion
rate [Jain et al. (1979)]. Meanwhile, the perfusion rate has strong effects on
the effectiveness of radiotherapy, because the potent radiosensitiser — oxygen,
which is able to increase the ability of a given dose of radiation by forming
DNA-damaging free radicals, is transported into tumour tissues along with
blood flow.
However, compared with the blood flow environment in normal tissues, the
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Figure 1.3: Path of drug delivery inside a solid tumour [Jain (1994)].
blood flow field inside a tumour is complicated, even chaotic [Fukumura and
Jain (2007a,b)]. The abnormal flow environment severely constrains the deliv-
ery of anti-cancer agents into tumour interior, and limits the effectiveness of
the non-surgical cancer treatments [Carmeliet and Jain (2000), Fukumura and
Jain (2007a,b), Jain (1989, 1994, 1997, 1998a,b, 2001), Jang et al. (2003)].
The irregular structure and function of tumour vasculature are at the bot-
tom of the abnormal blood flow field inside tumour [Carmeliet and Jain (2000),
Fukumura and Jain (2007a)]. In order to support tumour growth, new vessels
are recruited by vasculogenesis and angiogenesis to supply the nutrition when
tumour extends beyond the critical size (in general, tumour diameters of 1 to
2 mm) [Folkman (1971, 1995, 2006)]. Angiogenesis changes the architecture
of tumour vasculature significantly relative to the vasculature in normal tis-
sues. In contrast to normal vessels, angiogenesis not only creates out of order
vascular structures with excessive branches and loops inside tumour, but also
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makes tumour vessels tortuous, dilated and with uneven diameters [Konerding
et al. (1999), Less et al. (1991), Shubik (1982)].
Meanwhile, in the progress of angiogenesis (and/or required by angiogen-
esis), the vessels within tumour share another abnormal function: they are
more permeable relative to the vessels in normal tissues [Gerlowski and Jain
(1986), Yuan et al. (1993, 1994a,b)]. The tumour vascular walls have lots of
“openings” (endothelial fenestrate, vesicles and transcellular pores), widened
inter-endothelial junctions, and discontinuous or absent basement membranes.
In addition, the endothelial cells of tumour vascular walls are abnormal in
shape, growing on top of each other, and projecting into the lumen. These de-
fects make tumour vessels permeable [Dvorak et al. (1995, 1999), Hashizume
et al. (2000)]. The tumour vascular permeability plays a key role in forming
the complicated blood flow environment in tumour because it induces higher
interstitial pressure relative to normal tissues. Due to vascular permeability,
when blood flows through tumour vessels, there are exchanges of flux between
tumour vessels and interstitium. Because of the effects of tumour interstitial
resistance for fluid, the extravasation flux cannot be transported throughout
tumour interior instantly, which leads to blood flux accumulated in tumour
interstitium. As a result, tumour interstitial pressure is elevated.
As described above, tumour vasculature is highly disorganised in architec-
ture and abnormal in function. Vessels inside tumour are leaky, tortuous and
dilated, and tumour vascular network contains excessive branches and loops.
In addition, the elevated interstitial pressure caused by the permeability of
tumour vessels compresses lymphatic vessels in tumour, which makes tumour
lymphatic vessels not functional and impairs the lymphatic flow within tumour
[Helmlinger et al. (1997), Leu et al. (2000)]. These structural and functional ab-
normalities of tumour vessels contribute to the heterogeneity of tumour blood
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flow environment, which is characterised with interstitial hypertension (ele-
vated hydrostatic pressure outside the blood vessels), hypoxia, and acidosis
[Jain (2005), Maedaa et al. (2000)]. These features are very harmful to nor-
mal tissues. But, unfortunately, cancer cells are able to survive in this special
environment.
Further to this, the chaotic tumour blood flow forms physiological barriers
to compromise the effectiveness of cancer therapies [Jain (1994, 1997, 1998a,b,
1999b, 2001)]. Tumour blood environment hosts a low oxygen state known
as hypoxia. This is a major cause for the failure of radiotherapy as tumour
cells are deficient in oxygen [Fyles et al. (1998), Gatenby et al. (1988), Ho¨ckel
et al. (1993)]. The heterogeneous blood flow leads to abnormal blood perfu-
sion rates within tumour. This can harm the effectiveness of hyperthermia
[Jain and Ward-Hartley (1984)]. For chemotherapy, the success is suspended
because of the low transport rates into tumour interstitium across tumour vas-
culature and the small diffusion and convection of therapeutic macromolecules
[Dykes et al. (1987), Kohler and Milstein (1975)]. This is contributed to the
high interstitial pressure (interstitial hypertension) in tumour interior caused
by the permeability of tumour vessels. The primary role of the elevated in-
terstitial pressure is to reduce the driving force of transvascular exchange for
both fluid and macromolecules, which is regarded as one of the major reasons
for the low efficiency of drug delivery [Hobbs et al. (1998), Jain (1987a,b),
Jain and Baxter (1988)]. The hypertension can also aggravate the side effects
of chemotherapy and radiotherapy by purging toxic anti-cancer drugs and/or
radiosensitiser from tumour interstitium to the surrounded normal tissues [Jain
(1996)]. Meanwhile, the low efficiency and inadequate delivery of anti-cancer
agents can also result in residual tumour cells, which would in turn lead to
regrowth of tumour cells and development of drug resistant cells [Jang et al.
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(2003)].
1.4 Aim of the project
1.4.1 Aim of the project
Blood flow is one of the key factors for tumour growth. But, what mainly
concerns us in this work is its role in determination of the delivery profile and
the effectiveness of therapeutic agents to cure cancer. Without blood flow,
tumour cannot grow beyond a critical size or metastasise to other organs. On
the other hand, with an efficient blood supply, we are able to deliver anti-cancer
agents to all regions of tumour interstitium in optimal quantities.
In order to improve effectiveness of cancer treatment with minimal side
effects to normal tissues, detailed studies on tumour blood flow are necessary.
It will help us to achieve a better understanding of the path by which the ther-
apeutic agents reach tumour cells. Statistically, the malignant solid tumour
is responsible for over 85% human cancer mortality [Jain (2005), Jang et al.
(2003)]. This motives us to investigate the blood flow in a solid tumour.
1.4.2 The problems
The following problems will be the focus of this PhD study:
1. How do the various physical parameters, such as vessel permeability,
radius and curvature, the inlet and outlet vascular flow conditions, and
the hydraulic conductivity of tumour interstitium, affect tumour blood
flow?
2. What are the effects of periphery conditions on the blood environment
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inside tumour?
3. When the configuration of tumour vasculature becomes complicated, for
example a vascular network with branches and loops, what effects would
it have on tumour blood flow?
1.5 Synopsis
In the present chapter, the basic physiology of cancer has been introduced,
including the lethality, causes and therapeutical methods of cancer, the unusual
characters of the blood flow environment in tumours, and the effects of those
characters on cancer therapies. In addition, we have outlined the biomedical
problems to be solved, which form the overall aim of this study. The contents
in the following chapters are described below.
In Chapter 2, we go through briefly the previous research work on tumour
blood flow. We focus on the existing mathematical models on the simulations
of tumour blood flow, and highlight the blood pressure distributions inside
tumour vessels and within tumour interstitium. In the meantime, the scope of
our project is defined.
The chosen numerical simulation tools, finite difference method and bound-
ary element method, are reviewed in Chapter 3. We derive finite difference
method with non-uniform differencing schemes through the standard Taylor
serious expansions. Then, by Green’s identities, boundary element method
in context of the blood flow in tumour interstitium is presented. The integral
representative of the Green’s function is derived at the end of Chapter 3, which
is the key factor of applying boundary element method to do the simulations
in this study.
According to flow continuity and momentum conservation, Chapter 4 fully
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outlines the derivations of the governing equations for the blood flow in a solid
tumour when the vasculature is represented by a single vessel. In Chapters 5
and 6, the governing equations derived in Chapter 4 are applied to investigate
a simple but practical case for tumour blood flow, in which a single straight
vessel with permeability is embedded in a solid tumour. The rationality of
our mathematical model and the efficiency of the numerical procedure are
examined, and the effects of different physical parameters on tumour blood
flow are investigated, including the inlet and outlet vascular flow conditions,
tumour hydraulic conductivity, and tumour peripheral pressure.
In Chapters 7 to 9, we undertake the research on how the particular
characters of the irregular tumour vascular architecture affect tumour blood
flow, including the disordered tumour vessel radius, vessel curvature, and out
of order tumour vascular network with asymmetrical bifurcations and loops.
According to the observations on the results obtained in Chapters 6 to 9,
an approximation model for the blood flow through tumour vessels is developed
in Chapter 10. The validity and calculation efficiency of the approximation
model are discussed.
Finally, in Chapter 11, this thesis is summarised with a discussion of the
results and analysis.
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Chapter 2
Literature Review
Our motivation to investigate tumour blood flow through CFD is to have
a better understanding of tumour flow environment, potentially improve the
effectiveness of existing therapies, and hopefully lead to the development of
new cancer therapeutic methods. Before presenting our model and analysing
the results, we briefly go through the previous studies on tumour blood flow.
Following a short introduction on observing and measuring tumour blood flow
through experimental techniques, we place our focus of this literature review
on the existing mathematical models on simulating tumour blood flow. At the
end of this chapter, the scope of this thesis is given.
2.1 Observation and measurement on tumour
blood environment
Transparent chamber technique is an efficient and wide-used experimental
method to observe tumour blood environment. From the author’s knowledge,
Algire (1943, 1945) and Chalkley (1948) were the first to apply transparent
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chamber to study tumour vascular proliferation. Modified from the Sandiso-
Clark chamber for the investigation on inflammation [Clark et al. (1930), San-
dison (1924)], Algire (1943) and Chalkley (1948) designed a chamber as a
transparent window inserted into the back of a mouse. This allowed them
to observe vasculature of the transplantable tumours available in mice. From
observation, they noticed the phenomenon of angiogenesis in tumour. Since
then, the transparent chamber technique has been adopted and promoted to
investigate tumour by many scholars. For example, Jain and his group applied
the “window” technique (transparent chamber technique) to study the vascu-
lature and blood flow in a tumour grown or transplanted in the ear of a rabbit
or on the brain or dorsal skin of a rodent, when they put a glass over slip on
the tumour [Jain (1994)]. By focusing a microscope on the visible tissue, they
can directly investigate tumour blood environment.
Along with the transparent chamber technique for observation, many
methods are developed to measure tumour blood flow. Jain and Ward-Hartley
(1984) introduced the classification of various methods for tumour blood mea-
surement on the basis of six categorisations, which are isolated tumour tech-
nique [Gullino and Grantham (1961)], microsphere technique [Peterso (1979)],
uptake of radioactive tracers [Sapirstein (1958)], isotope clearance technique
[Gump and White (1968)], thermal clearance [Eberhart et al. (1980)], and
thermal probe techniques [Gibbs (1933)]. They also discussed the advantages
and disadvantages of each method. Among these methods, isolated tumour
technique and microsphere technique are the most popular ways to measure
tumour blood flow. Later on, due to the development of high resolution imag-
ing technology, more techniques could be applied alone and/or combined with
the conventional techniques to observe and measure tumour blood flow, includ-
ing magnetic resonances imagining (MRI) [Evelhoch (1992), Robinson et al.
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(1998)], positron emission tomography (PET) [Anderson and Price (2002),
Bacharach et al. (2000)], Doppler ultrasound imaging [Okihara et al. (1999),
Peters-Engl et al. (1999)], and intravital microscopy method [Jain (2002), Le-
unig et al. (1992)].
A lot of research on observing and measuring tumour flow environment
has been done through the methods mentioned above. For example, the study
by Gullino et al. (1964) was one of the earliest to measure high interstitial
tissue fluid pressures in tumours through isolated tumour technique. Peters
et al. (1980) recorded the pressures in tumour vessels, which was summarised
together with other tumour blood features by Jain (1988). Sevick and Jain
(1989a) studied the geometrical resistance of blood flow in tumour vessels, and
how it depended on tumour size and perfusion rate. Steinberg et al. (1990)
observed the tumour vascular distribution and measured vascular density in
a human xenotransplanted tumour. Less et al. (1991) was the first to re-
port the quantitative measurement of vessel branching patterns and vascular
dimensions in a mammary tumour.
Though MRI, PET and Doppler imaging techniques could be used in vivo
measurement in human, most of the measurement methods listed above require
harvesting tumours or surgical procedures which can be only conducted in ex-
perimental settings. However, a growing body of evidence has been shown that
various physiological functions of tumour micro-environment, such as vascular
permeability and vascular structure, are different in the original human tumour
from the xenotransplanted tumour, even between the primary tumour and the
metastatic tumour, because these physiological functions depend on the type of
tumour and the host organ where the tumour is growing [Dellian et al. (1996),
Fukumura et al. (1997), Jung et al. (2000), Monsky et al. (2002)]. For this rea-
son, in many circumstances, experimental results would be declinational, even
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opposite to actual in vivo physiological phenomena. Therefore, many efforts
have been donated to study tumour blood flow through biomechanical models
developed from fluid dynamics point of view, since biomechanical models can
overcome the limitation of experiments on vascular configuration, and serve
to test some biological aspects which are not easily accessible experimentally,
especially when the highly adaptable computational fluid dynamics modelling
is applied.
2.2 Mathematical models for blood flow in tu-
mour
Jain and Baxter developed a model to study the interstitial fluid field in a
spherical tumour [Baxter and Jain (1989, 1990), Jain and Baxter (1988)]. In
their model, there was a continuously distributed vasculature and lymphatics
in the tumour space. The flow pressure distribution in tumour space was de-
scribed by the Darcy’s law when regarding the tumour interstitium as a porous
media. The vessels were taken as constant sources for extravasation flux due
to their permeability, and the lymphatics as sinks because of their absorption
ability. They assumed that the net flow transported into the interstitium was
the balance of the flux exceeded from the vasculature by convection, the flux
absorbed into the lymphatics, and the flux delivered from tumour interstitium
into the surrounding normal tissues. Based on their model, Jain and Baxter
(1988) showed that the interstitial fluid pressure was elevated in the centre
of the tumour compared with normal tissues, which was equal to the average
pressure in capillary, and was determined by the balance between flux flowing
from the vasculature into the interstitium together with that from the inter-
stitium into the surrounding normal tissues. El-Kareh and Secomb (1995)
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applied a similar model to study the effects of tumour size and shape on the
interstitial blood flow. They showed that the dependence of the flux exceeded
from the vessels into tumour interior on tumour shape was much weaker than
tumour size.
Adopting a similar approach to describe the vasculature in normal tissues
proposed by Krogh (1919) and Apelblat et al. (1974), Netti et al. (1996) devel-
oped a model of steady-state tumour blood flow when applying a hypothetical
vessel with permeability to represent the entire vascular network in tumour. In
their model, the vascular elastic property was considered, and the dependence
of steady-state cross-section area of tumour vessel on the transmural pressure
difference was described mathematically based on a semi-empirical formula.
The interstitial fluid pressure was assumed to be constant, and independent
on the vascular flow pressure, vascular permeability, or tumour hydrodynam-
ical property. They investigated how the arterial (inlet) and venous (outlet)
vascular flow pressures affected the flux exceeded from vessels into tumour
interstitium according to the conservation of blood mass.
Milosevic et al. (1999) modified the elastic vessel model developed by Netti
et al. (1996) to investigate the unsteady property of tumour blood flow. They
assumed that the variation of the vessel cross section with respect to time is
directly proportional to the variation of transmural pressure difference with
respect to time. The proportion coefficient was obtained through artificially
differentiating the steady model proposed by Netti et al. (1996) with respect
to the transmural pressure difference. Using this model, they calculated the
elevated interstitial fluid pressure on the exterior surface of the permeable
vessel which was embedded in a spherical solid tumour.
Another model was developed by Mollica et al. (2003) to study the tempo-
ral characters of tumour blood flow. They simplified the tumour vasculature as
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a two-dimensional channel with permeability. The elastic property of the ves-
sel was considered in their simulation, and the membrane theory was adopted
to describe the vascular deformation. The tumour interstitial pressure was set
to be constant and not related with the pressure in vessel. They investigated
the blood pressure profile inside vessel based on the mass conservation, and
concluded that the average vascular pressure was not necessarily equilibrat-
ing with the tumour interstitial pressure, and the tumour vessel performed a
self-sustained oscillatory behaviour.
Baish et al. (1997) studied the steady-state coupling effects between tu-
mour vascular and interstitial fluid flows through a model when replacing the
vasculature by parallel rows of vessels which were spanned the full thickness of
a hypothetical square tumour. The vessels were perfused by the blood enter-
ing along one edge of the tumour, and drained along the opposite edge. The
direction of the tumour interstitial fluid flow was assumed to be perpendicular
to the vascular blood flow. The model predicted uniformly elevated interstitial
pressure in the central region of the tumour and a rapid reduce to low value
at the periphery. Baish et al. (1997) themselves summarised that one obvious
shortcoming of their model was the simplicity in vascular architecture. Having
accepted that limitation, the model demonstrated redistribution of blood flow
from the centre to the periphery of the tumour as a result of the interstitial
pressure inducing constriction of the venous end of the vessels.
Fleischman et al. (1986a,b) developed a mathematical model to investigate
the effects of pressure gradients on the exchange of flux exceeded from vessels
into a tissue, who took into account of the coupling effects between the blood
flow through the vessels and the flow field in the tissue. In their model, the
tissue was assumed to be an infinite isotropic porous medium without lymph
vessels, and the blood flow within it was governed by the Darcy’s law. The
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rigid vessels embedded in the tissue were straight with low permeability. The
vascular flow was described by the Poiseuille’s law, and the extravasation flux
was controlled by the Starling’s law. To solve the model, they converted the
Darcy’s law to a boundary-integral equation along the vessels, and then divided
them into small cylinder sections along the vessel centre lines. In this numerical
computation process, they only took the vessels as a set of sources, but ignored
full interactions between the sections. However, in general, these interactions
must be considered when the boundary-integral representative is applied to
replace the original differential equations (see Sec.3.3).
Pozrikidis and Farrow (2003) improved the theoretical model developed by
Fleischman et al. (1986a) to undertake the research on the blood flow in a solid
tumour when the whole vasculature was replaced by a single straight vessel.
They pointed out the weakness of the calculation in the work by Fleischman
et al. (1986a). They included the full interactions between the sections when
the boundary element method was applied, and showed that, though the error
introduced by the approximation was not significant under physiological and
physical conditions considered by Fleischman et al. (1986a), whereas for the
blood flow through a vessel with high permeability in tumour tissue, the full
interaction between the discretised cylinder sections has to be included. They
also concluded that the assumption of uniform interstitial pressure along the
outer surface of the vessel was not appropriate.
2.3 Scope of our project
Transporting anti-cancer therapeutic agents in optimal quantities is one of the
critical problems for drug and gene delivery in solid tumours [Jain (1997)].
However, delivery of anti-cancer agents into solid tumours is always limited
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Figure 2.1: An illustration of blood flow through a 3D vascular network em-
bedded in a solid tumour.
because of very slow diffusion [Boucher et al. (1998), Jain (1999a), Netti et al.
(1999)] since most anti-cancer agents are molecules with large size and heavy
weight [Costantini et al. (2000), Gabizon et al. (1998), Kulkarni et al. (1995)],
and inadequate convective transport due to elevated interstitial fluid pressure
[Jain (1997)]. Diffusive effects on molecules cannot be changed significantly
unless chemical structures of therapeutic agents or tissues are modified sub-
stantially. However, convection can be adjusted through varying either sys-
temic blood pressure gradients [Hori et al. (1994), Netti et al. (1997)], tumour
interstitial hydraulic conductivity [Zhang et al. (2000)] or some other physical
parameters. Therefore, it is relatively easy to process and control the convec-
tive effects in tumour, which can be investigated by fluid dynamics efficiently.
This demarcates the scope of our study in this thesis.
The main objective of our study is to develop a mathematical model and
numerical solution procedure for modelling the blood flow through a three-
dimensional vascular network which is embedded in a solid tumour, as illus-
trated in Fig.2.1. The effects of different physical parameters on tumour blood
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flow are investigated in context with the convective delivery of anti-cancer ther-
apeutic agents. The results provided here are preliminarily to demonstrate the
effectiveness of the method from computational point of view and their poten-
tial implications to the medical purpose, which are not yet at the stage to aim
at direct clinical applications.
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Chapter 3
Finite Difference Method and
Boundary Element Method
3.1 Introduction
In this chapter, we present the numerical tools which are applied in this study.
Finite difference method and boundary element method are chosen to un-
dertake the required simulations. These two numerical methods are selected
because they are believed to be convenient in programming and efficient for
calculating the problems in our project.
Firstly, we introduce finite difference method (FDM). Among usual nu-
merical simulation methods, including finite difference method, finite element
method (FEM), finite volume method (FVM), and boundary element method
(BEM), FDM is the most straightforward one in terms of its numerical dis-
cretisation procedure, which replaces the derivatives in differential equations
with differencing schemes. It is easy to program, especially on solving ordinary
differential equations. We are going to demonstrate the detailed differencing
schemes based on the standard Taylor expansion in nonuniform meshes. In
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our simulations, this method is mainly adopted to calculate the blood flow
through tumour vessels.
Then, we step forward to present the details of boundary element method
(BEM). In BEM, the governing differential equation in the calculation do-
main is converted, when possible, into a boundary-integral equation over the
boundary of that domain. This procedure makes the dimensionality of the
investigation problem lower by one order, and the discretised meshes are only
generated on the boundary instead of the entire simulation domain. This fea-
ture can help us to significantly reduce the number of unknowns, especially for
three-dimensional problems.
Finally, the integral representative of the free-space Green’s function is
derived. The Green’s function is the key factor when applying BEM to solve
the Laplace equation which is applied to describe the flow field within tumour
interior in this project. The integral expression of the Green’s function is con-
venient to solve the boundary-integral equation obtained in BEM, particularly
for the present study.
3.2 Finite difference method
Finite difference method (FDM) is one of the most common numerical meth-
ods. The details of FDM may be found in the books by Anderson (1995),
Chung (2002) and others. Compared with other popular numerical tools in
computational fluid dynamics, such as finite element method (FEM), finite
volume method (FVM), and boundary element method (BEM), FDM is the
simplest one in terms of its numerical discretisation procedure. It is particu-
larly powerful for ordinary differential equations or one-dimensional problems,
since no mapping is needed between the physical domain and the computa-
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Figure 3.1: Illustration of behaviour in standard Taylor series expansion.
tional domain, which is usually required by partial differential equations. The
basic principle of FDM is straightforward: using differencing schemes, the
derivatives in differential equations are written in terms of discretised quan-
tities of dependent and independent variables, resulting in simultaneous alge-
braic equations with all unknowns prescribed at discretised mesh points for
the entire domain [Anderson (1995)].
In order to apply FDM to simulate fluid flow, we need to choose appropri-
ate types of differencing schemes and suitable methods for solution. Normally,
the choice for the proper type of finite differencing schemes depends on the
particular physics of the flow, which may include inviscid/viscous, incompress-
ible/compressible, subsonic/transonic/supersonic, irrotational/rotational, lam-
inar/turbulent flow.
In this study, one-dimensional finite differencing schemes with nonuniform
49
spacing are used to investigate the blood flow through tumour vessels. This
kind of differencing schemes can be obtained through the standard Taylor series
expansion. As sketched in Fig.3.1, for some function u(x), from the value of
uj at xj , the value of uj+1 at xj+1 can be expressed in the form of the forward
formula of the standard Taylor series as
uj+1 =uj +∆xj+1
(
∂u
∂x
)
j
+
∆x2j+1
2
(
∂2u
∂x2
)
j
+
∆x3j+1
6
(
∂3u
∂x3
)
j
+O(h4). (3.2.1)
Similarly, the value of uj−1 at xj−1 can be written by the backward formula of
the standard Taylor series, which is
uj−1 = uj −∆xj
(
∂u
∂x
)
j
+
∆x2j
2
(
∂2u
∂x2
)
j
− ∆x
3
j
6
(
∂3u
∂x3
)
j
+O(h4). (3.2.2)
In both Eqs.(3.2.1) and (3.2.2), ∆xj = xj − xj−1, ∆xj+1 = xj+1 − xj , and h
stands for a typical order of spacing.
The first order derivative from the central difference formula with the
second order accuracy is obtained through combining Eqs.(3.2.1) and (3.2.2)
as
(
∂u
∂x
)
j
=
1
∆xj +∆xj+1
[
∆xj+1
∆xj
(uj − uj−1) + ∆xj
∆xj+1
(uj+1 − uj)
]
+O(h2). (3.2.3)
The three-point central difference formula for the second order derivative has
the form of
(
∂2u
∂x2
)
j
=
2
∆xj +∆xj+1
(
uj+1 − uj
∆xj+1
− uj − uj−1
∆xj
)
+O(h). (3.2.4)
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The order of accuracy of Eq.(3.2.4) will be O(h2) if ∆xj+1 = ∆xj .
Besides the central difference formulae, the forward and backward differ-
ence formulae are also applied in this study, for example, when we investigate
the blood flow features at the junction points in the vascular network. Ac-
cording to the Taylor series expansion,
uj+2 =uj +∆x¯j+1
(
∂u
∂x
)
j
+
∆x¯2j+1
2
(
∂2u
∂x2
)
j
+
∆x¯3j+1
6
(
∂3u
∂x3
)
j
+O(h4), (3.2.5)
and
uj−2 = uj −∆x¯j
(
∂u
∂x
)
j
+
∆x¯2j
2
(
∂2u
∂x2
)
j
− ∆x¯
3
j
6
(
∂3u
∂x3
)
j
+O(h4), (3.2.6)
in which ∆x¯j+1 = xj+2 − xj and ∆x¯j = xj − xj−2 as depicted in Fig.3.1.
Combining Eq.(3.2.1) with Eq.(3.2.5), we obtain the first order derivative from
the three-point forward difference as(
∂u
∂x
)
j
=
∆xj+1
∆x¯j+1(∆xj+1 −∆x¯j+1)uj+2 −
∆x¯j+1
∆xj+1(∆xj+1 −∆x¯j+1)uj+1
− (∆xj+1 +∆x¯j+1)
∆x¯j+1∆xj+1
uj +O(h
2), (3.2.7)
and the second order derivative from the three-point forward difference as(
∂2u
∂x2
)
j
=
2
∆x¯j+1(∆x¯j+1 −∆xj+1)uj+2 −
2
∆xj+1(∆xj+1 −∆x¯j+1)uj+1
+
2
∆x¯j+1∆xj+1
uj +O(h). (3.2.8)
Considering Eqs.(3.2.2) and (3.2.6), and following the same procedure stated
above, we have the first order derivative from the three-point backward differ-
ence as
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(
∂u
∂x
)
j
=− ∆xj
∆x¯j(∆xj −∆x¯j)uj−2 +
∆x¯j
∆xj(∆xj −∆x¯j)uj−1
+
(∆xj +∆x¯j)
∆x¯j∆xj
uj +O(h
2), (3.2.9)
and the second order derivative from the three-point backward difference as
(
∂2u
∂x2
)
j
=
2
∆x¯j(∆x¯j −∆xj)uj−2 −
2
∆xj(∆xj −∆x¯j)uj−1
+
2
∆x¯j∆xj
uj +O(h). (3.2.10)
Now, we have obtained all the finite differencing schemes required in our
project. In order to apply FDM to solve physical problems practically, we shall
replace the differential derivatives in the governing equations with the finite
difference schemes derived in this section. As a result, the original differential
equations are transformed into a set of algebraic equations which can be solved
efficiently by numerical programming. There are two common methods to
improve the accuracy of FDM. One is to adopt more-point (more than three
points) differencing schemes. The other is to decrease the value of typical
spacing size h.
3.3 The boundary element method
3.3.1 Introduction
The procedure of boundary element method (BEM), which may be found in
the books by Brebbia and Dominguez (1992), Pozrikidis (2002) and others, is
introduced in this section. In BEM, the governing differential equation in the
calculation domain is transformed into an integral equation over the boundary
of the domain, after using a fundamental solution which satisfies the governing
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differential equation inside the domain apart from some source point. The
integral equation is calculated numerically over the boundary which is divided
into small segments (boundary elements). Following the similar procedure in
other numerical approaches, when the boundary conditions are satisfied, a set
of linear algebraic equations emerges, for which the unique solution can be
found through numerical programming.
3.3.2 Advantages of BEM
The most important feature of BEM is that it only requires discretisation on
the boundary rather than in the whole calculation domain. The advantage of
this feature is obvious: the dimensionality of the problem is reduced by one
order, that is, only a surface instead of a volume discretisation is required.
This indicates that the number of unknowns is reduced dramatically, espe-
cially for a three-dimensional problem, because unknowns occur only on the
boundary. In the meantime, meshes for BEM can be easily generated and
adjusted, but do not require a complete re-meshing. This factor also makes
BEM conveniently accommodate geometrically complex boundaries and deal
with an infinite continuum.
3.3.3 Basic integral equation
In this part, the basic process on how to derive the boundary-integral equation
is presented. This boundary-integral equation can be obtained through some
different ways, such as weighted residuals, Betti’s reciprocal theorem, Green’s
identities, or fundamental principles. Here, Green’s identities is chosen to
present the process, because it is easy to understand, especially for the Laplace
equation.
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The three-dimensional Laplace equation
∇2φ(x) = 0 (3.3.1)
is adopted as the governing equation for the blood flow field within tumour
interstitium in our project, in which φ(x) is a twice-differentiable function.
The pressure distribution in tumour interior is described by Eq.(3.3.1), which
is solved by BEM in this study.
Green’s identities
Green’s identities are a set of vector derivative/integral identities which can be
derived from the vector derivative identities. For any two twice-differentiable
functions f and g, we have
∇ · (f∇g) = f∇2g +∇f · ∇g. (3.3.2)
When the divergence theorem
∫
Vc
(∇ · F)dV =
∫
S
F · dS =
∫
S
F · ndS (3.3.3)
is applied to Eq.(3.3.2), the first Green’s identity is derived as
∫
S
f∇g · ndS =
∫
Vc
(f∇2g +∇f∇g)dV, (3.3.4)
in which Vc is the calculation domain, S refers the boundary of Vc, and n is
the unit vector normal to S pointing out of Vc.
Interchanging the roles of f and g, we have
∫
S
g∇f · ndS =
∫
Vc
(g∇2f +∇g∇f)dV. (3.3.5)
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Subtracting Eq.(3.3.5) from Eq.(3.3.4), we obtain the second Green’s identity,
which is in the form of
∫
Vc
(f∇2g − g∇2f)dV =
∫
S
(f∇g − g∇f) · ndS. (3.3.6)
If both functions f and g are harmonic, the integrand on the left-hand
side of Eq(3.3.6) vanishes, or
f∇2g − g∇2f = ∇ · (f∇g − g∇f) = 0. (3.3.7)
Then, an integral form is found as
∫
S
f∇g · ndS −
∫
S
g∇f · ndS = 0. (3.3.8)
Fundamental solution of the Laplace equation
One key issue of applying BEM is to choose a proper fundamental solution
for the governing differential equation in the calculation domain. The three-
dimensional Laplace equation
∇2φ(x) = 0
shows that function φ is twice-differentiable and harmonic. The fundamental
solution for the Laplace equation is a special harmonic function, or the Green’s
function
G(x,x0).
In G(x,x0), x is a field point, and x0 is the location of a singularity.
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The Green’s function represents the field generated by a concentrated
unit source acting at point x0. The effect of this source is from x0 to infinity
without any consideration of boundary conditions. Thus,
∇2G(x,x0) = δ(x− x0), (3.3.9)
where
δ(x− x0) = δ(x− x0)δ(y − y0)δ(z − z0) (3.3.10)
is the three-dimensional Direct Delta function. The solution for Eq.(3.3.9) is
G(x,x0) = − 1
4π |r| , (3.3.11)
in which
|r| = |x− x0| =
√
(x− x0)2 + (y − y0)2 + (z − z0)2. (3.3.12)
Basic boundary-integral equation
When function f is replaced with φ(x) and g with G(x,x0), Eq.(3.3.7) is
rewritten as
∇ · [φ(x)∇G(x,x0)−G(x,x0)∇φ(x)] = 0, x 6= x0. (3.3.13)
In order to integrate Eq.(3.3.13) over a certain volume Vc and apply the diver-
gence theorem, a small sphere of radius ǫ is excluded, whose centre is located
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Figure 3.2: Sketch of a certain control volume Vc used to derive the
boundary-integral equation of BEM when x0 is inside the vol-
ume.
at point x0, as shown in Fig.3.3.3. This leads to
∫
Sǫ
n(x) · [φ(x)∇G(x,x0)−G(x,x0)∇φ(x)] dS(x)
+
∫
S
n(x) · [φ(x)∇G(x,x0)−G(x,x0)∇φ(x)] dS(x) = 0. (3.3.14)
Let us consider the integral over Sǫ on the left-hand side of Eq.(3.3.14),
or
∫
Sǫ
n(x) · [φ(x)∇G(x,x0)−G(x,x0)∇φ(x)] dS(x). (3.3.15)
Based on the definition of the Green’s function in Eq.(3.3.11), we have
∇G(x,x0) · n(x) = −∂G(x,x0)
∂ |r| = −
∂G(x,x0)
∂ǫ
= − 1
4πǫ2
. (3.3.16)
Introducing Eqs.(3.3.11) and (3.3.16) into Eq.(3.3.15), and letting ǫ → 0, we
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Figure 3.3: Sketch of a certain control volume Vc used to derive the
boundary-integral equation of BEM when x0 tends to the surface
of the volume.
obtain
lim
ǫ→0
∫
Sǫ
n(x) · [φ(x)∇G(x,x0)−G(x,x0)∇φ(x)] dS(x)
= lim
ǫ→0
4πǫ2
[
− 1
4πǫ2
φ(x0) +
1
4πǫ
∂φ(x0)
∂n
]
=− φ(x0). (3.3.17)
Substituting Eq.(3.3.17) into Eq.(3.3.14) yields the result as
φ(x0) =−
∫
S
G(x,x0) [n(x) · ∇φ(x)] dS(x)
+
∫
S
φ(x) [∇G(x,x0) · n(x)] dS(x). (3.3.18)
When point x0 tends to the surface of volume Vc, as plotted in Fig.3.3, only
half sphere is left inside the volume if the surface is smooth at point x0. This
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leads to
1
2
φ(x0) =−
∫
S
G(x,x0) [∇φ(x) · n(x)] dS(x)
+
∫
S
φ(x) [∇G(x,x0) · n(x)] dS(x). (3.3.19)
The Laplace equation is now transformed into an integral equation over
the boundary of a certain control volume, as described in Eq.(3.3.19). This
integral equation can be solved numerically when the boundary is divided into
small elements. The unique solution is then obtained for unknowns if the
boundary conditions are satisfied.
3.4 Integral representative of the free-space
Green’s function
As aforementioned in Section 3.1, the free-space Green’s function is the key
factor in applying BEM to solve the Laplace equation. In this section, we
represent the free-space Green’s function with its integral expression in Carte-
sian coordinate system (x, y, z). This integral representative is convenient
to solve the boundary-integral equation (3.3.19) in our project. In a certain
three-dimensional space with Cartesian coordinate system (x, y, z), the Green’s
function is defined as
G(x,x0) = − 1
4π
√
(x− x0)2 + (y − y0)2 + (z − z0)2
, (3.4.1)
which satisfies
∇2G(x,x0) = δ(x− x0), (3.4.2)
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where δ(x − x0) is the three-dimensional Dirac Delta function defined in
Eq.(3.3.10).
Making the spatial Fourier Transformation [Bronshtein et al. (2007)] on
both sides of Eq.(3.4.2), we have
Fx
{∇2G(x,x0)} = Fx {δ(x− x0)} , (3.4.3)
in which
Fx{f}(v) def=
∫ +∞
−∞
∫ +∞
−∞
∫ +∞
−∞
f(x)e−i(v·x)dxdydz, (3.4.4)
where i =
√−1, and v = (v1, v2, v3). As
Fx{f}
{∇2G(x,x0)} = [(iv1)2 + (iv2)2 + (iv3)2]Gf (v,x0), (3.4.5)
in which
Gf(v,x0) =
∫ +∞
−∞
∫ +∞
−∞
∫ +∞
−∞
G(x,x0)e
−i(v·x)dxdydz, (3.4.6)
and noticing that the integral of Dirac delta function multiplied by any other
function is equal to the value of the function at point x0, Eq.(3.4.3) can be
rewritten as
[(iv1)
2 + (iv2)
2 + (iv3)
2]Gf (v,x0) = e
−iv1x0−iv2y0−iv3z0. (3.4.7)
Then,
Gf(v,x0) = −e
−iv1x0−iv2y0−iv3z0
(v21 + v
2
2 + v
2
3)
. (3.4.8)
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According to the definition of the spatial Fourier Transformation in Eq.(3.4.4),
the pair inverse spatial Fourier Transformation [Bronshtein et al. (2007)] is in
the form of
F−1
v
{f}(x) = 1
8π3
∫ +∞
−∞
∫ +∞
−∞
∫ +∞
−∞
f(v)ei(v·x)dv1dv2dv3. (3.4.9)
Applying Eq.(3.4.9) to Eq.(3.4.8), we have
G(x,x0) =
1
8pi3
∫ +∞
−∞
∫ +∞
−∞
∫ +∞
−∞
−e
iv1(x−x0)+iv2(y−y0)+iv3(z−z0)
v21 + v
2
2 + v
2
3
dv1dv2dv3. (3.4.10)
Following the procedure presented in the book by Ziomek (1995), the above
equation is rewritten as
G(x,x0) = − 1
8pi3
∫ +∞
−∞
eiv1(x−x0)
v21 + k
2
ρ
dv1
∫ +∞
−∞
∫ +∞
−∞
eiv2(y−y0)+iv3(z−z0)dv2dv3, (3.4.11)
where
kρ =
√
v22 + v
2
3. (3.4.12)
Let us consider the first part of the integral on the right-hand side of
Eq.(3.4.11), or
∫ +∞
−∞
eiv1(x−x0)
v21 + k
2
ρ
dv1. (3.4.13)
Based on the definition of complex function, and considering the parity of
trigonometric functions, we have
∫ +∞
−∞
eiv1(x−x0)
v21 + k
2
ρ
dv1 =
∫ +∞
−∞
cos[v1 |x− x0|]
v21 + k
2
ρ
dv1 =
∫ +∞
−∞
eiv1|x−x0|
v21 + k
2
ρ
dv1. (3.4.14)
The term on the right-hand side of Eq.(3.4.14) is an improper integral in an
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Figure 3.4: The closed integral path with half circle arch in a complex plane.
infinite domain. It can be calculated by Residue Theorem in association with
Jordan’s Lemma [Bronshtein et al. (2007)].
Considering an integral with the same integrand in the term on the right-
hand side of Eq.(3.4.14) along a closed half-circle loop on a complex plane,
or ∮
ei̟|x−x0|
̟2 + k2ρ
d̟,
we can rearrange the integral as
∮
ei̟|x−x0|
̟2 + k2ρ
d̟ =
∫ +R
−R
ei̟|x−x0|
̟2 + k2ρ
d̟ +
∫
CR
ei̟|x−x0|
̟2 + k2ρ
d̟, (3.4.15)
where ̟ is the complex variable, CR is a half-circle arc located on the upper
half of the complex plane whose centre point is located at the origin, and R is
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the radius of CR, as sketched in Fig.3.4. When |̟| → ∞,
f(̟) =
1
̟2 + k2ρ
→ 0
uniformly. Then, according to Jordan’s Lemma [Bronshtein et al. (2007)],
lim
R → ∞
∫
CR
ei̟|x−x0|
̟2 + k2ρ
d̟ = 0. (3.4.16)
Thereby,
∫ +∞
−∞
ei̟|x−x0|
̟2 + k2ρ
d̟ =
∮
ei̟|x−x0|
̟2 + k2ρ
d̟. (3.4.17)
Applying Residue Theorem [Bronshtein et al. (2007)] to the integral on the
right-hand side of Eq.(3.4.17), we have
∮
ei̟|x−x0|
̟2 + k2ρ
d̟ = 2πi · lim
̟→kρi
[
(̟ − kρi)e
i̟|x−x0|
̟2 + k2ρ
]
=
π
kρ
e−kρ|x−x0|. (3.4.18)
Substituting Eq.(3.4.17) into Eq.(3.4.18), and introducing the result into Eq.(3.4.14),
we obtain
∫ +∞
−∞
eiv1(x−x0)
v21 + k
2
ρ
dv1 =
π
kρ
e−kρ|x−x0|, (3.4.19)
which indicates
∫ +∞
−∞
Gf(v1)e
iv1xdv1 =
π
kρ
e−kρ|x−x0|. (3.4.20)
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When Eq.(3.4.20) is substituted into Eq.(3.4.11), we have
G(x,x0) = − 1
8π2
∫ +∞
−∞
∫ +∞
−∞
e−kρ|x−x0|
kρ
e[iv2(y−y0)+iv3(z−z0)]dv2dv3. (3.4.21)
In terms of Eq.(3.4.12), we can define


v2 = kρ cos θ,
v3 = kρ sin θ.
(3.4.22)
Substituting Eq.(3.4.22) into Eq.(3.4.21), we successfully obtain the integral
representative of the Green’s function as
G(x,x0) = − 1
8π2
∫ +∞
0
∫ 2π
0
e−kρ|x−x0|eikρ[cos θ(y−y0)+sin θ(z−z0)]dkρdθ. (3.4.23)
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Chapter 4
Governing Equations for the
flow through Vessels and in
Tumour Interstitium
Fig.4.1 sketches a simple case when a single vessel with some curvature is
embedded in a solid tumour, in which κ is the hydraulic conductivity parameter
of tumour tissue, A stands for the connecting point of the vessel with the
afferent arteriole (upstream blood flow), and V for the connecting point of the
vessel with the efferent venule (downstream blood flow), as tumour vasculature
does not begin or end suddenly in tumour interstitium. Along the vessel,
the radius of vessel cross section is defined as a(l), Lp(l) donates the vessel
permeability, and qe(l) is the extravasation flux over the unit length along the
circumference of vessel cross section, where l is the length measured along the
vessel centre line from some given reference point.
In this chapter, based on the case illustrated in Fig.4.1, we derive the
governing equations for the blood flow through tumour vessels, the flow in
tumour interstitium, and the coupling effects between those two flows caused
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Figure 4.1: Sketch of a permeable vessel embedded in tumour interstitium.
by the permeability of tumour vessels. We start with the mathematical method
to describe the position and shape of a tumour vessel. Then, according to
flow continuity and momentum conservation, the governing equations for the
blood flow through the vessel are derived. After that, the equation for the
flow field in tumour interior and the relationship for the flux exceeded from
tumour vessels into interstitium are given. In the meantime, the detailed
procedure is presented on how to obtain the boundary-integral equation for
tumour interstitial flow and calculate the key coefficients in that boundary-
integral equation.
4.1 The parametric equation for vessel posi-
tion
In order to describe the complicated configuration of tumour vasculature math-
ematically, each vessel within tumour vascular network is assumed to have cir-
cular cross section. As the length scale in the transverse direction of a tumour
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vessel is usually much smaller than that in the longitudinal direction, the po-
sition and shape of a tumour vessel can be defined through the vessel centre
line. One mathematical method to express the three-dimensional centre line
of a tumour vessel is to use the parametric equation, for example
l : {x(s), y(s), z(s)}, (4.1.1)
in which s is the parameter. For line l, the arc length starting from some
reference point lo {x(so), y(so), z(so)} is
∫
lo
dl =
∫
so
√
[x′]2 + [y′]2 + [z′]2 ds, (4.1.2)
in which
x′ =
dx(s)
ds
, y′ =
dy(s)
ds
, z′ =
dz(s)
ds
. (4.1.3)
Considering a certain differential function f defined based on space line
l(s), we have the following relationships:
df(l)
dl
= Hb(s)
df(s)
ds
, (4.1.4)
and
d2f(l)
dl2
= Hb(s)Hb(s)
d2f(s)
ds2
+Hb(s)Hc(s)
df(s)
ds
. (4.1.5)
In the above two equations,
Hb(s) =
1√
[x′]2 + [y′]2 + [z′]2
, (4.1.6)
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and
Hc(s) =
dHb
ds
= − x
′x′′ + y′y′′ + z′z′′{
[x′]2 + [y′]2 + [z′]2
} 3
2
, (4.1.7)
where x′, y′, z′ are defined in Eq.(4.1.3), and
x′′ =
dx′
ds
, y′′ =
dy′
ds
, z′′ =
dz′
ds
. (4.1.8)
The introduction of Eqs.(4.1.1) to (4.1.8) is essential when tumour vessels
are not straight. They will significantly affect the development of the gov-
erning equations and solution procedure described below and in the following
chapters.
4.2 Flow through tumour vasculature
The blood flow through vascular system is determined by the resulting actions
of heart pulsating pumping together with vascular resistances. Whether the
unsteady forces (pumping effects) are needed to be considered is determined by
a non-dimensional parameter — the Womersley parameter [Ku (1997)]. This
parameter, which represents the ratio of the unsteady forces over the viscous
forces applied on the blood motion, is defined as
Nw = a
√
ωρ
µ
, (4.2.1)
where ρ is the blood density, µ is the dynamic viscosity of blood, and ω is
the frequency of heart pumping [Womersley (1955)]. When Nw is low, the
viscous forces dominate the blood flow through a vessel, and the velocity value
in that vessel is in direct proportion to pressure gradient along its centre line
[Nichols and O’Rourke (2005), Womersley (1955)]. On the other hand, if the
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Womersley parameter is larger than 10, the unsteady forces have to be involved.
For the blood flow through a tumour vessel, whose diameter is between 10µm
to 200µm under usual physical and physiological conditions in a solid tumour
[Less et al. (1991)], the value of the Womersley parameter is quite small (less
than 10) [Schmid-Scho¨nbein (1999)]. Consequently, the pumping effects on
the blood motion through tumour vasculature can be ignored. When blood is
taken as incompressible Newtonian fluid, the vector form of continuity equation
for the flow through a tumour vessel is
divU = 0, (4.2.2)
and the momentum equation is
(U · ∇)U = −1
ρ
∇p+ µ
ρ
∇2U, (4.2.3)
in which p is the flow pressure in the vessel, and U is the vascular flow veloc-
ity. The above two equations are independent on reference frames, but would
have different scalar forms when different coordinate systems are chosen. For
example, in Cartesian coordinate system o− xyz, Eqs.(4.2.2) and (4.2.3) can
be expanded in the scalar forms of
∂Ux
∂x
+
∂Uy
∂y
+
∂Uz
∂z
= 0, (4.2.4)
and

Ux
∂Ux
∂x
+ Uy
∂Ux
∂y
+ Uz
∂Ux
∂z
= −1
ρ
∂p
∂x
+
µ
ρ
(
∂2Ux
∂x2
+
∂2Ux
∂y2
+
∂2Ux
∂z2
)
,
Ux
∂Uy
∂x
+ Uy
∂Uy
∂y
+ Uz
∂Uy
∂z
= −1
ρ
∂p
∂y
+
µ
ρ
(
∂2Uy
∂x2
+
∂2Uy
∂y2
+
∂2Uy
∂z2
)
,
Ux
∂Uz
∂x
+ Uy
∂Uz
∂y
+ Uz
∂Uz
∂z
= −1
ρ
∂p
∂z
+
µ
ρ
(
∂2Uz
∂x2
+
∂2Uz
∂y2
+
∂2Uz
∂z2
)
,
(4.2.5)
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respectively, where Ux, Uy, and Uz are the components of U in system o−xyz.
In many circumstances, in order to study the flow features conveniently, it
is necessary for us to choose some orthogonal curvilinear coordinate (q1, q2, q3)
other than the regular Cartesian coordinate system (x, y, z). To convert the
continuity and momentum equations from Cartesian coordinate system o −
xyz to orthogonal curvilinear coordinate system (q1, q2, q3), we assume that
coordinates x, y and z are related to quantities q1, q2 and q3, as
x = x(q1, q2, q3), y = y(q1, q2, q3), z = z(q1, q2, q3), (4.2.6)
and the direct transformation functions in Eq.(4.2.6) are smooth functions. As
a result, Jacobian determinant
∂(q1, q2, q3)
∂(x, y, z)
=
∣∣∣∣∣∣∣∣∣∣∣∣
∂q1
∂x
∂q2
∂x
∂q3
∂x
∂q1
∂y
∂q2
∂y
∂q3
∂y
∂q1
∂z
∂q2
∂z
∂q3
∂z
∣∣∣∣∣∣∣∣∣∣∣∣
6= 0. (4.2.7)
This means that the transformation in Eq.(4.2.6) is invertible according to the
inverse function theorem, which gives
q1 = q1(x, y, z), q2 = q2(x, y, z), q3 = q3(x, y, z). (4.2.8)
The condition that the Jacobian determinant is not zero reflects the fact that
three surfaces from two different families of coordinate systems intersect in one
and only one point, and thus determine the position of this point in a unique
way [McConnell (1957)].
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Then, three coefficients are defined as


J1 =
√
(∂x/∂q1)
2 + (∂y/∂q1)
2 + (∂z/∂q1)
2,
J2 =
√
(∂x/∂q2)
2 + (∂y/∂q2)
2 + (∂z/∂q2)
2,
J3 =
√
(∂x/∂q3)
2 + (∂y/∂q3)
2 + (∂z/∂q3)
2.
(4.2.9)
Based on the theory of curvilinear coordinates derived by Lame´ [Wu (2004)],
for pressure p in system (q1, q2, q3), we have
∇p = 1J1
∂p
∂q1
e1 +
1
J2
∂p
∂q2
e2 +
1
J3
∂p
∂q3
e3, (4.2.10)
where e1, e2 and e3 stand for the unit vector of axes q1, q2 and q3 respectively.
For velocity vector U in system (q1, q2, q3), we get
divU =
1
J1J2J3
[
∂(U1J2J3)
∂q1
+
∂(U2J3J1)
∂q2
+
∂(U3J1J2)
∂q3
]
, (4.2.11)
(U·∇)U
= e1
[
U1
J1
∂U1
∂q1
+
U2
J2
∂U1
∂q2
+
U3
J3
∂U1
∂q3
+
U2
J1J2
(
U1
∂J1
∂q2
− U2∂J2
∂q1
)
+
U3
J1J3
(
U1
∂J1
∂q3
− U3∂J3
∂q1
)]
+e2
[
U1
J1
∂U2
∂q1
+
U2
J2
∂U2
∂q2
+
U3
J3
∂U2
∂q3
+
U3
J2J3
(
U2
∂J2
∂q3
− U3∂J3
∂q2
)
+
U1
J1J2
(
U2
∂J2
∂q1
− U1∂J1
∂q2
)]
+e3
[
U1
J1
∂U3
∂q1
+
U2
J2
∂U3
∂q2
+
U3
J3
∂U3
∂q3
+
U1
J1J3
(
U3
∂J3
∂q1
− U1∂J1
∂q3
)
+
U2
J2J3
(
U3
∂J3
∂q2
− U2∂J2
∂q3
)]
, (4.2.12)
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and
∇2U
= e1
{
1
J1
∂
∂q1
{
1
J1J2J3
[
∂(J2J3U1)
∂q1
+
∂(J3J1U2)
∂q2
+
∂(J1J2U3)
∂q3
]}
− 1J2J3
∂
∂q2
{ J3
J1J2
[
∂(J2U2)
∂q1
− ∂(J1U1)
∂q2
]}
+
1
J2J3
∂
∂q3
{ J2
J3J1
[
∂(J1U1)
∂q3
− ∂(J3U3)
∂q1
]}}
+e2
{
1
J2
∂
∂q2
{
1
J1J2J3
[
∂(J2J3U1)
∂q1
+
∂(J3J1U2)
∂q2
+
∂(J1J2U3)
∂q3
]}
− 1J3J1
∂
∂q3
{ J1
J2J3
[
∂(J3U3)
∂q2
− ∂(J2U2)
∂q3
]}
+
1
J3J1
∂
∂q1
{ J3
J1J2
[
∂(J2U2)
∂q1
− ∂(J1U1)
∂q2
]}}
+e3
{
1
J3
∂
∂q3
{
1
J1J2J3
[
∂(J2J3U1)
∂q1
+
∂(J3J1U2)
∂q2
+
∂(J1J2U3)
∂q3
]}
− 1J1J2
∂
∂q1
{ J2
J3J1
[
∂(J1U1)
∂q3
− ∂(J3U3)
∂q1
]}
+
1
J1J2
∂
∂q2
{ J1
J2J3
[
∂(J3U3)
∂q2
− ∂(J2U2)
∂q3
]}}
. (4.2.13)
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Since divU = 0, Eq.(4.2.13) is reduced to
∇2U
= e1
{
− 1J2J3
∂
∂q2
{ J3
J1J2
[
∂(J2U2)
∂q1
− ∂(J1U1)
∂q2
]}
+
1
J2J3
∂
∂q3
{ J2
J3J1
[
∂(J1U1)
∂q3
− ∂(J3U3)
∂q1
]}}
+e2
{
− 1J3J1
∂
∂q3
{ J1
J2J3
[
∂(J3U3)
∂q2
− ∂(J2U2)
∂q3
]}
+
1
J3J1
∂
∂q1
{ J3
J1J2
[
∂(J2U2)
∂q1
− ∂(J1U1)
∂q2
]}}
+e3
{
− 1J1J2
∂
∂q1
{ J2
J3J1
[
∂(J1U1)
∂q3
− ∂(J3U3)
∂q1
]}
+
1
J1J2
∂
∂q2
{ J1
J2J3
[
∂(J3U3)
∂q2
− ∂(J2U2)
∂q3
]}}
. (4.2.14)
In Eqs.(4.2.11) to (4.2.14), U1, U2 and U3 stand for the components of velocity
U in reference frame (q1, q2, q3). Substituting Eq.(4.2.11) into Eq.(4.2.2), and
Eqs.(4.2.10), (4.2.12) and (4.2.14) into Eq.(4.2.3), we obtain the flow conti-
nuity and momentum equations in orthogonal curvilinear coordinate system
(q1, q2, q3) successfully.
As the vascular cross section is assumed to be circular, for the blood flow
through a tumour vessel, the Reynolds number is defined as
Re =
ρaU0
µ
, (4.2.15)
where U0 is the peak velocity through vascular cross section. Under usual
physical and physiological conditions in a solid tumour, the Reynolds number
for the vascular flow is low [Sevick and Jain (1989a,b)]. Meanwhile, noticing
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that the Womersley parameter is small [Schmid-Scho¨nbein (1999)], and con-
sidering that the length scale in the transverse direction of a tumour vessel is
much smaller than that in the longitudinal direction, one can conclude that
the flow through a tumour vessel is laminar, and dominated by the pressure
gradient along the vessel centre line.
To investigate the blood flow characters along the vessel centre line, we
define a local cylindrical coordinate system (s, r, θ) on the cross section located
at l, where l is the length measured along the vessel centre line from some given
reference point l0, as illustrated in Fig.4.2. In system (s, r, θ), unit axis vector
es is along the tangential direction of the vessel centre line at l, unit axis
vector er is along any radial direction on the cross section plane, and unit
axis vector eθ is perpendicular to er on the cross section plane. Meanwhile,
in order to get the relationship between the local coordinate system (s, r, θ)
and the global Cartesian coordinate system o − xyz, we set up another local
Cartesian coordinate system o˜ − x˜y˜z˜ on the same cross section. For system
o˜− x˜y˜z˜, origin o˜ is located at centre point C of the cross section corresponding
to l, unit axis vector i˜ is identical to es, unit axis vector j˜ is along one given
radial direction on the cross section plane, and unit axis vector k˜ = i˜ × j˜ is
along another radial direction on the cross section plane. Therefore, in local
coordinate systems o˜− x˜y˜z˜ and (s, r, θ), for some point P on the cross section
plane at l, we have
x
P
(x˜, y˜, z˜) = x
P
(0, r cos θ, r sin θ) (4.2.16)
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Figure 4.2: Sketch of a vessel with some curvature.
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Supposing that the vessel centre line is defined by the parametric equation
in Eq.(4.1.1), we have
es = i˜ =
x′√
(x′)2 + (y′)2 + (z′)2
i
+
y′√
(y′)2 + (y′)2 + (z′)2
j
+
z′√
(x′)2 + (y′)2 + (z′)2
k, (4.2.17)
where x′, y′ and z′ are defined in Eq.(4.1.3). Since j˜ is the unit vector along a
given radius direction on the cross section plane corresponding to l, i˜ · j˜ = 0.
Therefore, it is easy for us to choose
j˜ =
y′ + z′√
(y′ + z′)2 + 2(x′)2
i
− x
′√
(y′ + z′)2 + 2(x′)2
j
− x
′√
(y′ + z′)2 + 2(x′)2
k, (4.2.18)
As k˜ = i˜× j˜, we have
k˜ =
x′z′ − x′y′√
(x′)2(z′ − y′)2 + [(x′)2 + z′(y′ + z′)]2 + [(x′)2 + y′(y′ + z′)]2 i
+
(x′)2 + z′(y′ + z′)√
(x′)2(z′ − y′)2 + [(x′)2 + z′(y′ + z′)]2 + [(x′)2 + y′(y′ + z′)]2 j
− (x
′)2 + y′(y′ + z′)√
(x′)2(z′ − y′)2 + [(x′)2 + z′(y′ + z′)]2 + [(x′)2 + y′(y′ + z′)]2k,
(4.2.19)
According to the forms of Eqs.(4.2.17) to (4.2.19), it is convenient for us to
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write
i˜ = ll1i+mm1j+ nn1k; j˜ = ll2i+mm2j + nn2k; k˜ = ll3i+mm3j+ nn3k.
(4.2.20)
In the above equation, ll1, mm1, nn1, ll2, mm2, nn2, ll3, mm3 and nn3 are the
corresponding terms in Eqs.(4.2.17) to (4.2.19).
For a point P (x˜
P
, y˜
P
, z˜
P
) in system o˜− x˜y˜z˜, according to the relationships
of transformation and rotation between two different families of coordinate
systems, its coordinates in system o− xyz are


x
P
= x(s) + ll1 · x˜P + ll2 · y˜P + ll3 · z˜P ,
y
P
= y(s) +mm1 · x˜P +mm2 · y˜P +mm3 · z˜P ,
z
P
= z(s) + nn1 · x˜P + nn2 · y˜P + nn3 · z˜P .
(4.2.21)
Introducing Eq.(4.2.16) into Eq.(4.2.21), we have


x
P
=x(s) +
(y′ + z′)r cos θ√
(y′ + z′)2 + 2(x′)2
+
(x′z′ − x′y′)r sin θ√
(x′)2(z′ − y′)2 + [(x′)2 + z′(y′ + z′)]2 + [(x′)2 + y′(y′ + z′)]2 ,
y
P
=y(s)− x
′r cos θ√
(y′ + z′)2 + 2(x′)2
+
[(x′)2 + z′(y′ + z′)]r sin θ√
(x′)2(z′ − y′)2 + [(x′)2 + z′(y′ + z′)]2 + [(x′)2 + y′(y′ + z′)]2 ,
z
P
=z(s)− x
′r cos θ√
(y′ + z′)2 + 2(x′)2
− [(x
′)2 + y′(y′ + z′)]r sin θ√
(x′)2(z′ − y′)2 + [(x′)2 + z′(y′ + z′)]2 + [(x′)2 + y′(y′ + z′)]2 .
(4.2.22)
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Substituting Eq.(4.2.22) into Eq.(4.2.9), we obtain


Jr = J1 = 1,
Jθ = J2 = r,
Js = J3 =
√(
∂xp
∂s
)2
+
(
∂yp
∂s
)2
+
(
∂zp
∂s
)2
.
(4.2.23)
Introducing Eq.(4.2.23) into Eqs.(4.2.10), (4.2.11), (4.2.12) and (4.2.14), and
rearranging the results according to Eqs.(4.2.2) and (4.2.3), we obtain, for the
blood flow through a three-dimensional curved tumour vessel, the continuity
equation as
∂Ur
∂r
+
1
r
Ur +
Ur
Js
∂Js
∂r
+
1
r
∂Uθ
∂θ
+
Uθ
rJs
∂Js
∂θ
+
1
Js
∂Us
∂s
= 0, (4.2.24)
and the momentum equations as
er:
Ur
∂Ur
∂r
+
Uθ
r
∂Ur
∂θ
+
Us
Js
∂Ur
∂s
− U
2
θ
r
− U
2
s
Js
∂Js
∂r
=− 1
ρ
∂pc
∂r
− µ
ρ
[
1
rJs
∂
∂θ
(JsUθ
r
+ Js∂Uθ
∂r
− Js
r
∂Ur
∂θ
)
− 1Js
∂
∂s
(
1
Js
∂Ur
∂s
− ∂Us
∂r
− UsJs
∂Js
∂r
)]
; (4.2.25)
eθ:
Ur
∂Uθ
∂r
+
Uθ
r
∂Uθ
∂θ
+
Us
Js
∂Uθ
∂s
− U
2
s
Js
∂Js
∂θ
+
UrUθ
r
=− 1
rρ
∂pc
∂θ
− µ
ρJs
[
∂
∂s
(
Us
rJs
∂Js
∂θ
+
1
r
∂Us
∂θ
− 1Js
∂Uθ
∂s
)
− ∂
∂r
(
UθJs
r
+ Js∂Uθ
∂r
− Js
r
∂Ur
∂θ
)]
; (4.2.26)
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and
es:
Ur
∂Us
∂r
+
Uθ
r
∂Us
∂θ
+
Us
Js
∂Us
∂s
+
UrUs
Js
∂Js
∂r
+
UθUs
rJs
∂Js
∂θ
=− 1
ρJs
∂pc
∂s
− µ
ρr
[
∂
∂r
(
r
Js
∂Ur
∂s
− r∂Us
∂r
− rUsJs
∂Js
∂r
)
− ∂
∂θ
(
1
r
∂Us
∂θ
+
Us
rJs
∂Js
∂θ
− 1Js
∂Uθ
∂s
)]
. (4.2.27)
Since the above Eqs.(4.2.24) to (4.2.27) are derived in system (s, r, θ), J1, J2,
J3, U1, U2 and U3 are replaced with Jr, Jθ, Js, Ur, Uθ and Us respectively.
Applying mathematical analysis on Eqs.(4.2.24) to (4.2.27) directly would
be highly complex, but they can be simplified according to the explicit expres-
sion of the parametric equation for the vessel centre line and the assumptions
of the microcirculation based on the physiological and physical characters of
tumour blood flow, which will be presented in detail in the following chapters.
4.3 Flow in tumour interstitium
4.3.1 Flow in tumour space
Tumour interstitial space is composed of cancer cells and tumour extracellu-
lar matrix. From flow dynamics point of view, tumour interstitium can be
regarded as porous media. In the meantime, though lymphatic vessels can be
detected in tumour interior [Guillino (1975), Jain and Fenton (2002)], the lym-
phatic effects are excluded in our model, since lymphatic vessels in tumour are
impaired and/or not functional [Helmlinger et al. (1997), Leu et al. (2000)] due
to the over proliferation of cancer cells and tumour interstitial hypertension
[Jain (1994)]. As a result, the blood flow within tumour interstitium can be
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described by the Darcy’s law, which indicates that the fluid velocity in tumour
interstitium is proportional to the gradient of interstitial pressure, as
u = −κ∇pi, (4.3.1)
where u is the flow velocity in tumour interstitium, κ is the hydraulic conduc-
tivity of tumour interstitium, and pi is the interstitial blood pressure. Substi-
tuting Eq.(4.3.1) into flow continuity equation
divu = 0, (4.3.2)
and assuming that κ is constant in tumour interstitium, we find that tumour
interstitial pressure satisfies the Laplace equation, or
∇2pi(x) = 0. (4.3.3)
4.3.2 Extravascular flux through vessel walls
Through observing the flow absorbed from the connective tissues by blood ves-
sels, Starling (1896) concluded that the exchange of fluid and large molecules
between tissues and vessels is determined primarily by the difference of hydro-
static pressure in association with oncotic pressure. Named as the Starling’s
law, this conclusion can be written in the mathematical form of
qe(l) = Lp(l)[pc(l)− pi(l)− σ(πv(l)− πi(l))], (4.3.4)
where qe(l) is the transmission flux over the unit length along the circumference
of the vessel cross section at l, Lp(l) is the vessel permeability, pc(l) is the
blood pressure inside vessel, pi(l) is the interstitial pressure evaluated on the
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exterior vascular surface, πv(l) and πi(l) are the oncotic pressures in vessel
fluid and tumour interstitial fluid respectively, and σ is the oncotic reflection
coefficient. σ is used to correct the magnitude of the measured gradient for
the ineffectiveness of the oncotic pressure gradient, whose value varies from 0
up to 1 [Curry (1984)].
Landis (1927) emphasised that increased vascular permeability would re-
duce the effects of colloid osmotic pressure. Considering the high permeability
of tumour vessels, Jain and co-workers proposed a hypothesis that the oncotic
pressures in tumour vessels and interstitium are similar [Boucher and Jain
(1992), Jain (1987a,b)]. Stohrer et al. (2000) confirmed the above hypothesis
through directly measuring the oncotic pressures in solid tumours. As a result,
Eq.(4.3.4) is reduced to
qe(l) = Lp(l)[pc(l)− pi(l)]. (4.3.5)
Eq.(4.3.5) has assumed that both pc and pi are the functions of locations
along vessel centre line. According to the foregoing analysis in Section 4.2,
the flow through a tumour vessel is mainly dominated by pressure gradient
along the vessel centre line, then pc can be regarded as a function of vessel
centre line, and it does not vary in the radial direction measured by r or
in the circumferential direction by θ. Interstitial pressure pi on the external
vascular surface, on the other hand, does vary along θ since the direction
of interstitial flow is unconstrained. There is therefore a mismatch for the
pressures in Eq.(4.3.5). To avoid that, pi is expanded into a Fourier series in
the circumferential direction of vessel cross section, as
pi(l, θ) = pi0(l) +
+∞∑
n=1
pain(l) cosnθ +
+∞∑
n=1
pbin(l) sin nθ, (4.3.6)
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in which pi0 is the mean value of pi along the circumferential direction of vessel
cross section, or
pi0(l) =
1
2π
∫ 2π
0
pi(l, θ)dθ. (4.3.7)
As tumour vessel radius is much smaller relative to the size of tumour, it can be
regarded that the interstitial pressure on the exterior vascular surface is nearly
independent on the angular position around vessel cross section, or mean value
pi0 is the main component of pi. Consequently, pi0 is the target of our solution.
To make it concise, pi0 will be written as pi in the following equations.
Based on mass conservation, the flux transported into tumour interior
from each section of a tumour vessel must be equal to the gradient of flux
Qc(l) flowing along the longitudinal direction of the vessel, or
d[Qc(l)]
dl
+ 2πa(l)qe(l) = 0, (4.3.8)
in which the assumption of circular vessel cross section has been applied. Sub-
stituting Eq.(4.3.5) into Eq.(4.3.8), and considering that the vessel centre line
is defined by parametric equation l : {x(s), y(s), z(s)}, we obtain a differen-
tial governing equation for the coupling effect between the flow flux through a
tumour vessel and the exceeded flux from its surface into tumour interstitium
as
Hb(s)
d[Qc(s)]
ds
+ 2πa(s)Lp(s) [pc(s)− pi(s)] = 0, (4.3.9)
in which the relationship in Eq.(4.1.4) is applied, and Hb(s) is defined in
Eq.(4.1.6).
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4.3.3 Boundary-integral representative of the governing
equation for the flow in tumour interstitium
Let us consider a study case for tumour blood flow, in which a single permeable
vessel is embedded in a solid tumour whose surface is far away from the blood
vessel. The boundary condition requires interstitial pressure pi to be equal to
peripheral pressure p0 at the tumour surface, or
pi(x) = p0 at x→∞. (4.3.10)
Following the procedure described in Section 3.3, the Laplace equation in
Eq.(4.3.3) is converted into a boundary-integral equation. This gives an ex-
pression for the interstitial pressure at point x0 according to the values of the
pressure and its normal derivative on boundary S(x) of a certain calculation
domain Vc, which is
pi(x0)− p0 =−
∫
S
G(x,x0) [n(x) · ∇pi(x)] dS(x)
+
∫
S
[pi(x)− p0] [∇G(x,x0) · n(x)] dS(x), (4.3.11)
where n(x) is the unit normal vector of S(x) pointing out of Vc, and G(x,x0)
is the Green’s function which is defined in Eq.(3.3.11).
In the case that the tumour is virtually infinitely large, S refers to vascular
surface Sv only as the contribution for infinity in Eq.(4.3.11) is zero. When x0
is on the surface of the vessel which is assumed to be smooth, we have
1
2
[pi(x0)− p0] =−
∫
Sv
G(x,x0) [n(x) · ∇pi(x)] dS(x)
+
∫
Sv
[pi(x)− p0] [∇G(x,x0) · n(x)] dS(x). (4.3.12)
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According to flow continuity, combining the Darcy’s law and the Starling’s
law on the vessel surface, and considering that the vessel centre line is defined
by l : {x(s), y(s), z(s)}, we have
n(x) · ∇pi(x) = Lp(l)
κ
[pc(l)− pi(l)] = Lp(s)
κ
[pc(s)− pi(s)] , (4.3.13)
where n(x) is the unit vector normal to the vessel surface pointing out of
tumour interstitium. As vascular cross section is assumed to be circular, and
noticing the relationship described in Eq.(4.1.4), we have
dS(x) =
∫ 2π
0
a(l)dldθ =
∫ 2π
0
a(s)
Hb(s)
dsdθ, (4.3.14)
in which Hb(s) is defined in Eq.(4.1.6). Introducing Eqs.(4.3.13) and (4.3.14)
into Eq.(4.3.12), integrating the result at point x0 over 0 ≤ θ0 ≤ 2π, and then
dividing 2π on both sides of the equation, we obtain
1
2
[pi(x0)− p0]
=− 1
2π
∫
lv(s)
∫ 2π
0
∫ 2π
0
a(s)
Hb(s)
Lp(s)
κ
[pc(s)− pi(s)]G(x,x0)dθ0dθds
+
1
2π
∫
lv(s)
∫ 2π
0
∫ 2π
0
a(s)
Hb(s)
[pi(s)− p0]∇G(x,x0)n(x)dθ0dθds, (4.3.15)
where lv(s) donates the length of the vessel.
Eq.(4.3.15) is now a one-dimensional integral equation, which can be
solved numerically together with Eq.(4.3.9). After the solution for pc(s) and
pi(s) along the vessel is found, the pressure distribution in tumour can be ob-
tained. In fact, this can be achieved by introducing the coordinates of a point
inside tumour space into Eq.(4.3.12), after Eqs.(4.3.13) and (4.3.14) have been
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Figure 4.3: Discretisation of a vessel into cylindrical elements along its centre
line.
substituted into it and 1/2 on its left-hand side has been deleted, which is
pi =p0 − 1
2π
∫
lv(s)
∫ 2π
0
a(s)
Hb(s)
Lp(s)
κ
[pc(s)− pi(s)]G(x,x0)dθds
+
1
2π
∫
lv(s)
∫ 2π
0
a(s)
Hb(s)
[pi(s)− p0]∇G(x,x0)n(x)dθds. (4.3.16)
4.3.4 Numerical procedure on solving Eq.(4.3.15)
In order to solve Eq.(4.3.15) numerically, the vessel is divided into NE cylin-
drical elements along its centre line, as presented in Fig.4.3. The segments
can be distributed in nonuniform schemes. Within each element, the vessel
permeability, the pressures in vessel, and the interstitial pressures on the exte-
rior vascular surface are approximated to be constant, expressed by L
[j]
p , p
[j]
c ,
and p
[j]
i respectively. The continuity condition is then imposed at the middle
of every element. For the nth segment, where n = 1, · · · , NE, Eq.(4.3.15) is
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discretised as
1
2
(
p
[n]
i − p0
)
= −
NE∑
j=1
L
[j]
p
κ
(
p[j]c − p[j]i
)
A¯[j]n +
NE∑
j=1
(
p
[j]
i − p0
)
B¯[j]n , (4.3.17)
where
A¯[j]n =
1
2π
∫ 2π
0
A[j]n dθ0, (4.3.18)
and
B¯[j]n =
1
2π
∫ 2π
0
B[j]n dθ0, (4.3.19)
in which
A[j]n =
∫ δsj
2
−
δsj
2
aj
H
[j]
b
ds
∫ 2π
0
G(x,x0)dθ, (4.3.20)
and
B[j]n =
∫ δsj
2
−
δsj
2
aj
H
[j]
b
ds
∫ 2π
0
[∇G(x,x0) · n(x)] dθ. (4.3.21)
In the above two equations, δsj donates the longitudinal length of the jth
segment. Rearranging terms in Eq.(4.3.17), we get
NE∑
j=1
{
δnj − 2B¯[j]n −
2L
[j]
p
κ
A¯[j]n
}
p
[j]
i
=−
NE∑
j=1
2L
[j]
p
κ
A¯[j]n p
[j]
c + p0
{
1−
NE∑
j=1
2B¯[j]n
}
, (4.3.22)
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where δnj is Kronecker’s delta function which is defined as
δnj =

 1 n = j,0 n 6= j. (4.3.23)
The major issue to construct the computing matrix in Eq.(4.3.22) is to
obtain the values of influence coefficients A¯
[j]
n and B¯
[j]
n which are defined in
Eqs.(4.3.18) and (4.3.19) respectively. The key feature to obtain A¯
[j]
n and B¯
[j]
n
is to calculate A
[j]
n and B
[j]
n in Eqs.(4.3.20) and (4.3.21) respectively. In order
to calculate A
[j]
n and B
[j]
n , the integral representative of the Green’s function
derived in Section 3.4 is applied. This allows us to calculate the integrals with
respect to θ analytically. As a result, the Green’s function will be written
through the complete elliptical integrals of first and second kind, which can
be calculated for each pair of given x and x0 according to the polynomial
schemes in Abramowitz and Stegun (1972) efficiently. Once A
[j]
n and B
[j]
n are
obtained, the integrals with respect to θ0 in A¯
[j]
n and B¯
[j]
n can be calculated
through numerical methods, e.g. the Simpson’s method.
According to the definitions in Eqs.(4.3.20) and (4.3.20), A
[j]
n and B
[j]
n are
determined by the values of the Green’s function and its derivative along the
normal direction of tumour vascular surface. As stated in Section 3.3, the
Green’s function is
G(x,x0) = − 1
4π
√
(x− x0)2 + (y − y0)2 + (z − z0)2
. (4.3.24)
It is worth to be noticed that the Green’s function in the above equation
depends only on the distance between field point x and source point x0, which
indicates that its value is independent on the reference coordinate frames. As
a result, we are free to choose any convenient coordinate system to calculate
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Figure 4.4: Sketch of a vessel inside tumour interstitium.
the values of the Green’s function and its derivative. Two local reference
coordinate frames are set up at the jth segment corresponding to point x, as
sketched in Fig.4.4. One local reference frame is a Cartesian coordinate system
o¯ − x¯y¯z¯, which has the same definition as system o˜ − x˜y˜z˜ defined in Section
4.2. The other local reference frame is a cylinder coordinate system (x¯, R, α)
similar to system (s, r, θ), in which ex¯ is identical to i¯, eR is along any radial
direction on the cross section plane, and eα = ex¯ × eR.
In coordinate systems o¯−x¯y¯z¯ and (x¯, R, α), we have the following relation-
ship for a point xw on the vascular surface at the jth segment corresponding
to point x, which is
xw(x¯, y¯, z¯) = xw(0, aj cosα, aj sinα), (4.3.25)
where aj is the radius of the vessel cross section at the jth segment. Similarly,
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for a point xw0 on the vascular surface of the nth segment corresponding to
point x0, we have
xw0 (x¯0, y¯0, z¯0) = x
w
0
(
x¯[j]n , R
[j]
n cosα0, R
[j]
n sinα0
)
. (4.3.26)
According to the foregoing outcome obtained in Section 3.4, the integral
expression of the Green’s function is
G(x,x0) = − 1
8π2
∫ +∞
0
∫ 2π
0
e−kρ|x−x0|eikρ[cos θ(y−y0)+sin θ(z−z0)]dkρdθ. (4.3.27)
Introducing Eqs.(4.3.25) and (4.3.26) into Eq.(4.3.27), we get
G(xw,xw0 ) = −
1
8π2
∫ +∞
0
∫ 2π
0
e
−kρ
∣
∣
∣x¯
[j]
n
∣
∣
∣
eikρ[aj cos(θ−α)−R
[j]
n cos(θ−α0)]dkρdθ. (4.3.28)
Based on the definition of complex function, it follows
eikρ[aj cos(θ−α)−R
[j]
n cos(θ−α0)]
=
{
cos[kρaj cos(θ − α)] + i sin[kρaj cos(θ − α)]
}
× {cos[kρR[j]n cos(θ − α0)]− i sin[kρR[j]n cos(θ − α0)]}. (4.3.29)
According to the expansions in Abramowitz and Stegun (1972), the terms on
the right-hand side of Eq.(4.3.29) can be further expanded to
cos[kρaj cos(θ − α)] + i sin[kρaj cos(θ − α)]
=J0 (kρaj) + 2
∞∑
m=1
(−1)mJ2m (kρaj) cos[2m(θ − α)]
+ i2
∞∑
m=0
(−1)mJ2m+1 (kρaj) cos[(2m+ 1)(θ − α)], (4.3.30)
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and
cos[kρR
[j]
n cos(θ − α0)]− i sin[kρR[j]n cos(θ − α0)]
=J0
(
kρR
[j]
n
)
+ 2
∞∑
m=1
(−1)mJ2m
(
kρR
[j]
n
)
cos[2m(θ − α0)]
− i2
∞∑
m=0
(−1)mJ2m+1
(
kρR
[j]
n
)
cos[(2m+ 1)(θ − α0)], (4.3.31)
respectively, in which Jk (k = 0, 1, 2, · · · ) are the Bessel functions. Substituting
Eqs.(4.3.30) and (4.3.31) into Eq.(4.3.29), we then introduce the result into
Eq.(4.3.28). Due to the orthogonality of trigonometric function, when the
integral with respect to variable θ is considered, Eq.(4.3.28) is reduced to
G(xw,xw0 ) = −
1
4π
∫ +∞
0
e
−kρ
∣
∣
∣x¯
[j]
n
∣
∣
∣
{
2
∞∑
m=1
J2m (kρaj)J2m
(
kρR
[j]
n
)
cos[2m(α− α0)]
+ 2
∞∑
m=0
J2m+1 (kρaj) J2m+1
(
kρR
[j]
n
)
cos[(2m+ 1)(α− α0)]
+ J0 (kρaj)J0
(
kρR
[j]
n
)}
dkρ. (4.3.32)
After substituting Eq.(4.3.32) into Eqs.(4.3.20) and (4.3.21), we follow the
steps mentioned in the beginning of this section. Eqs.(4.3.20) and (4.3.21) can
be calculated by performing the integrals with respect to the meridional angle
around a cylindrical element first. Considering the orthogonality of trigono-
metric function with respect to variable α, we have
A[j]n = −
1
2
∫ δsj
2
−
δsj
2
aj
H
[j]
b
ds
∫ +∞
0
e
−kρ
∣
∣
∣x¯
[j]
n
∣
∣
∣
J0 (kρaj) J0
(
kρR
[j]
n
)
dkρ, (4.3.33)
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B[j]n = −
1
2
∫ δsj
2
−
δsj
2
aj
H
[j]
b
ds
∫ +∞
0
e
−kρ
∣
∣
∣x¯
[j]
n
∣
∣
∣
kρJ1 (kρaj)J0
(
kρR
[j]
n
)
dkρ, (4.3.34)
in which
∇G · n(x) = − ∂G
∂r
∣∣∣∣
r=aj
,
and
J
′
0 (kρaj) =
d [J0(kρr)]
dr
∣∣∣∣
r=aj
= −kρJ1 (kρaj)
have been used.
It has been showed by Eason et al. (1955) that
∫ +∞
0
e
−kρ
∣
∣
∣x¯
[j]
n
∣
∣
∣
J0 (kρaj) J0
(
kρR
[j]
n
)
dkρ =
√
mˆ
2
√
ajR
[j]
n
F (mˆ), (4.3.35)
and
∫ +∞
0
e
−kρ
∣
∣
∣x¯
[j]
n
∣
∣
∣
kρJ1 (kρaj) J0
(
kρR
[j]
n
)
dkρ
=
√
mˆ
4aj
√
ajR
[j]
n
F (mˆ) +
mˆ3/2
[
(aj)
2 −
(
R
[j]
n
)2
−
(
x¯
[j]
n
)2]
16ajmˆ1
(
ajR
[j]
n
)3/2 E(mˆ), (4.3.36)
where
E(mˆ) =
2
π
∫ π/2
0
(1− mˆ sin2 ξ)1/2dξ, (4.3.37)
F (mˆ) =
2
π
∫ π/2
0
(1− mˆ sin2 ξ)−1/2dξ, (4.3.38)
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Table 4.1: Coefficients within uˆ1(mˆ1), uˆ2(mˆ1), vˆ1(mˆ1) and vˆ2(mˆ1)
k aˆk bˆk cˆk dˆk
0 1.38629436112 0.5 — —
1 0.09666344259 0.12498593597 0.44325141463 0.24998368310
2 0.03590092383 0.06880248576 0.06260601220 0.09200180037
3 0.03742563713 0.03328355346 0.04757383546 0.04069697526
4 0.01451196212 0.00441787012 0.01736506451 0.00526449639
mˆ =
4ajR
[j]
n(
aj +R
[j]
n
)2
+
(
x¯
[j]
n
)2 , (4.3.39)
and
mˆ1 = 1− mˆ =
(
aj − R[j]n
)2
+
(
x¯
[j]
n
)2
(
aj +R
[j]
n
)2
+
(
x¯
[j]
n
)2 . (4.3.40)
F (mˆ) and E(mˆ) are the complete elliptic integrals of the first and second kind
respectively. There are two popular ways to calculate these two integrals. One
method is to adopt the efficient polynomial approximations [Abramowitz and
Stegun (1972)]. The other is to use the recursive formulae, as presented in
Appendix A (also in the book by Pozrikidis (1997)). Abramowitz and Stegun
(1972) provided that
∫ π/2
0
(1− mˆ sin2 ξ)−1/2dξ = uˆ1(mˆ1) + uˆ2(mˆ1) + ǫ(mˆ) |ǫ(mˆ)| ≤ 2× 10−8,
where
uˆ1(mˆ1) = aˆ0 + aˆ1 · mˆ1 + aˆ2 · mˆ21 + aˆ3 · mˆ31 + aˆ4 · mˆ41,
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and
uˆ2(mˆ1) =
(
bˆ0 + bˆ1 · mˆ1 + bˆ2 · mˆ21 + bˆ3 · mˆ31 + bˆ4 · mˆ41
)
· ln
(
1
mˆ1
)
,
in which the values of aˆk and bˆk (k = 0, 1, · · · , 4) are listed in Table4.1. Also,
∫ π/2
0
(1− mˆ sin2 ξ)1/2dξ = vˆ1(mˆ1) + vˆ2(mˆ1) + ǫ(mˆ) |ǫ(mˆ)| ≤ 2× 10−8,
where
vˆ1(mˆ1) = 1 + cˆ1 · mˆ1 + cˆ2 · mˆ21 + cˆ3 · mˆ31 + cˆ4 · mˆ41,
and
vˆ2(mˆ1) =
(
dˆ1 · mˆ1 + dˆ2 · mˆ21 + dˆ3 · mˆ31 + dˆ4 · mˆ41
)
· ln
(
1
mˆ1
)
,
in which the values of cˆk and dˆk (k = 1, 2, 3, 4) are presented in Table4.1. As
a result,
A[j]n = −
∫ δsj
2
−
δsj
2
aj
√
mˆ
2πH
[j]
b
√
ajR
[j]
n
[uˆ1(mˆ1) + uˆ2(mˆ1)] ds, (4.3.41)
and
B[j]n =−
∫ δsj
2
−
δsj
2
√
mˆ
4πH
[j]
b
√
ajR
[j]
n
[uˆ1(mˆ1) + uˆ2(mˆ1)] ds
−
∫
δsj
mˆ3/2
[
(aj)
2 −
(
R
[j]
n
)2
−
(
x¯
[j]
n
)2]
16πH
[j]
b mˆ1
(
ajR
[j]
n
)3/2 [vˆ1(mˆ1) + vˆ2(mˆ1)] ds. (4.3.42)
We, now, proceed to calculate the integrals with respect to the distance
along the element (regarding it as a straight section) axis on the right-hand
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sides of Eqs.(4.3.41) and (4.3.42). There are two kinds of situations for the
integrals. One is that the evaluation point does not lie on the host element, or
j 6= n. In this situation, the integrals in both Eqs.(4.3.41) and (4.3.42) do not
contain any singularity. The integrals on the right-hand sides of Eqs.(4.3.41)
and (4.3.42) can be solved easily and efficiently by Gauss-Legendre Quadrature
[Zwillinger (2003)] as
I
[j]
{A
[j]
n ,B
[j]
n }
∼= δsj
2
n∑
k=1
cˆgk · f{A[j]n ,B[j]n }
(
δsj
2
xˆgk
)
, (4.3.43)
where I
{A
[j]
n ,B
[j]
n }
stands for a certain integral term on the right-hand side of
Eq.(4.3.41) or (4.3.42), f
{A
[j]
n ,B
[j]
n }
represents the integrand of that term, and cˆgk
and xˆgk are the Gauss-Legendre Quadrature parameters whose values are listed
in Table.4.2. When the evaluation point is on the host segment as j = n,
R
[j]
n = aj and x¯
[j]
n = 0 in the middle of the element. This leads to a logarithmic
singularity with term
ln
[(
aj − R[j]n
)2
+
(
x¯[j]n
)2]
in uˆ2(mˆ1). The singularity can be dealt analytically as
∫ δsj
2
−
δsj
2
1
H
[j]
b
ln

( ξ
H
[j]
b
)2 dξ = 2
[
ln
(
δsj
2H
[j]
b
)
− 1
]
δsj
H
[j]
b
. (4.3.44)
Consequently, when n = j, the singularities within A
[j]
n and B
[j]
n should be
calculated according to Eq.(4.3.44) together with integral mean value theorem.
The rest of integral terms in A
[j]
n and B
[j]
n are calculated by Gauss-Legendre
Quadrature. In this way, A
[j]
n and B
[j]
n are found. Using the results, we are
now able to calculate A¯
[j]
n and B¯
[j]
n by numerical integration methods, e.g. the
Simpson’s Rule.
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Table 4.2: Six-point Gauss-Legendre Quadrature
k Roots Coefficients
1 xˆg1 = 0.23861919 cˆ
g
1 = 0.46791393
2 xˆg2 = 0.66120939 cˆ
g
2 = 0.36076157
3 xˆg3 = 0.93246951 cˆ
g
3 = 0.17132449
4 xˆg4 = −0.23861919 cˆg4 = 0.46791393
5 xˆg5 = −0.66120939 cˆg5 = 0.36076157
6 xˆg6 = −0.93246951 cˆg6 = 0.17132449
However, values of
∣∣∣x¯[j]n ∣∣∣ and R[j]n are also needed to be calculated. R[j]n
is the distance of point xw0 to the line which passes through point x in the
direction of ex¯, where ex¯ is the unit vector along the tangential direction of
the vessel centre line at point x, as shown in Fig.4.5.
∣∣∣x¯[j]n ∣∣∣ has the following
relationship with R
[j]
n :
∣∣x¯[j]n ∣∣ =
√
|x− xw0 |2 −
(
R
[j]
n
)2
. (4.3.45)
∣∣∣x¯[j]n ∣∣∣ and R[j]n are independent on the coordinate systems. To calculate
them, two local reference coordinate systems are defined at the nth segment
corresponding to point x0. As depicted in Fig.4.5, one is Cartesian coordinate
system o˜ − x˜y˜z˜ which has the same definition as system o˜ − x˜y˜z˜ defined in
Section 4.2. The other one is cylinder coordinate system (x˜, r0, θ0) which is
similar to system (x¯, R, α). In (x˜, r0, θ0), ex˜ is identical to i˜, er0 is along
any radial direction on the cross section plane corresponding to point x0, and
eθ0 = ex˜ × er0 . On the vessel surface at the nth segment corresponding to
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Figure 4.5: Sketch of a vessel inside tumour interstitium.
point x0, we have
xw0 (x˜
w, y˜w, z˜w) = xw0 (0, a0 cos θ0, a0 sin θ0), (4.3.46)
where a0 is the radius of the vessel cross section at the nth segment. Similar
to the procedure described in Section 4.2, in the original coordinate system
o− xyz, we have
i˜ =
x′0√
(x′0)
2 + (y′0)
2 + (z′0)
2
i+
y′0√
(x′0)
2 + (y′0)
2 + (z′0)
2
j
+
z′0√
(x′0)
2 + (y′0)
2 + (z′0)
2
k, (4.3.47)
j˜ =
y′0 + z
′
0√
(y′0 + z
′
0)
2 + 2(x′0)
2
i− x
′
0√
(y′0 + z
′
0)
2 + 2(x′0)
2
j
− x
′
0√
(y′0 + z
′
0)
2 + 2(x′0)
2
k, (4.3.48)
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and
k˜ =
x′0z
′
0 − x′0y′0√
(x′0)
2(z′0 − y′0)2 + [(x′0)2 + z′0(y′0 + z′0)]2 + [(x′0)2 + y′0(y′0 + z′0)]2
i
+
(x′0)
2 + z′0(y
′
0 + z
′
0)√
(x′0)
2(z′0 − y′0)2 + [(x′0)2 + z′0(y′0 + z′0)]2 + [(x′0)2 + y′0(y′0 + z′0)]2
j
− (x
′
0)
2 + y′0(y
′
0 + z
′
0)√
(x′0)
2(z′0 − y′0)2 + [(x′0)2 + z′0(y′0 + z′0)]2 + [(x′0)2 + y′0(y′0 + z′0)]2
k,
(4.3.49)
in which
x0 = x(s0), y0 = y(s0), z0 = z(s0),
and
x′0 =
dx
ds
∣∣∣∣
s=s0
, y′0 =
dy
ds
∣∣∣∣
s=s0
, z′0 =
dz
ds
∣∣∣∣
s=s0
,
where s0 is position for point x0 along the vessel centre line. According to
Eq.(4.3.46), in Cartesian coordinate system o− xyz, we have


xw0 =x0 +
(y′0 + z
′
0)a0 cos θ0√
(y′0 + z
′
0)
2 + 2(x′0)
2
+
(x′0z
′
0 − x′0y′0)a0 sin θ0√
(x′0)
2(z′0 − y′0)2 + [(x′0)2 + z′0(y′0 + z′0)]2 + [(x′0)2 + y′0(y′0 + z′0)]2
,
yw0 =y0 −
x′0a0 cos θ0√
(y′0 + z
′
0)
2 + 2(x′0)
2
+
[(x′0)
2 + z′0(y
′
0 + z
′
0)]a0 sin θ0√
(x′0)
2(z′0 − y′0)2 + [(x′0)2 + z′0(y′0 + z′0)]2 + [(x′0)2 + y′0(y′0 + z′0)]2
,
zw0 =z0 −
x′0a0 cos θ0√
(y′0 + z
′
0)
2 + 2(x′0)
2
− [(x
′
0)
2 + y′0(y
′
0 + z
′
0)]a0 sin θ0√
(x′0)
2(z′0 − y′0)2 + [(x′0)2 + z′0(y′0 + z′0)]2 + [(x′0)2 + y′0(y′0 + z′0)]2
.
(4.3.50)
Based on the definition of the distance from a point to a line [Bronshtein
97
et al. (2007)], we get
R[j]n =
{ [
(xj − xw0 )y′j − (yj − yw0 )x′j
]2
+
[
(xj − xw0 )z′j − (zj − zw0 )x′j
]2
+
[
(zj − zw0 )y′j − (yj − yw0 )z′j
]2} 12 [
(x′j)
2 + (y′j)
2 + (z′j)
2
]− 1
2 . (4.3.51)
In terms of the definition in Eq.(4.3.45), we have
∣∣x¯[j]n ∣∣ =
∣∣(xj − xw0 )x′j + (yj − yw0 )y′j + (zj − zw0 )z′j∣∣√
(x′j)
2 + (y′j)
2 + (z′j)
2
. (4.3.52)
In Eqs.(4.3.51) and (4.3.52), xj , yj and zj are the coordinates of point x in
system o− xyz, and
x′j =
dx
ds
∣∣∣∣
s=sj
, y′j =
dy
ds
∣∣∣∣
s=sj
, z′j =
dz
ds
∣∣∣∣
s=sj
,
where sj is the position for point x along the vessel centre line. Introduc-
ing Eq.(4.3.50) into Eqs.(4.3.51) and (4.3.52),
∣∣∣x¯[j]n ∣∣∣ and R[j]n are calculated
successfully.
4.4 Summary
In this chapter, the governing equations for tumour blood flow are derived
based on a case when a single permeable vessel is embedded in a solid tu-
mour to some large extent. The vessel centre line is expressed by the para-
metric equation. According to the parameter in that parametric equation, a
one-dimensional differential equation and a one-dimensional integral equation
which include the coupling effect between the flows inside and outside the tu-
mour vessel are obtained, as described in Eqs.(4.3.9) and (4.3.15) respectively.
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Those two equations establish the mathematical basis of our project, which are
discretised and solved by FDM and BEM respectively. The detailed numerical
procedure on solving Eq.(4.3.15) by BEM has been presented in Section 4.3.4,
while for Eq.(4.3.9), the numerical procedure will be discussed in the following
chapters in detail when the explicit expression of the parametric equation for
the vessel centre line is given.
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Chapter 5
Flow through a Single Straight
Permeable Vessel in a Solid
Tumour
In the present and next chapters, we apply the governing equations derived
in the previous chapter to investigate a simple case for tumour blood flow
when tumour vasculature is represented by a single straight permeable vessel
which is embedded in a solid tumour whose surface is far away from the vessel.
The simplicity of this tumour vasculature allows us to examine the rationality
of our model and the efficiency of the numerical procedure (in the present
chapter), and study in detail how different types of physical parameters affect
tumour blood flow (in Chapter 6), including the inlet and outlet vascular flow
conditions, vessel permeability, tumour hydraulic conductivity, and tumour
peripheral pressure.
Though using a single straight vessel to represent the entire tumour vas-
culature may be an idealised model, it provides us a good platform to study
the effects of various physical parameters on the distributions of the blood
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pressures inside and outside the vessel and the flux exceeded from vessel into
tumour interstitium. The results obtained here have useful and important im-
plications on medical applications. As stated in Section 2.3, convective effect
is our major concern in this study, because it is the leading mechanism for the
delivery of the therapeutic anti-cancer agents with heavy weight and large size
from tumour vessels into interstitium to kill cancer cells. Netti et al. (1999)
described the transvascular delivery of molecules by convection as
Js = LpAs[(pc − pi)− σ(πv − πi)](1− σF )cv, (5.0.1)
where Js is the flux of molecules, Lp is the vessel permeability, As is the
vascular surface area, pc and pi are the hydrostatic pressures in vessel and
interstitium respectively, σ and σ
F
are the oncotic and plasmadrag reflection
coefficients respectively, πv and πi are the oncotic pressures in vascular and
interstitial fluid respectively, and cv is the drug concentration in the vessel fluid.
Since oncotic gradient πv − πi in tumours is almost zero as stated in Section
4.3.2, the transvascular movement of macromolecules would rely mostly on
the extravasation flux driven by hydrostatic pressure gradient pc − pi. Since
vascular cross section is assumed to be circular in our model, vascular surface
area As can be written as
As = 2π
∫
lv
a(l)dl, (5.0.2)
in which a(l) is vessel radius, and lv is the length of the vessel. Then, Eq.(5.0.1)
is reduced to
Js = 2π
∫
lv
a(l)Lp(l) [pc(l)− pi(l)] (1− σF )cvdl. (5.0.3)
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Some conclusions have been drawn that elevated tumour interstitial flow pres-
sure (IFP) is the major physiological barrier to macromolecular uptake in
solid tumours, for example in the papers by Jain (1994), Jain and Baxter
(1988). However, based on the above discussions, we notice that extravasation
flux Lpa(pc − pi) dominates the transvascular delivery of macromolecules in
tumour, while interstitial flow pressure pi is one of the factors which have in-
fluence on the extravasation flux. In this thesis, we assume drug concentration
cv and plasmadrag reflection coefficient σF are constant. Our investigation
then focuses on how other various physical parameters affect extravasation
flux Lpa(pc − pi) in tumour.
Another feature that we are interested in is the relative flux coefficient
γ
Q
, which is the ratio of blood flux exceeded from the vessel into tumour
interstitium over the flux perfused into the vessel, or
γ
Q
=
Qa −Qv
Qa
, (5.0.4)
where Qa stands for the inlet afferent blood flux perfused into the vessel,
and Qv is the outlet efferent blood flux flowing out of the vessel. Transporting
therapeutic anti-cancer agents throughout vascular surface into tumour interior
is one aspect of our concerns. Meanwhile, we hope to delivery the agents with
high efficiency. Here, γ
Q
represents the efficiency of flux exceeded into tumour
interstitium from the vessel. High value of γ
Q
means that relatively more blood
flux is delivered into tumour interior throughout vascular surface rather than
transported through the vessel into other parts of human body, e.g. normal
organs and tissues. When we choose radiotherapy and/or chemotherapy to
treat cancer, if the radiosensitiser and/or the anti-cancer chemical drugs are
uniformly dissolved in blood, we shall make ways to increase the value of
γ
Q
, as we prefer more anti-cancer agents are exceeded out of the vessel into
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Figure 5.1: Sketch of a single vessel embedded in a solid tumour
tumour interstitium along with blood flow. Lowering γ
Q
not only reduces the
effectiveness of radiotherapy and chemotherapy, but also aggravates the side
effects of these two treatments, because relatively more radiosensitiser and/or
anti-cancer chemical drugs are transported to the surrounding normal tissues
rather than into tumour. This leads to that tumour is more likely survive
from the therapies, whereas the normal tissues are more likely to be killed by
radiation and/or toxic anti-cancer chemical drugs.
5.1 Governing equations for the flow and nu-
merical simulation procedure
Similar to the case illustrated in Fig.4.1, Fig.5.1 sketches a case when a single
straight permeable vessel is embedded in tumour interior. For this case, it is
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natural for us to choose the following parametric equation
x(s) = s, y(s) = 0, z(s) = 0, (5.1.1)
to describe the vessel centre line. We then have
x′(s) = 1, y′(s) = 0, z′(s) = 0, (5.1.2)
and
x′′(s) = 0, y′′(s) = 0, z′′(s) = 0. (5.1.3)
Introducing Eqs.(5.1.2) and (5.1.3) into Eqs.(4.1.6) and (4.1.7), we obtain
Hb(s) = 1, Hc(s) = 0. (5.1.4)
Substituting Eqs.(5.1.2) to (5.1.4) into Eq.(4.2.23), we get
Jr = 1, Jθ = r, Js = 1. (5.1.5)
Introducing Eq.(5.1.5) into Eqs.(4.2.10), (4.2.11), (4.2.12) and (4.2.14), and
rearranging the results according to mass- and momentum-conservation for-
mulations in Eqs.(4.2.3) and (4.2.2), we obtain the continuity equation for the
blood flow through a straight vessel as
∂Ur
∂r
+
1
r
Ur +
1
r
∂Uθ
∂θ
+
∂Us
∂s
= 0, (5.1.6)
and the momentum equations as
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Ur
∂Ur
∂r
+
Uθ
r
∂Ur
∂θ
+ Us
∂Ur
∂s
− U
2
θ
r
=− 1
ρ
∂p
∂r
− µ
ρ
(
1
r2
∂2Ur
∂θ2
− 1
r2
∂Uθ
∂θ
− 1
r
∂2Uθ
∂r∂θ
+
∂2Ur
∂s2
− ∂
2Us
∂r∂s
)
, (5.1.7)
Ur
∂Uθ
∂r
+
Uθ
r
∂Uθ
∂θ
+ Us
∂Uθ
∂s
+
UrUθ
r
=− 1
ρr
∂p
∂θ
− µ
ρ
(
∂2Uθ
∂s2
− 1
r
∂2Us
∂θ∂s
+
1
r
∂Uθ
∂r
− 1
r2
Uθ +
∂2Uθ
∂r2
− 1
r
∂2Ur
∂θ∂r
+
1
r2
∂Ur
∂θ
)
, (5.1.8)
and
Ur
∂Us
∂r
+
Uθ
r
∂Us
∂θ
+ Us
∂Us
∂s
=− 1
ρ
∂p
∂s
− µ
ρ
(
1
r
∂Us
∂r
− 1
r
∂Ur
∂s
+
∂2Us
∂r2
−∂
2Ur
∂s∂r
+
1
r2
∂2Us
∂θ2
− 1
r
∂2Uθ
∂s∂θ
)
. (5.1.9)
As aforementioned in Section 4.3.2, under the usual physical and physio-
logical conditions in tumour, the blood flow through a tumour vessel is steady,
fully developed, laminar, and dominated by the pressure gradient along the
vessel centre line. As a result, we are able to assume that Ur = Uθ = 0,
and Us = Us(s), p = pc(s). Noticing that Hb(s) = 1, the flux Qc flowing
through a single straight tumour vessel can be described by the Poiseuille’s
law [Nichols and O’Rourke (2005)] as
Qc(s) = −πa
4(s)
8µ
dpc(s)
ds
. (5.1.10)
Substituting Eq.(5.1.10) into Eq.(4.3.9), and considering that Hb(s) = 1 and
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Hc(s) = 0, we get
d2pc
ds2
+
4
a(s)
da
ds
dpc
ds
=
16µLp(s)
a3(s)
[pc(s)− pi(s)] . (5.1.11)
Similarly, another equation linking the blood pressures on both sides of vascu-
lar surface, or Eq.(4.3.15), becomes
1
2
[pi(x0)− p0]
=− 1
2π
∫
lv
∫ 2π
0
∫ 2π
0
a(s)
Lp(s)
κ
[pc(s)− pi(s)]G(x,x0)dθ0dθds
+
1
2π
∫
lv
∫ 2π
0
∫ 2π
0
a(s) [pi(s)− p0]∇G(x,x0)n(x)dθ0dθds. (5.1.12)
Together with the inlet and outlet vascular flow conditions, we obtain a set
of self-contained equations to calculate vascular blood flow pressure pc(s) and
interstitial pressure pi(s) on the external vascular surface.
In Section 4.3.4, we have stated that, during the numerical procedure
of our simulation, the vessel is divided into NE cylindrical elements along its
centre line, as shown in Fig.4.3. Within each element, all the physical variables
are approximated to be constant. This makes the continuity condition imposed
at the middle of every element. Based on the segments generated along the
vessel, the differential equation (5.1.11) can be discretised by finite difference
method. Both the first and second order derivatives in Eq.(5.1.11) are replaced
with the three-point central difference formulae. This gives us a set of linear
equations for the pressures inside and outside the vessel as
NE∑
j=1
Tjnp
[j]
c = −
16µL
[n]
p
(an)
3 p
[n]
i , n = 2, 3, · · · , NE − 1, (5.1.13)
where Tjn is the finite difference computing matrix. According to Eqs.(3.2.2)
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and (3.2.4), we have
Tjn =


− ∆sn+1
(∆sn +∆sn+1)∆sn
(
4a′n
an
)
+
2
(∆sn +∆sn+1)∆sn
j = n− 1,
∆sn+1 −∆sn
∆sn∆sn+1
(
4a′n
an
)
− 2
∆sn∆sn+1
− 16µL
[n]
p
(an)
3 j = n,
∆sn
(∆sn +∆sn+1)∆sn+1
(
4a′n
an
)
+
2
(∆sn +∆sn+1)∆sn+1
j = n+ 1,
0 else,
(5.1.14)
in which
a′n =
(
da
ds
)
n
=
∆sn+1(an − an−1)
∆sn(∆sn+1 +∆sn)
+
∆sn(an+1 − an)
∆sn+1(∆sn+1 +∆sn)
, (5.1.15)
∆sn = sn − sn−1, ∆sn+1 = sn+1 − sn, (5.1.16)
and sn donates the mid-point position of the nth segment. Eqs.(5.1.13) to
(5.1.16) are available for the segments when 2 ≤ n ≤ NE−1. For the segments
on the two ends of the vessel, i.e. n = 1 or n = NE , Eq.(5.1.13) is solved
together with the inlet and outlet vascular flow conditions respectively. In
our model, the vessel is set to be connected with the arterial (upstream) and
the venous (downstream) ends. As the afferent arteriole and efferent venule
are not included in our simulations, the coupling effects between the inlet and
outlet vascular flow conditions and tumour interstitial flow are ignored. As
a result, the inlet and outlet vascular flow conditions can be introduced into
Eq.(5.1.13) directly. If inlet vascular flow pressure pa is given at the afferent
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connecting point of the vessel, for segment n = 1, Eq.(5.1.13) is reduced to
NE∑
j=1
Tj1p
[j]
c = −
16µL
[1]
p
(a1)
3 p
[1]
i − Tapa, (5.1.17)
where
Tj1 =


∆s2 −∆sa
∆sa∆s2
(
4a′1
a1
)
− 2
∆sa∆s2
− 16µL
[1]
p
(a1)
3 j = 1,
∆sa
(∆sa +∆s2)∆s2
(
4a′1
a1
)
+
2
(∆sa +∆s2)∆s2
j = 2,
0 else,
(5.1.18)
and
Ta = − ∆s2
(∆sa +∆s2)∆sa
(
4a′1
a1
)
+
2
(∆sa +∆s2)∆sa
. (5.1.19)
In Eqs.(5.1.18) and (5.1.19),
∆sa = s1 − sa, (5.1.20)
where sa stands for the afferent arterial connection point of the vessel; and a
′
1
is calculated through the three-point forward difference formula as
a′1 =
(
da
ds
)
1
=
∆s2
∆s¯2(∆s2 −∆s¯2)a3 −
∆s¯2
∆s2(∆s2 −∆s¯2)a2
− (∆s2 +∆s¯2)
∆s¯2∆s2
a1, (5.1.21)
in which
∆s¯2 = s3 − s1. (5.1.22)
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Similarly, when outlet vascular flow pressure pv is given at the efferent con-
necting point of the vessel, for segment n = NE, Eq.(5.1.13) is reduced to
NE∑
j=1
TjNEp
[j]
c = −
16µL
[NE ]
p(
a
NE
)3 p[NE ]i − Tvpv, (5.1.23)
where
TjNE =


2
(∆s
NE
+∆sv)∆sNE
− ∆sv
(∆s
NE
+∆sv)∆sNE
(
4a′
NE
a
NE
)
j = NE − 1,
∆sv −∆sNE
∆s
NE
∆sv
(
4a′
NE
a
NE
)
− 2
∆s
NE
∆sv
− 16µL
[NE ]
p(
a
NE
)3 j = NE ,
0 else,
(5.1.24)
and
Tv =
∆s
NE
(∆s
NE
+∆sv)∆sv
(
4a′
NE
a
NE
)
+
2
(∆s
NE
+∆sv)∆sv
. (5.1.25)
In Eqs.(5.1.24) and (5.1.25),
∆sv = sv − sNE , (5.1.26)
where sv stands for the efferent venous connection point of the vessel, and a
′
NE
is calculated through the three-point backward difference formula as
a′
NE
=
(
da
ds
)
NE
=
(∆s
NE
+∆s¯
NE
)
∆s¯
NE
∆s
NE
a
NE
+
∆s¯
NE
∆s
NE
(∆s
NE
−∆s¯
NE
)
a
NE−1
− ∆sNE
∆s¯
NE
(∆s
NE
−∆s¯
NE
)
a
NE−2
, (5.1.27)
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in which
∆s¯
NE
= s
NE
− s
NE−2
. (5.1.28)
If the inlet vascular flow condition at the arterial point is given by the
perfused flux Qa rather than pressure pa, according to the Poiseuille’s law,
when adopting the three-point forward difference formula in Eq.(3.2.7) for the
first order derivative, we have
pa =
8µQaH
[1]
b ∆s¯a∆sa
π(a1)4(∆sa +∆s¯a)
+
(∆sa)
2 p
[2]
c
(∆sa)
2 − (∆s¯a)2
− (∆s¯a)
2 p
[1]
c
(∆sa)
2 − (∆s¯a)2
, (5.1.29)
in which
∆s¯a = s2 − sa. (5.1.30)
Substituting Eq.(5.1.29) into Eq.(5.1.17), and rearranging the terms, for seg-
ment n = 1, we have
NE∑
j=1
Tˆj1p
[j]
c = −
16µL
[1]
p
(a1)
3 p
[1]
i −
8µQaTa∆s¯a∆sa
π(a1)4(∆sa +∆s¯a)
, (5.1.31)
where
Tˆj1 =


∆s2 −∆sa
∆sa∆s2
(
4a′1
a1
)
− 2
∆sa∆s2
− 16µL
[1]
p
(a1)
3 +
Ta (∆s¯a)
2
(∆sa)
2 − (∆s¯a)2
j = 1,
∆sa
(∆sa +∆s2)∆s2
(
4a′1
a1
)
+
2
(∆sa +∆s2)∆s2
− Ta (∆sa)
2
(∆sa)
2 − (∆s¯a)2
j = 2,
0 else,
(5.1.32)
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As derived in Section 4.3.4, Eq.(5.1.12) is discretised as
NE∑
j=1
{
δnj − 2B¯[j]n −
2L
[j]
p
κ
A¯[j]n
}
p
[j]
i
=−
NE∑
j=1
2L
[j]
p
κ
A¯[j]n p
[j]
c + p0
{
1−
NE∑
j=1
2B¯[j]n
}
. (5.1.33)
Then, when the inlet and outlet vascular flow pressures are given, we can
solve Eqs.(5.1.13), (5.1.17), (5.1.23) and (5.1.33) together through iteration
to obtian the solution for the pressures inside the vessel and on the external
vascular surface. The detailed procedure is summarised as below:
1) Set initial guess for blood pressure pc(s) inside the vessel.
2) Evaluate the right-hand side of Eq.(5.1.33).
3) Solve Eq.(5.1.33) to obtain tumour interstitial pressure pi(s) on the ex-
ternal surface of the vessel.
4) Evaluate the right-hand sides of Eqs.(5.1.13), (5.1.17), and (5.1.23).
5) Solve Eqs.(5.1.13), (5.1.17), and (5.1.23) together to obtain pc.
6) Go back to step 2 and repeat the procedure until convergence has been
achieved, or the difference in either pc(s) or pi(s) from two successive
steps is sufficiently small.
If the vascular inlet condition at the arterial point is given by Qa instead of
pa, we only need to adjust the fourth step in the above numerical procedure
correspondingly.
In order to check the convergence of our simulations, we define a relative
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round error function as
Er = Max


∣∣∣p[j]k − p[j]k−1∣∣∣
p
[j]
k

 1 ≤ j ≤ NE , (5.1.34)
in which, p
[j]
k represents the iterative result for either pi or pc at the kth iteration
step when k ≥ 2. We are able to adopt the relative round error function Er
in our simulations because the value of
∣∣∣p[j]k ∣∣∣ is always larger than zero in our
model. If Er → 0, the solution would approach to the exact one. However,
in practical, when Er is less than a very small positive value ǫ, we conclude
that our simulations are successful, and the obtained results are accurate and
consistent with all the physical and constrain conditions.
5.2 Convergence and validation study
Before investigating tumour blood flow by our model, we have to be sure
that our numerical procedure is mesh independent and convergent. A test
case is set up, in which a single straight permeable vessel with length lv =
1 cm is embedded in a solid tumour to a large extent with peripheral pressure
p0 = 6.666 × 102 g cm−1s−2. The vessel radius is set as a = 0.01 cm, vessel
permeability as Lp = 1 × 10−9 g−1cm2s, and tumour interstitial hydraulic
conductivity as κ = 1×10−10 g−1cm3s. In the meantime, the inlet vascular flow
condition is given as pa = 5.59952 × 104 g cm−1s−2, and the outlet condition
as pv = 1.19990× 104 g cm−1s−2. Since we regard the blood as incompressible
Newtonian fluid, blood density ρ = 1.05 g cm−3 and dynamic viscosity µ =
4 g cm−1s−1 remain constant in this thesis.
Fig.5.2a plots the dependence of the relative flux coefficient γ
Q
i on number
ithe relative flux coefficient γ
Q
is plotted on a linear-log10 scale. The same scale for γQ
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Figure 5.2: Dependence of (a) the relative flux coefficient γ
Q
and (b) calcu-
lation time on NE when Er = 1.× 10−6.
of discretised segments NE when Er = 1.× 10−6. The results in Fig.5.2a indi-
cate that the value of γ
Q
converges to a constant (mesh independent) rapidly
when NE increases. However, an increase of NE induce the calculation time or
CPU timeii to rise dramatically, as depicted in Fig.5.2b. The numerical simu-
lation time can be affected by some factors. To take the present study case as
an example, since the vessel is rigid, all of the elements in the coefficient matri-
ces derived by FDM and BEM are constant throughout the entire simulation.
Therefore, these two matrices can be composed and stored before the iteration.
The coefficient matrix obtained in FDM is a tridiagonal system, which costs
computer 3NE FLOPS (Floating point Operations Per Second) to construct
it. However, the global matrix derived in BEM is fully populated, which takes
the computer (NE)
2 FLOPS to calculate all the coefficients in it. When the
iteration starts, within each step, the tridiagonal system in FDM can be solved
is used throughout this thesis.
iiCPU time (calculation or simulation time) on a personal laptop with 2.00 GHz Intel
Centrino Duo processor. The same definition for simulation time is used throughout this
thesis.
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by Thomas’ Algorithm [Anderson (1995)], which requires O(NE) FLOPS to do
the calculation [Hamming (1986)]. As to the fully populated matrix in BEM,
Gauss-Seidel method [Schilling and Harris (2000)] can be adopted to solve it.
Gauss-Seidel method is an iterative method, and the calculation time taken by
each iterative step of it is O(NE)
2 FLOPS [Schilling and Harris (2000)]. The
convergence of Gauss-Seidel method is guaranteed when the matrix is either di-
agonally dominant or symmetric and positive definite. Though sometimes the
Gauss-Seidel method may be convergent even though neither of the above two
conditions is satisfied, the convergence rate could be very slow and the num-
ber of iteration could be larger than NE FLOPS. Under this circumstance, we
can apply Gauss Elimination method [Schilling and Harris (2000)] to solve the
matrix, whose calculation time is in the order of (NE)
3 FLOPS [Schilling and
Harris (2000)]. All these features indicate that, along the increasing of NE ,
the calculation time spent on calculating the coefficient matrices and every
step of iteration increases rapidly. Moreover, when NE increases, the number
of iterative steps to achieve the convergence normally grows, because the con-
vergence rate of simulation usually slows down along the decreasing of the size
of discretised segment. Under such a circumstance, multigrid method [Briggs
et al. (2000)] can be adopted to accelerate the convergence rate. The basic
idea of multigrid method is to use the results obtained from coarser grids as
the initial solution for the finer grids through interpolation. In this way, the
number of iterative steps for the finer grids could be reduced. Considering that
the convergence rate with coarser grids is usually faster, the convergence rate
for the entire simulation procedure can be accelerated.
For some other cases which will be investigated later in this thesis, the
simulation time varies significantly compared with the present test case. For
example, if the vessel is compliant, the vessel radius relies on the transmural
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Figure 5.3: Dependence of the relative flux coefficient γ
Q
on Er when element
size δsj = 0.2a (j = 1, 2, · · · , NE)
pressure difference monotonically along the vessel. Then, there would be an-
other iteration external to the numerical procedure, which is stated in Section
5.1, to calculate vessel radius. Furthermore, in each step of this new iteration,
the coefficient matrices of FDM and BEM have to be updated. Thus, it can
be expected that there would be a tremendous increase of computation time
for that case relative to the current study case (Section 7.2). Another situ-
ation is that the configuration of tumour vasculature becomes complicated,
such as it contains branches with multiple generations. This could lead to
billions of coefficients in FDM and BEM, which might cause our simulation to
encounter with prohibitive computer memory and CPU, mainly because the
global matrix of BEM is fully populated. A realistic approach is therefore to
use domain decomposition method [Wu and Taylor (2003)] which has been
adopted in water wave problems (Section 9.1).
Fig.5.3 plots the dependence of the relative flux coefficient γ
Q
on Er when
NE = 500. It shows that there is no significant difference in our simulation
results when Er decreases from 1.×10−3 to 1.×10−8. Therefore, for the present
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Figure 5.4: Distributions of (a) interstitial pressures on the external vascu-
lar surface and (b) vascular flow pressures. Solid line: present
results; square symbols: Pozrikidis and Farrow (2003).
study case, taking the simulation time into account, our calculation solution is
accurate enough when we choose the relative error as Er = 1.× 10−6, and the
segment size as δsj = 0.2a (j = 1, 2, · · · , NE) which corresponds to NE = 500.
In the work conducted by Pozrikidis and Farrow (2003), they investigated
the case when the tumour vessel has the same geometrical sizes as here, while
they let Lp = 2.5× 10−10 g−1cm2s and κ = 2.5× 10−11 g−1cm3s. They set the
tumour peripheral pressure to be equal to the outlet vascular flow pressure,
or p0 = pv. Their results provide a good bench mark to validate our model.
Fig.5.4 presents the pressures inside the vessel and the interstitial pressures
along the external vascular surface obtained by Pozrikidis and Farrow (2003)
and by our model. It shows that the results are in excellent agreement.
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Chapter 6
Effects of Physical Variables on
the Blood Flow Environment in
Tumour
Having validated the rationality of our model and examined the efficiency
of the numerical procedure, we proceed to investigate the effects of different
physical parameters on tumour blood flow. The study case in this chapter is a
single straight permeable vessel embedded in a solid tumour whose surface is
far away from the vessel. The vessel radius and length are set as a = 0.01 cm
and lv = 1 cm respectively. For the tumour vessel with radius a = 0.01 cm
(a ≥ 0.003 cm), the physiological and physical parameters relative to tumour
blood flow are summarised in Table6.1, which provide us the reference range of
our simulations. In order to present our simulation results clearly, we choose
three basic physical parameters, pressure pˇ = 1.33322 × 104 g cm−1s−2, vas-
cular permeability Lˇp = 10
−8 g−1cm2s, and vessel radius aˇ = 0.01 cm, as the
characteristic units (natural units). For the simulation results, the physiolog-
ical and physical parameters relative to tumour blood flow, including blood
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Table 6.1: Physical parameters of tumour blood flow when a ≥ 0.003 cm
Parameter (dimensional) Value
Arterial pressure pa (g cm
−1s−2) (5.93283± 1.29322)× 104
[Jain (1988), Wiig (1982)]
Venous pressure pv (g cm
−1s−2) (1.19990± 0.33331)× 104
[Jain (1988), Wiig (1982)]
Blood density ρ (g cm−3) 1.05
[Pedley (1980)]
Blood dynamic viscosity µ (g cm−1s−1) 4× 10−2
[Pedley (1980)]
Tissue hydraulic conductivity κ (g−1cm3s) 3× 10−11 ∼ 1.5× 10−10
[Swabb et al. (1974)]
Vascular Permeability Lp (g
−1cm2s) 2.7× 10−10 ∼ 2.1× 10−9
[Baish et al. (1997)]
pressure, vessel radius, vessel length, vessel permeability, tumour interstitial
hydraulic conductivity parameter, and flow flux, are divided by the dimen-
sional normalisation constants derived according to the above three natural
units, and represented by pn, an, lnv , L
n
p , κ
n, and Qn respectively. The values
of the dimensional normalisation constants are listed in Table6.2.
6.1 Influence of systemic pressure gradients
on tumour blood flow
Pressure gradient is the prime force to drive blood flow through tumour vessels
and transport flux from vessels into tumour interstitium. The flow through a
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tumour vessel is dominated by the pressure difference between inlet vascular
flow pressure pa at the arterial end and outlet vascular flow pressure pv at the
venous end of the vessel, the transvascular flux is driven by the transmural
pressure difference of pressure pc(s) in the vessel and interstitial pressure pi(s)
on the external vascular surface, and the tumour interstitial blood flow is
driven by the pressure difference between pi(s) and tumour peripheral pressure
p0. Therefore, pressure difference pa − pv and pa− p0 are the two determinant
issues for tumour blood flow.
6.1.1 Effects of inlet outlet vascular flow pressures on
tumour blood flow
For the investigations in this section, we let tumour tissue hydraulic coeffi-
cient κ = 10−10 g−1cm3s and vessel permeability Lp = 10
−9 g−1cm2s remain
constant. When we set the inlet vascular flow pressure as pa = 5.93283 ×
104 g cm−1s−2, and the tumour peripheral pressure as p0 = 6.666×102 g cm−1s−2,
the distributions of vascular flow pressure pc(s) with different outlet vascular
flow pressure pv are plotted in Fig.6.1a. Along the increasing of pv, pc(s) is
elevated, and the variation of pc(s) near the venous end is more significant
than that around the arterial end. The vascular flow pressure at the arterial
point remains the same under different pv since the inlet vascular flow pressure
pa is not changed. According to the coupling effect relationship between the
vascular flow and tumour interstitial flow in Eq.(4.3.13), which is
κ
∂pi(s)
∂n
= Lp(s) [pc(s)− pi(s)] , (6.1.1)
along the increasing of pressure pc(s) in the vessel, transmural pressure differ-
ence pc(s)− pi(s) is elevated. Consequently, the interstitial pressure gradient
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Table 6.2: Normalisation formulae for physical and physiological parameters
Normalisation formula Normalisation parameter value
Vessel typical length lnv =
lv
aˇ
aˇ = 0.01 cm
Vessel radius an =
a
aˇ
aˇ = 0.01 cm
Pressure pn =
p
pˇ
pˇ = 1.33322× 104 g cm−1s−2
Tissue hydraulic parameter κn =
κ
κˇ
κˇ = aˇLˇp = 10
−10 g−1cm3s
Vascular permeability Lnp =
Lp
Lˇp
Lˇp = 10
−8 g−1cm2s
Blood flow velocity Un =
U
Uˇ
Uˇ = pˇLˇp = 1.33322× 10−4 cm s−1
Flow flux Qn =
Q
Qˇ
Qˇ = aˇ2pˇLˇp = 1.33322× 10−8 cm3s−1
∂pi(s)/∂n on the exterior vascular surface is increased since vascular perme-
ability Lp and tumour tissue hydraulic conductivity coefficient κ are constant.
In Figs.6.1c and 6.1d, we present the distributions of transmural pressure dif-
ference pc − pi and extravasation flux Lpa (pc − pi) along the vessel together.
Due to that vessel permeability and radius remain constant in the current in-
vestigation, the transmural pressure difference and the extravasation flux share
the same curve, but with different scales. Noticing that the interstitial pres-
sures on the exterior vascular surface are elevated, and considering that the
vascular flow pressures do not change significantly around the arterial point
of the vessel due to the fixed inlet vascular flow pressure pa, the extravasa-
tion flux in that area is decreased along the increasing of outlet vascular flow
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Figure 6.1: Distributions of (a) vascular flow pressures, (b) interstitial pres-
sures on the external vascular surface, and (c) (d) extravasation
flux and transmural pressure difference, when pna = 4.45 and
pn0 = 0.05.
pressure pv (Fig6.1d). However, the results in Fig.6.1c indicate that, when the
outlet vascular flow pressure is raised at given inlet vascular flow pressure and
tumour peripheral pressure, the average amount of the extravasation flux over
the entire vessel is improved despite the elevated interstitial pressures.
Supposing that outlet vascular flow pressure pv could be elevated to the
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v = 4.45 and p
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0 = 0.05.
special situation as pv → pa, there would be no flux flowing through the vessel
according to the Poiseuille’s law if the vessel is not leaky, and pressure pc(s)
in the vessel is equal to pa. However, when the vessel is permeable, due to
the difference between inlet vascular flow pressure pa and tumour peripheral
pressure p0, there would be some flux exceeded from the vessel into the tu-
mour interior, as displayed in Fig.6.2b. Furthermore, because pv = pa, the
blood would flow into tumour from both arterial and venous ends of the vessel
(Fig.6.2b). Under such a special circumstance, pc decreases from pa at the
arterial point to reach the minimum at the middle point of the vessel, then
rises up to pv (pa) at the venous point, as plotted in Fig.6.2a. Meanwhile, the
value of the relative flux coefficient γ
Q
defined in Eq.(5.0.4) would be higher
than 100%. However, we should be aware that, under such a special situa-
tion, the Poiseuille’s law in Eq.(5.1.10) for the vascular flow in our model is
not accurate enough as it requires the velocity of the flow along the radius
direction to be much smaller than the velocity along the vessel centre line. To
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get accurate calculation results for this particular case, the governing equation
for the vascular blood flow has to be revised. Nevertheless, it is necessary for
us to notice that this special case of pa = pv is very rare in practical tumour
blood flow environment. The investigation presented here is for the purpose
of illustrating the particular flow phenomena for such an extreme case.
If we let the outlet vascular flow pressure decrease to reach the tumour
peripheral pressure as pv → p0, there would be some flux transported back
into the vessel from tumour interior near the venous end (intravascular flow),
as shown in Fig.6.3b. This is because the flux exceeded from the upstream
part of the vessel into tumour interior elevates the interstitial pressures within
the entire tumour interior, which are higher than the pressures near the ve-
nous end in the vessel, as shown in Fig.6.3a. The intravascular flow is very
harmful for cancer treatment as it reduces the extravasation flux. It may also
induce metastasis of tumour cells since some of them might be transported
together with the intravascular flow into circulation system and delivered to
other healthy organs.
When outlet venous pressure pv = 1.19990 × 104 g cm−1s−2 and tumour
peripheral pressure p0 = 6.666 × 102 g cm−1s−2 remain constant, along the
increasing of pa, vascular flow pressure pc(s) is increased, as shown in Fig.6.4a.
In this circumstance, the variation of vascular flow pressure near the arterial
point is more remarkable relative to that near the venous end of the vessel.
According to the same mechanism as the case investigated above, the intersti-
tial pressures along the external vascular surface are elevated, and the average
transmural pressure difference and extravasation flux over the whole vessel are
improved, as presented in Figs.6.5b and 6.4 respectively.
When we increase pa and pv together but letting pressure difference pa−pv
remain unchanged at a given tumour peripheral pressure, vascular flow pres-
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Figure 6.3: Distributions of (a) vascular flow pressures, interstitial pressures
on the external vascular surface, and (b) extravasation flux, when
pna = p
n
0 = 0.05 and p
n
a = 4.45.
sures almost increase uniformly along the vessel. This leads to the interstitial
pressures on the external vascular surface, the transmural pressure difference,
and the extravasation flux all elevated along the vessel, as presented in Fig.6.5.
The results presented above indicate that increasing the inlet vascular flow
pressure and/or the outlet vascular flow pressure at a given tumour peripheral
pressure can improve the amount of the extravasation flux, which would be
beneficial for the delivery of anti-cancer agents with heavy weight through
vessel surface into tumour interior.
Fig.6.6 presents the dependence of the relative flux coefficient γ
Q
on pa and
pv at a given tumour peripheral pressure p0. We observe that γQ displays an
upward trend along the increasing of outlet vascular flow pressure pv, when pv
is within the range in the figure and inlet vascular flow pressure pa is constant.
However, γ
Q
presents a downward trend along the increasing of pa when pv is
fixed. At a given p0, when pa is constant, elevating pv lowers pressure difference
pa−pv, which causes the perfused flux into the vessel, Qa, to decrease according
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Figure 6.4: Distributions of (a) vascular flow pressures, (b) interstitial pres-
sures on the external vascular surface, and (c) extravasation flux
and transmural pressure differences along vessel, when pnv = 0.9
and pn0 = 0.05.
to the Poiseuille’s law. However, in this circumstance, the extravasation flux
is increased (Fig.6.1c). As a result, the relative flux coefficient γ
Q
is improved,
as shown in Fig.6.6a. On the contrary, when pv is fixed, increasing pa leads to
pressure gradient pa − pv elevated, which causes relatively more flux flowing
through the vessel. Under such a circumstance, though the extravasation flux
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Figure 6.5: Distributions of (a) vascular flow pressures, (b) interstitial pres-
sures on the external vascular surface, and (c) extravasation flux
and transmural pressure difference, when pna − pnv = 3.55 and
pn0 = 0.05.
is improved (Fig.6.4c), γ
Q
decreases, as shown in Fig.6.6b. When pa and pv
are raised together while pressure difference pa − pv remains constant, the
extravasation flux is increased (Fig.6.5c), whereas the flux flowing through the
vessel is almost unchanged, since we notice that the distribution curves for
the pressures in the vessel are parallel with each other, as plotted in Fig.6.5a.
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Figure 6.6: Dependence of the relative flux coefficient γ
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lar flow pressure pv and (b) inlet vascular flow pressure pa when
pn0 = 0.05.
Then, γ
Q
is improved in this situation.
Based on the above discussions, if we would like to improve the effective-
ness of radiotherapy and chemotherapy as well as to reduce their side effects,
elevating the tumour outlet venous pressure within reasonable ranges is a good
option to achieve the goal. However, venous pressure pv in tumour is always
lower compared with that in normal tissues [Jain (1988)]. Lowered pv not only
deceases the extravasation flux and the value of the relative flux coefficient
γ
Q
, but also might cause intravascular flow from the tumour interior into the
vessel when it is decreased to some level, for example when pv tends to tu-
mour peripheral pressure p0 in our model. This could cause tumour cells to
be transported into circulation system and delivered to other normal tissues
(metastasis). These factors indicate that the abnormal tumour blood environ-
ment forms physiological barriers for cancer treatment, and plays an important
role in tumour growth.
Our results and conclusions presented here is supported by the previously
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study by Netti et al. (1999). They have shown that angiotensin II can increase
systemic vessel blood pressure in mice and can create an increase of pressure
gradient across tumour vessel walls, which can improve the delivery of spe-
cific antibodies in solid tumors. However, elevating the systemic vascular flow
pressure in human body is very critical because it might lead to tachycardia,
stroke and some other hypertension related disease. Nevertheless, once these
side effects are carefully monitored, our results still have potential in practical
applications.
6.1.2 Influence of tumour peripheral pressure on tu-
mour blood flow
As aforementioned in the beginning of Section 6.1, the tumour interstitial blood
flow is driven by the pressure difference between interstitial pressure pi(s) on
the external vascular surface and tumour peripheral pressure p0. Considering
the symmetrical geometry of the study case in this chapter, and noticing that
the blood flow is dependent on the pressure gradients linearly in our model,
one can conclude that the variation of the extravasation flux along the increas-
ing of p0 at given pa and pv is similar to the situation when we decrease pa
and pv together with constant pressure difference pa − pv at a given p0. In
the later situation, the vascular flow pressures are affected by the variations of
pa and pv, then the interstitial pressures, the transmural pressure difference,
and the extravasation flux are changed correspondingly. However, if we in-
crease p0 at given pa and pv, the interstitial pressure gradients are reduced.
This requires transmural pressure difference pc(s)−pi(s) to decrease according
to the coupling effect relationship defined in Eq.(6.1.1). Since the inlet and
outlet vascular flow pressures are constant, the variation of vascular flow pres-
sure pc(s) is insignificant along the variation of p0, as presented in Fig.6.7a.
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Figure 6.7: Distributions of (a) vascular flow pressures and (b) interstitial
pressures on the external surface along vessel when pna = 4.45
and pnv = 0.9.
Consequently, interstitial pressure pi(s) on the exterior vascular surface is el-
evated, as displayed in Fig.6.7b. Meanwhile, the decreasing of the transmural
pressure difference makes the extravasation flux decreased. This leads to that
the relative flux coefficient γ
Q
is reduced along the increasing of p0 because
the perfused flux into the vessel is almost unchanged, as plotted in Fig.6.8.
In Fig.6.8b, we present the dependence of γ
Q
on p0 at given pa and pv (solid
line), and the dependence on pv when pa − pv is constant at a given p0. They
are parallel with each other, which confirms the above analysis that these two
situations have the similar effects on tumour blood flow. The results presented
here indicate that the elevated peripheral pressure is harmful for transporting
macromolecules with heavy weight from vessel into tumour interior and the
effectiveness of radiotherapy and chemotherapy.
In the foregoing investigations, we have separately studied the effects of
inlet vascular arterial pressure pa, outlet vascular venous pressure pv and tu-
mour peripheral pressure p0 on tumour blood flow, whereas we are aware that
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Figure 6.8: (a) Distributions of extravasation flux and transmural pressure
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tumour peripheral pressure p0.
flow is driven by pressure difference pa−p0 and pv−p0 (or pa−pv and pa−p0),
not these parameters individually. For the previous study cases, either pa−p0,
pv − p0 or both of them has been modified as we varied pa, pv, p0 or some
combinations of them. When pa − p0 and pv − p0 remain constant, the pres-
sure itself will of course change when pa, pv and p0 vary together. If we set
pa − p0 = 5.86617 × 104 g cm−1s−2 and pv − p0 = 1.1332 × 103 g cm−1s−2,
the distributions of vascular flow pressure pc(s) and interstitial pressure pi(s)
on the exterior vascular surface with different p0 (pa and pv) are presented in
Fig.6.9. However, when we check Eqs.(5.1.11) and (5.1.12), we notice that,
if pc and pi are the solution for given pa, pv and p0, pc + ∆p and pi + ∆p
will be the solution for pa + ∆p, pv + ∆p and p0 + ∆p. As a result, when
we vary pa, pv and p0 together but fix pressure difference pa − p0 and pv − p0,
the transmural pressure difference, the extravasation flux, and the relative flux
coefficient γ
Q
remain unchanged, as shown in Fig.6.10. This indicates that,
if pressure difference pa − p0 and pv − p0 remain constant, there would be no
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Figure 6.9: Distributions of (a) vascular flow pressures and (b) interstitial
pressures on the external vascular surface.
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Figure 6.10: (a) Distributions of extravasation flux and transmural pressure
difference; (b) dependence of the relative flux coefficient γ
Q
.
effects on the transvascular movement of anti-cancer agents or the effectiveness
of radiotherapy and chemotherapy when we adjust pa, pv and p0. Therefore,
the conclusion can be drawn that the variations of pressure difference pa − p0
and pv − p0 are the primary mechanics to affect tumour flow flied. According
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to the foregoing observations and analysis, we find that elevating the pressure
difference pa − p0 and pv − p0, but reducing pa − pv within some reasonable
limits can be beneficial for the delivery of anti-cancer agents with heavy weight
through vascular surface into tumour interior, and improving the effectiveness
of chemotherapy and radiotherapy.
Our results are consistent with some previous investigations, for example
the papers by Hori et al. (1994), Netti et al. (1997, 1999). However, adjusting
blood pressure itself can lead to some danger for human health. As afore-
mentioned, elevating systemic vascular flow pressure can lead to hypertension
related disease. Meanwhile, increasing pressure gradient in tumour intersti-
tium may cause tissue compression, which can cause a significant increase
in the interstitial resistance to convective transport [Kroll et al. (1996)], be-
cause biological tissues are viscoelastic materials [Fung (1981)]. Nevertheless,
if these adverse effects are carefully controlled, our results can still be applied
practically.
6.2 Effects of tumour hydraulic conductivity
parameter on tumour blood flow
Though tumour blood flow is driven by the pressure gradients, it is also af-
fected by other characters of tumour blood environment. Tumour tissue hy-
draulic conductivity coefficient κ is one of the factors which have effects on
tumour blood flow. If the value of κ is very low, for example tending to
zero, blood would hardly be able to move within tumour interstitium due to
the high resistance. Under such a circumstance, according to the coupling
effect relationship in Eq.(6.1.1), flux cannot be transported from the vessel
into tumour interior even if the vessel is permeable. As a result, transmural
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Figure 6.11: Distributions of interstitial pressures on the external vascular
surface.
pressure difference pc(s) − pi(s) would tend to zero, which indicates that in-
terstitial pressure pi(s) on the exterior vascular surface is equal to pressure
pc(s) in the vessel. Along the increasing of κ, the resistance for the blood
flow inside tumour interior is lowered, and blood can be transported through
tumour interstitium more easily. If the value of κ is very high, the blood can
be delivered through tumour interior freely, and no flux would be accumulated
inside tumour interstitium. In such a case, the interstitial pressures, including
the interstitial pressures on the external vascular surface, would be equal to
the tumour peripheral pressure, as pi(x) = p0. This indicates that the high
interstitial pressure within tumour interior would disappear. Letting Lp =
10−9 g−1cm2s, pa = 5.93283 × 104 g cm−1s−2, pv = 1.19990 × 104 g cm−1s−2,
and p0 = 6.666 × 102 g cm−1s−2, the results in Fig.6.11 reflect the foregoing
discussions. Fig.6.12 displays the pressure distributions along the vessel under
different values of κ. The results in Fig.6.12a show that κ has insignificant
effects on the vascular flow pressures as the inlet and outlet vascular flow pres-
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Figure 6.12: Distributions of (a) vascular flow pressures and (b) interstitial
pressures on the external vascular surface.
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Figure 6.13: (a) Distributions of extravasation flux and transmural pressure
differences along vessel; (b) dependence of the relative flux co-
efficient γ
Q
on tumour tissue hydraulic conductivity coefficient
κ.
sures are fixed, whereas it has clear influence on tumour interstitial pressures
(Fig.6.12b). Based on the coupling effect relationship in Eq.(6.1.1), when κ
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is raised, the interstitial pressures on the external vascular surface decrease
(Fig.6.12b), which leads to the increase of the transmural pressure difference
and the extravasation flux, as presented in Fig.6.13a. As a result, the value
of the relative flux coefficient γ
Q
is improved because the perfused flux into
the vessel is almost unchanged, as displayed in Fig.6.13b. These results in-
dicate that we can adjust tumour tissue hydraulic conductivity parameter κ
to achieve better efficiency of drug delivery in tumour. When the tumour
interstitial hydrodynamic conductibility is poor, raising κ is helpful to trans-
port macromolecules out of tumour vessels into interstitium and improve the
effectiveness of chemotherapy and radiotherapy. The results and conclusions
obtained in this section are consistent with the previous study in the paper by
Zhang et al. (2000), in which they investigated interstitial hydraulic conductiv-
ity and gave a brief implication for drug and gene delivery through controlling
interstitial hydraulic conductivity.
6.3 Influence of vessel permeability on tumour
blood flow
The tumour vasculature owns a unique functional abnormality as which it
is more permeable compared with the vasculature in normal tissues. This
special abnormal function of tumour vessels plays a critical role in form-
ing the disordered tumour flow environment, which has strong effects on tu-
mour growth and cancer therapies. Tumour vessel permeability induces high
interstitial pressure in tumour, which is one of the primary features con-
tributing to the abnormal blood flow field within tumour interior. When
the vessel is not permeable, or Lp = 0, there would be no flux transported
through vascular surface into tumour interstitium. Under this circumstance,
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according to the coupling effect relationship defined in Eq.(6.1.1), interstitial
pressure gradient ∂pi(s)/∂n = 0. Since the interstitial pressure satisfies the
Laplace equation, or ∇2pi(x) = 0, this gives pi(x) = p0 everywhere within
tumour interior, including the interstitial pressures on the external vascular
surface. When we let κ = 5 × 10−8 g−1cm3s, pa = 5.93283 × 104 g cm−1s−2,
pv = 1.19990× 104 g cm−1s−2, and p0 = 6.666× 102 g cm−1s−2, the results in
Fig.6.14 reflect the above discussions. Fig.6.15 displays the dependence of tu-
mour blood flow on vessel permeability. According to the results in Fig.6.15a,
we notice that the vascular flow pressures are almost unaffected when vessel
permeability Lp varies. However, the variation of Lp has significant effects on
the pressures in tumour interstitium. Based on the coupling effect relationship
in Eq.(6.1.1), along the increasing of vessel permeability Lp, the interstitial
pressure gradient ∂pi(s)/∂n on the external vascular surface is elevated. This
indicates that the interstitial pressure pi(s) on the exterior vascular surface is
increased since the tumour peripheral pressure remains constant. Due to the
elevated pi(s) and unchanged pc(s), transmural pressure difference pc(s)−pi(s)
decreases. However, the increasing of Lp makes the extravasation flux raised,
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Figure 6.15: Distributions of (a) vascular flow pressures, (b) interstitial pres-
sures on the external vascular surface, (c) transmural pressure
difference, and (d) extravasation flux.
which also leads to the relative flux coefficient γ
Q
improved. When the value
of Lp is raised to some high level, the tumour interstitial pressures on the
external vascular surface would be elevated until they are balanced with the
pressures inside the vessel, as shown in Fig.6.17. In such a case, the transmural
pressure difference would tend to zero, and there would be no difference for
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Figure 6.17: Distributions of (a) interstitial pressures on the external vascu-
lar surface and (b) extravasation flux along vessel.
the extravasation flux if we keep increasing Lp, as plotted in Fig.6.17b. From
the above discussions, we can conclude that if the value of vascular permeabil-
ity Lp is quite low, we can improve the ability of transvascular movement of
macromolecules with heavy weight and the effectiveness of radiotherapy and
chemotherapy by elevating the permeability of tumour vessel.
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Our conclusions in this section may not be consistent with some previous
study, for example the paper by Tong et al. (2004). The experimental observa-
tions in Tong et al. (2004) indicated that a drop of tumour vessel permeability
can improve delivery of anti-cancer agents in solid tumours. However, there is
some clear difference between our investigation case and theirs. Our study in
this section is based on a simplified case, in which tumour vasculature is rep-
resented by a single straight vessel and the tumour is regarded to be virtually
large. However, for the case investigated by Tong et al. (2004), the vasculature
is a fully developed three-dimensional vascular network and tumour is within
a certain finite size. In their case, the interstitial pressure is high, even close to
the pressure inside tumour vessels. That situation is similar to our investiga-
tion case presented in Fig.6.17. As a result, Tong et al. (2004) decreased vessel
permeability to make a drop of interstitial pressure, which can consequently
increase the transmural pressure difference. This feature is consistent with our
findings. When the interstitial pressure is lowered, considering our simulation
results, for a practical tumour as illustrated by Tong et al. (2004), we might be
able to propose a strategy to make periodic modulations of vessel permeabil-
ity, which can induce cycles of fluid exchange between vascular and interstitial
space, to optimise the delivery of anti-cancer agents in solid tumours.
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Chapter 7
Influence of Vessel Radius on
Tumour Blood Flow
In the previous chapter, adopting the governing equations derived in Chapters
4 and 5, we have studied the blood flow in a solid tumour when tumour vascu-
lature is represented by a single straight vessel. Taking the advantage of the
simplicity of the vasculature, we have obtained some insightful results on how
the inlet and outlet vascular flow pressures, tumour peripheral pressure and
tumour interstitial hydraulic conductivity coefficient affect tumour blood flow.
Further to this, we have investigated the effects of vessel permeability, the
functional abnormality of tumour vessels compared with the vessels in normal
tissues, on tumour blood flow. Nevertheless, there is another special feature of
tumour vasculature relative to normal vasculature, which is the irregular vas-
cular architecture in tumour. As summarised in Section 1.3, and also described
in the literatures by Konerding et al. (1999), Less et al. (1991), Ryschich et al.
(2004) and Shubik (1982), unlike normal vessels, the vascular architecture in
tumour is characterised with disordered vessel radius, curved vessels, and out
of order vascular network with excessive branches and loops. From the present
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chapter to Chapter 9, we will orderly investigate how the above three abnormal
characters of tumour vascular architecture affect tumour blood flow.
In this chapter, we investigate how dilated and uneven vessel radius affects
tumour blood flow. Vessel radius has strong influence on tumour blood flow.
In our model, for the vascular flow, the Poiseuille’s law in Eq.(5.1.10) states
that the flow flux through a tumour vessel is in direct proportion to the forth
power of vessel radius. In the discretised equation (5.1.12) for the vascular
flow pressures and the interstitial pressures on the external vascular surface,
influence coefficients A¯
[j]
n and B¯
[j]
n depend on vessel radius. Furthermore, as
described in Eq.(5.0.3), flux of molecules Js is also correlative with vessel
radius.
7.1 Dilated tumour vessel
One of the special characters of tumour vasculature is that vessel radius in
tumour is dilated compared with the vessels in normal tissues [Ryschich et al.
(2004)]. The vessel radius in our previous investigations is set as a = 0.01 cm,
which is within practical tumour physiological ranges. However, tumour ves-
sel radius varies stage by stage along tumour growth, because the angiogenesis
process normally requires tumour vessels to dilate to support tumour growth
[Ryschich et al. (2004)]. The variation of vessel radius has clear effects on
tumour blood environment, especially on the vascular flow. In order to inves-
tigate the influence of dilated vessel on tumour blood flow, we set up a study
case, in which a single straight vessel with length lv = 1.0 cm and leakage
Lp = 10
−9 g−1cm2s is embedded in a solid tumour to a large extent whose
hydraulic conductivity coefficient κ = 10−10 g−1cm3s and peripheral pressure
p0 = 6.666 × 102 g cm−1s−2. The cross section radius is uniform along the
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Figure 7.1: Distributions of (a) vascular flow pressures, (b) interstitial pres-
sures on the external vascular surface, (c) transmural pres-
sure difference, and (d) extravasation flux when pna = 4.7 and
pnv = 1.15.
vessel.
When the inlet and outlet pressures for the vascular flow are given, the
dilated vessel leads to a rapid increase of flux Qa at the arterial point in
the vessel since the flow flux through a tumour vessel is in direct propor-
tion to the forth power of vessel radius as described by the Poiseuille’s law
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in Eq.(5.1.10). Though the enlarged vessel radius also makes the vascular
surface area broadened, which can induce more extravasation flux, the value
of the relative flux coefficient γ
Q
is reduced as the increasing rate of Qa is
much higher than that of the extravasation flux. Fig.7.1 displays the varia-
tion of tumour blood flow along the dilated vessel when the inlet vascular flow
pressure is set as pa = 5.93283 × 104 g cm−1s−2 and the outlet pressure as
pv = 1.19990× 104 g cm−1s−2. The results in Fig.7.1a show that the effect of
the variation of vessel radius on vascular flow pressure pc(s) is insignificant.
However, interstitial pressure pi(s) on the external vascular surface is elevated
when the vessel radius is enlarged, as displayed in Fig.7.1b. Consequently,
transmural pressure difference pc(s)− pi(s) is reduced (Fig.7.1c). Due to that
the vascular surface area is extended because of the enlarged vessel radius, the
extravasation flux is increased despite the drop of transmural pressure differ-
ence, as presented in Fig.7.1d. However, based on the foregoing discussions, the
relative flux coefficient γ
Q
is reduced in the current case, as plotting in Fig.7.2
by the dash dot line. This indicates that, under this circumstance, though
it can be beneficial for the delivery of anti-cancer agents with heavy weight
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through vascular surface into tumour interstitium when vessel is dilated, one
has to consider the possibility of losing the effectiveness and aggravating the
side effects of chemotherapy and radiotherapy.
Since the variation of vessel radius has powerful effects on vascular flow,
when different types of inlet and outlet vascular flow conditions are given,
there will be different phenomena of tumour blood flow caused by the di-
lated tumour vessel. For example, when we set the perfused vascular flow
flux as Qa = 4.3196 × 10−3 cm3s−1 and the inlet vascular flow pressure as
pa = 5.93283 × 104 g cm−1s−2 at the arterial connecting point of the vessel,
while outlet vascular flow pressure pv is part of unknowns, transmural pressure
difference pa−pv is reduced when the vessel radius is enlarged, which indicates
that pv is elevated. As a result, vascular flow pressure pc(s) is increased, as
plotted in Fig.7.3a. Due to the increased vascular flow pressures and enlarged
vessel radius, though the interstitial pressures on the exterior vascular surface
are elevated, the average transmural pressure difference over the whole vessel
is raised. Multiplying the broadened vascular surface area caused by the di-
lated vessel, the extravasation flux through the vessel surface is increased, as
displayed in Fig.7.3. In Section 6.1.1, we have investigated the case when pv is
elevated while the vessel radius remains unchanged. The results in the current
case look similar to the results of that case, as shown in Figs.6.1 and 6.2a.
However, there are some difference between these two cases, especially for the
interstitial pressures and extravasation flux near the arterial point of the ves-
sel, which is mainly due to the variation of vessel radius. As Qa is fixed, and
noticing that the extravasation flux is increased, the relative flux coefficient γ
Q
is improved under the present circumstance, as plotted in Fig.7.2 by the solid
line.
For the same reason, when Qa = 4.3196×10−3 cm3s−1 and pv = 1.19990×
144
l n
v
pn c
0 20 40 60 80 1000
1
2
3
4
5
a
n
= 0.95
a
n
= 1.0
a
n
= 1.05
(a)
l n
v
pn i
0 20 40 60 80 1000
0.3
0.6
0.9
1.2
1.5
a
n
= 0.95
a
n
= 1.0
a
n
= 1.05
(b)
l n
v
pn c
-
pn i
0 20 40 60 80 1000
0.5
1
1.5
2
2.5
3
3.5
4
a
n
= 0.95
a
n
= 1.0
a
n
= 1.05
(c)
l n
v
Ln p
a
n
(pn c
-
pn i
)
0 20 40 60 80 1000
0.05
0.1
0.15
0.2
0.25
0.3
0.35
0.4
a
n
= 0.95
a
n
= 1.0
a
n
= 1.05
(d)
Figure 7.3: Distributions of (a) vascular flow pressures, (b) interstitial pres-
sures on the external vascular surface, (c) transmural pressure
difference, and (d) extravasation flux when Qna = 3.24× 105 and
pna = 4.7.
104 g cm−1s−2 are given but pa is part of unknowns, the dilated vessel cross
section makes the pressure gradient in the vessel decreased, which leads to a
drop of arterial pressure pa. As a result, the vascular flow pressures are lowered,
the interstitial pressures on the external vascular surface are decreased, and
the average transmural pressure difference is reduced, as shown in Figs.7.4a,
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Figure 7.4: Distributions of (a) vascular flow pressures, (b) interstitial pres-
sures on the external vascular surface, (c) transmural pressure
difference, and (d) extravasation flux when Qna = 3.24× 105 and
pnv = 1.15.
7.4b and 7.4c respectively. Even though the vascular surface area is extended,
the average extravasation flux along the whole vessel is decreased, as presented
in Fig.7.4d. Consequently, the relative flux coefficient γ
Q
is reduced since Qa
is constant, as plotted in Fig.7.2 by the dash line.
Based on the above results, we find that the effects of dilated vessel on
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tumour blood flow are complicated, which rely on the inlet and outlet vas-
cular flow conditions strongly. When Qa and pa are given, dilated tumour
vessel can improve the efficacy of transporting anti-cancer agents with heavy
weight through vascular surface into tumour interior, and the effectiveness of
chemotherapy and radiotherapy. However, if Qa and pv are fixed, enlarged
tumour vessel diameter has negative effects on transvascular delivery of heavy
macromolecules in tumour or the effectiveness of chemotherapy and/or radio-
therapy. On the other hand, if we can control and fix the inlet and outlet
vascular flow pressures, enlarged tumour vessel can be beneficial for trans-
porting anti-cancer agents with heavy weight through vascular surface into
tumour interior, but would have to sacrifice the effectiveness of chemotherapy
and radiotherapy.
7.2 Effects of vessel elastic property on tu-
mour blood flow
Another character of disordered tumour vessel radius is that it is not always
uniform along the vessel. One major reason for uneven diameters along tumour
vessels is due to the elastic property of tumour vascular walls together with the
abnormal interstitial pressure distributions within tumour. However, the elas-
tic behaviour of blood vessels is complicated. A mathematical model capable
of exactly describing the elastic behaviour of vessels would not only require a
complete understanding of the coupling effects between vascular, transvascular
and interstitial flows, but also need full knowledge about the elastic properties
of vascular walls. So far, based on the best of author’s knowledge, there is yet a
precise mathematical model to describe the elastic behaviour of blood vessels,
although some efforts have been donated in this area, such as the literatures
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by Baish et al. (1997) and Lee and Schmid-Scho¨nbein (1996).
We investigate a case for tumour blood flow, in which a single straight
compliant vessel is embedded in a solid tumour whose surface is far away from
the vessel. For the elastic behaviour of the vessel, the empirical constitutive
equation developed by Baish et al. (1997) is adopted, which describes the func-
tional relationship between vessel radius and transmural pressure difference as
a(s) = a0
[
pc(s)− pi(s)
Ecl
+
pcl
Ecl
] br
2
, (7.2.1)
where a0 is the vessel radius in the reference state, Ecl is the compliance
coefficient, br is the compliance exponent, pcl is the collapse pressure, and the
values of these parameters are listed in Table7.1. This model is suitable for
the tumour vessels when a0 is around 5 µm. Hence, the geometrical sizes of
the vessel are assigned as followings: lv = 200 µm and radius a0 = 5 µm in
the reference state. The vessel permeability Lp = 10
−9 g−1cm2s, interstitial
hydraulic conductivity coefficient κ = 10−10 g−1cm3s, and tumour peripheral
pressure p0 = 666.61 gcm
−1s−2 are set to remain constant for the present case.
Meanwhile, using all the same physical parameters, we simulate another case
for comparison, in which the vessel is rigid, and its radius and length are set
as a = 5 µm and lv = 200 µm respectively.
For the current study case, though the vessel is compliant, the vascular
cross section is assumed to remain circular. Therefore, the governing equations
for tumour blood flow derived in Section 5.1 are still available. Due to that
the vessel radius relies on the transmural pressure difference as described in
Eq.(7.2.1), the numerical procedure for the present case is modified by adding
another iteration external to the numerical procedure stated in Section 5.1 to
calculate the vessel radius. The detailed procedure is summarised as below:
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Table 7.1: Physiological parameter values when 5µm ≤ a ≤ 10µm
Parameter (dimensions) Value
Arterial pressure pa (g cm
−1s−2) (1.58653± 0.25331)× 104
[Jain (1988), Peters et al. (1980)]
Venous pressure pv (g cm
−1s−2) (8.9326± 2.4531)× 103
[Jain (1988), Peters et al. (1980)]
Tissue hydraulic conductivity κ (g−1cm3s) 3× 10−11 ∼ 1.5× 10−10
[Swabb et al. (1974)]
Vascular Permeability Lp (g
−1cm2s) 2.7× 10−10 ∼ 2.1× 10−9
[Baish et al. (1997)]
Collapse pressure pcl (g cm
−1s−2) 3.99966× 103
[MacPhee and Michel (1995)]
Compliance coefficient Ecl (g cm
−1s−2) 8.66593× 103
[Mason (1975)]
Compliance exponent br 0.2
[Mason (1975)]
1) Adopt radius a0 in the reference state as the initial value for vessel radius.
2) Set initial guess for blood pressure pc(s) inside the vessel.
3) Evaluate the right-hand side of Eq.(5.1.33).
4) Solve Eq.(5.1.33) to obtain tumour interstitial pressure pi(s) on the ex-
ternal vascular surface.
5) Evaluate the right-hand sides of Eqs.(5.1.13), (5.1.17) and (5.1.23).
6) Solve Eqs.(5.1.13), (5.1.17) and (5.1.23) together to obtain pc(s).
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Figure 7.5: Dependence of the relative flux coefficient γ
Q
on number of dis-
cretised segments NE when the relative round error function
Er = 1.× 10−6.
7) Repeat the procedure between step 2 and 6 until the difference in either
pc or pi from two successive steps is sufficiently small.
8) Get new vessel radius according to Eq.(7.2.1).
9) Repeat the procedure between step 2 and 8 until the convergence for the
vessel radius has been achieved.
Fig.7.5 displays the dependence of the relative flux coefficient γ
Q
on num-
ber of discretised segments NE when the relative round error function is set
as Er = 1. × 10−6. The results in Fig.7.5 indicate that for either compliant
vessel or rigid vessel, the value of γ
Q
becomes mesh independent when NE
is sufficiently large. The comparison results of simulation time for the case
of compliant vessel and rigid vessel under different NE are listed in Table7.2.
These results have confirmed our foregoing analysis in Section 5.1, which states
that there is a significant increase (one order higher) of the computation time
for the case of compliant vessel relative to the case of rigid vessel. Therefore,
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Table 7.2: Calculation time for compliant vessel and rigid vessel
NE 300 450 600 750 900
Rigid vessel Time (s) 76 170 303 474 684
Compliant vessel Time (s) 690 1438 2550 4016 5733
for the case of compliant vessel, based on the results in Fig.7.5, and consider-
ing the simulation time, our calculation results are accurate enough when the
element size is chosen as δsj = 0.066667a0 (j = 1, 2, · · · , NE).
Since compliance exponent br = 0.2 as listed in Table7.1, according to the
relationship between the vessel radius and the transmural pressure difference
in Eq.(7.2.1), we notice that the vessel radius relies on the transmural pressure
difference monotonically along the vessel. In the meantime, when transmural
pressure difference pc(s) − pi(s) > (Ecl − pcl) = 0.35 · pˇ, the vessel is dilated
compared with radius a0 in the reference state, while if pc(s)− pi(s) < 0.35 · pˇ,
the vessel is compressed relative to a0. If tumour vessel is not permeable, based
on the discussions in Section 6.3, tumour interstitial pressure pi(x) would be
constant, and equal to tumour peripheral pressure p0. Under this circumstance,
when inlet and outlet vascular flow pressures pa and pv are given, pressure pc(s)
in the vessel decreases from pa to pv monotonically according to the Poiseuille’s
law. As a result, the transmural pressure difference descends monotonically
along the vessel. According to the relationship in Eq.(7.2.1), we can conclude
that the vessel radius near the arterial point is larger than that around the
venous point. Since there is no flux exceeded from the vessel into tumour
interior, the perfused flux into the vessel at the arterial point, Qa, is equal to
Qv, which is the flux flowing out of the vessel at the venous end. Consequently,
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Figure 7.6: Comparison of distributions of (a) vascular flow pressures, (b)
interstitial pressures on the external vascular surface, (c) trans-
mural pressure difference, and (d) extravasation flux for the cases
of compliant vessel and rigid vessel.
according to the Poiseuille’s law, the vascular pressure gradient at the upstream
part of the vessel is lower than that at the downstream part of the vessel, which
indicates that the vascular flow pressures along the compliant vessel are higher
than the pressures in the rigid vessel. Since the effects of vessel permeability on
the vascular flow pressures are insignificant based on the foregoing discussions
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Figure 7.7: Distributions of vessel radius.
in Section 6.3, the above analysis is also available for tumour blood flow,
as shown in Fig.7.6a, when we let pa = 1.58653 × 104 g cm−1s−2 and pv =
8.9326 × 103 g cm−1s−2. Similar to the results in Section 6.1.1, we observe
that, in the present case, though the elevated vascular flow pressures induce the
interstitial pressures on the exterior vascular surface to increase, the average
transmural pressure difference over the entire vessel is raised, as shown in
Figs.7.6b and 7.6c respectively. For the current study case, as pc(s)− pi(s) >
0.35 · pˇ along the vessel, the vessel radius is enlarged along the entire vessel
relative to radius a0 in the reference state, as plotted in Fig.7.7 by the solid line.
This leads to the vascular surface area extended. Under this circumstance,
considering the increased transmural pressure difference, the extravasation flux
transported from the compliant vessel is higher than that from the rigid vessel,
as displayed in Fig.7.6d. However, since the enlarged vessel radius leads to the
rapid increasing of Qa as pa and pv are fixed, the relative flux coefficient γQ is
lowered when the vessel is compliant relative to that when the vessel is rigid,
as shown in Fig.7.8.
The simulation results on tumour blood flow are displayed in Fig.7.9, when
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we decrease the outlet vascular flow pressure to pv = 1.3332 × 103 g cm−1s−2
but let pa = 1.58653 × 104 g cm−1s−2 remain unchanged. Fig.7.9a and 7.9b
show that the distributions of inner and outer pressures along the vessel present
the similar aspects to the results obtained above. However, under the current
inlet and outlet vascular flow conditions, transmural pressure difference pc(s)−
pi(s) > 0.35 · pˇ at the upstream part of the vessel, but at the downstream part
of the vessel, pc(s) − pi(s) < 0.35 · pˇ, as plotted in Fig.7.9c. Consequently,
the vessel is dilated at the upstream part of the vessel but compressed at the
downstream part of the vessel relative to radius a0 in the reference state, as
shown in Fig.7.7 by the dash line. Since the inlet and outlet pressures for the
vascular flow are given, the compressed vessel radius near the venous end makes
the flux flowing out of the vessel reduced, which respectively requires flux Qa
at the arterial point to decrease. As a result, the relative flux coefficient γ
Q
is improved when the vessel is compliant compared with that when the vessel
is rigid, as shown in Fig.7.8. This figure also plots the dependence of γ
Q
on
outlet vascular flow pressure pv when the vessel is either compliant or rigid.
Though there is some difference in the value of γ
Q
between these two cases,
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Figure 7.9: Comparison of distributions of (a) vascular flow pressures, (b)
interstitial pressures on the external vascular surface, (c) trans-
mural pressure difference, and (d) extravasation flux for the cases
of compliant vessel and rigid vessel.
the trends of the variation of γ
Q
along the variation of the outlet vascular flow
pressure are similar to each other.
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Chapter 8
Effects of Vessel Curvature on
Tumour Blood Flow
In Chapter 7, we have studied how disordered tumour vessel radius, which is
regarded as one of the abnormal characters of tumour vascular architecture,
affects tumour blood flow. Except for the disordered vessel radius, there are
some other particular characters of tumour vascular configuration compared
with the vessels in normal tissues. One of these special characters is that,
unlike the normal vessels, the practical vessels within tumour are not in good
shapes, but with curvature. Obviously, vessel curvature has clear effects on
tumour blood flow. It also induces new difficulty in our mathematical model.
For a curved vessel, the detailed expression of the parametrical equation for the
vessel centre line becomes more complex relative to that for a straight vessel,
which consequently leads to significant variations of vascular shape functions
Hb(s) and Hc(s), which are defined in Eqs.(4.1.6) and (4.1.7) respectively.
This results in the rapid changes of the continuity and momentum equations
in Eqs.(4.2.10) to (4.2.12) for the vascular flow, which further affects the equa-
tions linking the blood flows in the vessel and tumour interstitium, such as
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Eqs.(4.3.9) and (4.3.15). In this chapter, we investigate the mathematical dif-
ficulty mentioned above and the influence of vessel curvature on tumour blood
flow in detail through a case, in which a single curved vessel is embedded in
a large solid tumour whose surface is far away from the vessel. The vessel is
permeable, and bent with constant curvature in a plane. It is assumed that
the vascular walls are rigid, vessel cross section is circular, and vessel radius
is uniform along the vessel centre line. In the meantime, we set the vessel
length as lv = 1.0 cm, the vessel permeability as Lp = 10
−9 g−1cm2s, the tu-
mour hydraulic conductivity coefficient as κ = 10−10 g−1cm3s, and the tumour
peripheral pressure as p0 = 6.666 × 102 g cm−1s−2. All of these parameters
remain constant in this chapter.
8.1 Governing equations and numerical simu-
lation procedure
In Fig.8.1, we sketch a case of a curved vessel with constant curvature radius
Rc embedded in a solid tumour. The arterial point of the vessel is located at
the origin of Cartesian coordinate system o− xyz. As a result, we can choose
parametric equation
x(s) = Rc sin s, y(s) = Rc − Rc cos s, z(s) = 0, (8.1.1)
to describe the vessel centre line, which gives us
x′(s) = Rc cos s, y
′(s) = Rc sin s, z
′(s) = 0; (8.1.2)
x′′(s) = −Rc sin s, y′′(s) = Rc cos s, z′′(s) = 0; (8.1.3)
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Figure 8.1: Sketch of a tumour vessel with constant curvature.
and
Hb(s) =
1
Rc
, Hc(s) = 0. (8.1.4)
Introducing Eqs.(8.1.2) to (8.1.4) into Eq.(4.2.23), we get


Jr = 1,
Jθ = r,
Js = Rc − r cos θ.
(8.1.5)
Substituting Eq.(8.1.5) into Eqs.(4.2.10), (4.2.11), (4.2.12), and introducing
the results into Eqs.(4.2.3) and (4.2.2), we obtain the continuity equation for
the flow through a curved tumour vessel as
∂Ur
∂r
+
Ur
r
− Ur cos θ
Rc − r cos θ +
1
r
∂Uθ
∂θ
+
Uθ sin θ
Rc − r cos θ +
1
Rc − r cos θ
∂Us
∂s
= 0, (8.1.6)
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and the momentum equations as
Ur
∂Ur
∂r
+
Uθ
r
∂Ur
∂θ
+
Us
Rc − r cos θ
∂Ur
∂s
− U
2
θ
r
+
U2s cos θ
Rc − r cos θ
=− 1
ρ
∂p
∂r
− µ
ρ
[
1
r(Rc − r cos θ)
∂
∂r
(
r
∂Us
∂s
)
− Rc
r (Rc − r cos θ)2
∂Us
∂s
− 1
(Rc − r cos θ)2
∂2Ur
∂s2
+
(
1
r
∂
∂θ
+
sin θ
Rc − r cos θ
)(
∂Uθ
∂r
+
Uθ
r
− 1
r
∂Ur
∂θ
)]
, (8.1.7)
Ur
∂Uθ
∂r
+
Uθ
r
∂Uθ
∂θ
+
Us
Rc − r cos θ
∂Uθ
∂s
− U
2
s sin θ
Rc − r cos θ +
1
r
UrUθ
=− 1
ρ
1
r
∂p
∂θ
+
µ
ρ
[
1
(R− r cos θ)2
∂2Uθ
∂s2
− sin θ
(R− r cos θ)2
∂Us
∂s
+
(
∂
∂r
+
sin θ
Rc − r cos θ
)(
∂Uθ
∂r
+
Uθ
r
− 1
r
∂Ur
∂θ
)]
, (8.1.8)
and
Ur
∂Us
∂r
+
Uθ
r
∂Us
∂θ
+
Us
Rc − r cos θ
(
∂Us
∂s
− Ur cos θ + Uθ sin θ
)
=− 1
ρ
1
Rc − r cos θ
∂p
∂s
+
µ
ρ
{
Rc
r2(Rc − r cos θ)2
∂Ur
∂s
− Us
(Rc − r cos θ)2
− sin θ
(Rc − r cos θ)2
∂Uθ
∂s
− 1
r(Rc − r cos θ)
∂2Uθ
∂θ∂s
− 1
Rc − r cos θ
∂2Ur
∂r∂s
+
∂2Us
∂r2
+
1
r
∂Us
∂r
+
Rc − r cos θ
r2
∂
∂θ
[
1
Rc − r cos θ
∂Us
∂θ
]}
. (8.1.9)
As aforementioned in Section 4.3.2, the blood flow through tumour vessels
is fully developed, steady and laminar. When the vessel curvature is mild,
which means that the value of the ratio of vessel cross section radius a over
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vessel curvature radius Rc, or a/Rc, is small, following the procedure illustrated
by Dean (1928) (also in the book by Pedley (1980)), we can presume that Ur,
Uθ, Us and ∂p/∂s are independent of s. We can further replace term
Rc − r cos θ
with Rc, and term
∂/∂r + sin θ/(Rc − r cos θ)
with ∂/∂r respectively. In this way, Eqs.(8.1.6) to (8.1.9) are reduced to
∂Ur
∂r
+
Ur
r
+
1
r
∂Uθ
∂θ
= 0. (8.1.10)
Ur
∂Ur
∂r
+
Uθ
r
∂Ur
∂θ
− U
2
θ
r
+
U2s cos θ
Rc
=− 1
ρ
∂p
∂r
− 1
r
µ
ρ
∂
∂θ
(
∂Uθ
∂r
+
Uθ
r
− 1
r
∂Ur
∂θ
)
, (8.1.11)
Uθ
∂Uθ
∂θ
+ rUr
∂Uθ
∂r
+ UrUθ − rU
2
s sin θ
Rc
=− 1
ρ
∂p
∂θ
+ r
µ
ρ
∂
∂r
(
∂Uθ
∂r
+
Uθ
r
− 1
r
∂Ur
∂θ
)
, (8.1.12)
and
Ur
∂Us
∂r
+
Uθ
r
∂Us
∂θ
=− 1
ρ
1
Rc
∂p
∂s
+
µ
ρ
{
∂2Us
∂r2
+
1
r2
∂2Us
∂θ2
+
1
r
∂Us
∂r
}
. (8.1.13)
Since Ur, Uθ, Us, and ∂p/∂s are independent of s, pressure p can be
assumed in the form of sf1(r, θ)+ f2(r, θ). Based on Eqs.(8.1.11) and (8.1.12),
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we are able to conclude that f1(r, θ) is a constant. As a result, the mean
pressure gradient along the vessel centre line,
− 1
Rc
∂p
∂s
, (8.1.14)
is a constant.
According to Eq.(8.1.10), we set
Ur = −1
r
∂fc
∂θ
, Uθ =
∂fc
∂r
, (8.1.15)
in which fc is a function of r and θ. Introducing the expressions in Eq.(8.1.15)
into Eqs.(8.1.11) to (8.1.13), and eliminating p from Eqs.(8.1.11) and (8.1.12),
we obtain
(
∂fc
∂r
∂
∂θ
− ∂fc
∂θ
∂
∂r
)
∇21fc −
2Us
Rc
(
r
∂Us
∂r
sin θ +
∂Us
∂θ
cos θ
)
=
rµ
ρ
∇41fc, (8.1.16)
and
1
r
(
∂fc
∂r
∂Us
∂θ
− ∂fc
∂θ
∂Us
∂r
)
= −1
ρ
1
Rc
∂p
∂s
+
µ
ρ
∇21Us, (8.1.17)
where
∇21 ≡
∂
∂r2
+
1
r
∂
∂r
+
1
r2
∂
∂θ2
. (8.1.18)
Three non-dimensional relationships are defined as
fc =
µ
ρ
φˆc, Us = U0wˆ, r = arˆ, (8.1.19)
where U0 is the dimensional peak velocity in a straight vessel with the same
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cross-section radius of the curved vessel which is driven by the pressure gradient
defined in Eq.(8.1.14) as
U0 = − 1
Rc
a2
4µ
∂pc
∂s
. (8.1.20)
Applying the definitions to Eq.(8.1.19), Eqs.(8.1.16) and (8.1.17) can be rewrit-
ten in non-dimensional form, which are
(
∂φˆc
∂rˆ
∂
∂θ
− ∂φˆc
∂θ
∂
∂rˆ
)
∇21φˆc +Dwˆ
(
rˆ
∂wˆ
∂rˆ
sin θ +
∂wˆ
∂θ
cos θ
)
= rˆ∇41φˆc, (8.1.21)
and
1
rˆ
(
∂φˆc
∂rˆ
∂wˆ
∂θ
− ∂φˆc
∂θ
∂wˆ
∂rˆ
)
= 4 +∇21Us, (8.1.22)
where
D =
2U20a
3ρ2
µ2Rc
=
ρ2a7
8µ4R3c
(
∂pc
∂s
)2
, (8.1.23)
in which Eq.(8.1.20) has been used. In Eqs.(8.1.21) and (8.1.22), ∇21 has the
same form of the expression in Eq.(8.1.18) through replacing r with rˆ.
Dean (1928) obtained the approximate analytic solution for Eqs.(8.1.21)
and (8.1.22) in powers of constant D (also in the book by Pedley (1980)). The
main application of his work is to calculate the flow rate through the curved
vessel corresponding to the particular value of D, which is
Qc = CDQ¯c, (8.1.24)
where Qc and Q¯c represent the flow rates due to a given pressure gradient
in two vessels with the same cross section which are respectively curved and
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straight, and
CD = 1− 0.03058 ·
[
D
576
]2
+ 0.01195 ·
[
D
576
]4
+O(D6). (8.1.25)
Though the expression in Eq.(8.1.24) is for the flow through an impermeable
vessel with constant curvature, we can assume for certain that Eq.(8.1.24) is
available for our model, since we have noticed that the permeability of tumour
vessel has insignificant effects on the vascular flow, as stated in Section 6.3.
When the high order terms in the perturbation are ignored, Eq.(8.1.24)
is adopted to describe the blood flow through a curved tumour vessel. Sub-
stituting the Poiseuille’s law for the flow flux through a straight vessel in
Eq.(5.1.10) into Eq.(8.1.24), introducing the result into Eq.(4.3.9), and notic-
ing that Hb(s) = 1/Rc and Hc(s) = 0, we get a differential equation for the
vascular flow as
CDd
2pc
ds2
+ CD 4
a(s)
da
ds
dpc
ds
+
dCD
ds
dpc
ds
=
16µR2cLp(s)
a3(s)
[pc(s)− pi(s)] . (8.1.26)
Another equation, or Eq.(4.3.15), which links the vascular flow pressures and
the interstitial pressures on the outer vascular surface, is modified to
1
2
[pi(x0)− p0]
=− 1
2π
∫
lv
∫ 2π
0
∫ 2π
0
Rca(s)
Lp(s)
κ
[pc(s)− pi(s)]G(x,x0)dθ0dθds
+
1
2π
∫
lv
∫ 2π
0
∫ 2π
0
Rca(s) [pi(s)− p0]∇G(x,x0)n(x)dθ0dθds. (8.1.27)
Together with the inlet and outlet conditions for the vascular flow, we obtain
a set of self-contained equations to simulate tumour blood flow when a curved
permeable vessel is embedded in tumour interstitium.
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Following the discretisation procedure stated in Section 4.3.4, the vessel is
divided into NE cylindrical elements along its centre line, and all the physical
variables are approximated to be constant within each element. The continuity
condition is imposed at the middle of every element. Therefore, Eq.(8.1.26)
can be discretised and solved by FDM as
NE∑
j=1
T cjnp
[j]
c = −
16µR2cL
[n]
p
(an)
3 p
[n]
i . (8.1.28)
In the meantime, Eq.(8.1.28) can be discretised and solved by BEM as
NE∑
j=1
{
δnj + 2B¯
[j]
n −
2L
[j]
p
κ
A¯[j]n
}
p
[j]
i
=−
NE∑
j=1
2L
[j]
p
κ
A¯[j]n p
[j]
c + p0
{
1 +
NE∑
j=1
2B¯[j]n
}
. (8.1.29)
By analogy with the numerical procedure in Section 5.1, we are able to solve
Eqs.(8.1.28) and (8.1.29) through iteration. The detailed procedure is de-
scribed as following:
1) Set initial guess for pressure pc(s) inside the vessel, and let coefficient
CD = 1.0.
2) Evaluate the right-hand side of Eq.(8.1.29).
3) Solve Eq.(8.1.29) to obtain interstitial pressure pi(s) on the vascular ex-
terior surface.
4) Evaluate the right-hand side of Eq.(8.1.28).
5) Solve Eq.(8.1.28) to obtain pc(s), and update the value of coefficient CD
according to Eq.(8.1.25).
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6) Go back to step 2 and repeat the procedure until convergence has been
achieved, or the difference in either pc(s), pi(s) or CD from two successive
steps is sufficiently small.
8.2 Results and analysis
For a straight vessel, its curvature radius Rc →∞, which leads to Dean number
D = 0 according to the definition in Eq.(8.1.23). In such a circumstance, flux
ratio parameter CD = 1, and the vascular flow is described by the Poiseuille’s
law. If the curvature of the vessel with the same cross-section area is increased,
one can conclude for certain that the flow rate driven by the same pressure
gradient will decrease. As a result, along the increasing of the value of ratio
a/Rc, the value of flux ratio parameter CD drops, and will reach to the mini-
mum value when the value of D is roughly 650. Therefore, Eq.(8.1.24) will not
be available when D exceeds that critical value due to limit of perturbation
analysis.
Based on the definition in Eq.(8.1.23), vessel radius a has the most pow-
erful effects on D, since D is in direct proportion to the seventh power of a.
Given that inlet pressure for the vascular flow pa = 5.93283× 104 g cm−1s−2,
the outlet vascular flow pressure pv = 1.19990 × 104 g cm−1s−2, vessel length
lv = 1.0 cm and vessel curvature lv/Rc = 4π/3, when D tends to 650, vessel
radius a ≈ 0.02 cm. However, under usual physical and physiological con-
ditions in a solid tumour, vessel radius is within the range between 5 µm to
100 µm [Less et al. (1991)]. Therefore, the expression in Eq.(8.1.24) is suitable
for our simulations. Fig.8.2 displays the dependence of the relative flux coeffi-
cient γ
Q
on number of discretised segments NE , when we adopt the geometric
sizes and physical parameters stated above and set the relative round error as
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Figure 8.2: Dependence of γ on number of segments NE .
Er = 1.×10−6. The results in Fig.8.2 show that the value of γQ becomes mesh
independent as NE increases, and indicate that γQ is accurate enough when
the element size is chosen as δsj = 0.2a/Rc.
For the case of a curved vessel with radius a = 0.01 cm, the inner and outer
pressure distributions along the vessel with difference curvatures are plotted in
Fig.8.3, when the same inlet and outlet vascular flow conditions stated above
are used. Along the increase of vessel curvature, the variation of vascular flow
pressures is insignificant, while the interstitial pressures on the external vascu-
lar surface are clearly elevated. This is mainly because the relative positions
of vessel cross sections have changed because of the vessel curvature, which
affects the interactions of the transmural flow among these cross sections. As
a result, the extravasation flux is decreased since the vessel permeability and
radius remain constant, which leads to a drop of the relative flux coefficient γ
Q
,
as presented in Fig.8.4. These results show that vessel curvature is harmful for
the transvascular movement of anti-cancer agents with heavy weight and the
effectiveness of chemotherapy and radiotherapy. However, we should be aware
that the governing equations presented in this chapter are available for the
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Figure 8.3: Distributions of (a) vascular flow pressures, and (b) interstitial
pressures on the external vascular surface.
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Figure 8.4: Dependence of γ on the vessel curvature.
vessel with mild curvature, or the value of ratio a/Rc is low. For large vascular
curvature, or high value of ratio a/Rc, a different model may be needed, and
conditions might be different.
In the meantime, the complex shape of tumour vessel has strong influence
on the distributions of the interstitial pressure and the flow fluid within tumour
interior. Figs.8.5 and 8.6 display the three-dimensional simulation results for
167
x/
y/
-0.5 0 0.5 1 1.5
-1
-0.5
0
0.5
1
a(100 )
∨ a
(10
0
)
∨
(a) when lv/Rc = 0
x/
y/
-0.5 0 0.5 1 1.5
-1
-0.5
0
0.5
1
a(100 )
∨ a
(10
0
)
∨
(b) when lv/Rc = 0
x/
y/
-0.5 0 0.5 1 1.5
-1
-0.5
0
0.5
1
a(100 )
∨ a
(10
0
)
∨
(c) when lv/Rc = pi/3
x/
y/
-0.5 0 0.5 1 1.5
-1
-0.5
0
0.5
1
a(100 )
∨ a
(10
0
)
∨
(d) when lv/Rc = pi/3
x/
y/
-1 -0.5 0 0.5 1 1.5
-1
-0.5
0
0.5
1
a(100 )
∨ a
(10
0
)
∨
(e) when lv/Rc = 2pi/3
x/
y/
-1 -0.5 0 0.5 1 1.5
-1
-0.5
0
0.5
1
a(100 )
∨ a
(10
0
)
∨
(f) when lv/Rc = 2pi/3
Figure 8.5: Slides of 3D simulation results for (a, c, e) pressure contours and
(b, d, f) blood flow velocity streamlines on the vessel located
plane.
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Figure 8.6: Slides of 3D simulation results for (a, c, e) pressure contours and
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plane.
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the interstitial pressure contours and the flow velocity streamlines when the
vessel is bent with different curvatures. The shapes of pressure contours vary
rapidly near the vessel, but tend to be circle away from the vessel. This
indicates that the effects of vessel curvature are more significant on the blood
flow field around the vessel than that far away from the vessel. Meanwhile,
the results of the interstitial flow velocity streamlines show that the interstitial
flow on the concave side of the vessel is less active than that on the convex
side, and this phenomena becomes more visible along the increasing of vessel
curvature. This can lead to uneven distribution of flow flux within tumour
space, which would cause insufficient, maybe no supply of anti-cancer agents
in some area of tumour interior. As a result, the cancerous cells might not be
removed thoroughly within the entire interstitium, which may induce tumour
regrowth, and/or develop drug resistance tumour cells. All these results prove
that vessel curvature, which is one of the special characters of tumour vascular
configuration relative to normal vessels, forms physiological barriers for cancer
treatment.
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According to the results in Fig.8.3a, we notice that the change of the
vascular flow pressures is insignificant along the variation of vessel curvature.
Eq.(8.1.24) describes that the flux through a curved vessel with given cross-
section area and pressure gradient is equal to the flow rate through a straight
vessel with the identical geometric and physical conditions multiplying flux ra-
tio parameter CD. When the Dean number is with the critical value asD = 650,
CD = 0.98044. This indicates that, when the vessel curvature is mild, the flux
through a curved vessel obtained by the expression in Eq.(8.1.24) is very close
to that calculated by the Poiseuille’s law directly. Therefore, we can assume
that for the blood flow through a curved vessel in tumour, the Poiseuille’s law
in Eq.(5.1.10) can be applied to replace Eq.(8.1.24). Fig.8.7 shows that when
D = 647, the results obtained by the Poiseuille’s law (symbols) are in good
agreement with the results calculated by Eq.(8.1.24) (solid line). Meanwhile,
the results in Fig.8.8, which present the dependence of γ
Q
on Dean number D,
also confirm our assumption.
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Chapter 9
Flow through a Permeable
Vascular Network in a Solid
Tumour
In Chapters 7 and 8, adopting the governing equations derived in Chapter 4,
we have investigated the effects of two abnormal characters of tumour vascular
architecture, which are the disordered vessel radius and vessel curvature, on
tumour blood flow when tumour vasculature is represented as a single vessel.
Nevertheless, the practical tumour vasculature is a three-dimensional vascular
network characterised with excessive branches and loops. The tumour vas-
cular configuration is complex and disorganised relative to the vasculature in
normal tissues. The normal vasculature forms a well-organized, regulated and
functional architecture featured by symmetrical dichotomous branching [Jain
(2003)]. In contrast, the vascular architecture in tumour is disordered and has
atypical bifurcations, trifurcations, self loops and true loops [Less et al. (1991)].
Such a kind of complicated vascular network has strong effects on tumour blood
flow, which can significantly affect the delivery of anti-cancer agents in tumour.
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Figure 9.1: Sketch of vascular configuration around the junction point when
one mother vessel splits into two daughter vessels.
In this chapter, we study three representative vascular structures of tumour
vasculature, including symmetrical dichotomous branching, asymmetrical bi-
furcation with uneven radius of daughter vessels, and trifurcation. Under most
circumstances, the practical tumour vascular network can be decomposed into
these three types of structures, which is the motivation of the investigations
in this chapter.
For tumour vasculature with complicated configuration, some new chal-
lenges are presented in both our mathematical model and the numerical pro-
cedure compared with the case in which tumour vasculature is represented
by a single vessel. For example, when vessels meet together at a junction
point, such as a structure of bifurcation (Fig.9.1), it is required to establish
the mathematical description for the flow pattern around the junction. The
features of the vascular flow at the junction can affect the flow inside each
vessel connecting with it, and eventually have effects on the entire tumour
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blood flow. In the meantime, for the complicated vascular network, along the
increasing of the number of vessels, the total number of discretised segments
generated within the whole vascular network will increase. As aforementioned
in Section 5.1, this can make the size of the global fully populated coefficient
matrix in BEM enlarged rapidly, which would lead to our numerical simulation
encountering with prohibitiveness of computer memory and CPU. Under such
a circumstance, some special numerical methods, the domain decomposition
method [Wu and Taylor (2003)] for instance, are applied to solve the problem.
These issues will be investigated in detail in the following sections.
9.1 Continuity conditions for the flow at the
junction in vascular network
Based on the analysis in Section 8.2, under the usual physical and physiological
conditions, we can directly apply the Poiseuille’s law,
Qc = −πa
4(l)
8µ
dpc
dl
, (9.1.1)
to describe the blood flow through a tumour vessel even if the vessel is not
straight.
Within a vascular network in either normal or tumour tissues, a typical
configuration with junction is that mother vessel m with radius am separates
into two daughter vessels d1 and d2 with radii a
d1 and ad2 respectively at
junction point J, as illustrated in Fig.9.1. The outside angle between the
mother vessel centre line and the centre line of the kth daughter vessel (dk) is
represented by βk (k = 1, 2 for the case in Fig.9.1). In our model, it is assumed
that all the vessels are perfectly matched at the junction. Consequently, at
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junction point J, the pressure for the flow in vascular network is continuous,
or
pmc (l) = p
dk
c (l) = p
J
c , (9.1.2)
and the mass conservation holds, or
Qmc (l) =
Nd∑
k=1
Qdkc (l), (9.1.3)
in which pJc is the vascular flow pressure at junction point J, and Nd (Nd = 2
for the case in Fig.9.1) is the number of the daughter vessels connecting with
the junction. Introducing Eq.(9.1.1) into Eq.(9.1.3), we get
[amJ (l)]
4 d
dl
∣∣∣∣
J
[pmc (l)] =
Nd∑
k=1
[
adkJ (l)
]4 d
dl
∣∣∣∣
J
[
pdkc (l)
]
. (9.1.4)
Eq.(9.1.4) offers us a mathematical relationship to calculate pJc . Similar to
Eq.(5.1.11), the flow through each vessel within the vascular network is de-
scribed by
[Hb(s)]
2d
2pc
ds2
+
{
4[Hb(s)]
2
a(s)
da(s)
ds
+Hc(s)Hb(s)
}
dpc
ds
=
16µLp(s)
a3(s)
[pc(s)− pi(s)] . (9.1.5)
In the above equation, Hb(s) and Hc(s) are kept to represent the effects of
vessel shape on the vascular flow, which are defined in Eqs.(4.1.6) and (4.1.7)
respectively. Meanwhile, at junction point J, the pressure gradient condition
in Eq.(9.1.4) is rewritten as
[amJ (s)]
4Hmb (s)
d
ds
∣∣∣∣
J
[pmc (s)] =
Nd∑
k
[
adkJ (s)
]4
Hdkb (s)
d
ds
∣∣∣∣
J
[
pdkc (s)
]
. (9.1.6)
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Another relationship linking the vascular internal and external pressures is
described in Eq.(4.3.15). Eq.(4.3.15) is available for the case when the vascu-
lature is represented by a single vessel. If there are more than one vessel em-
bedded in tumour interstitium, the whole coupling effects of all vessels should
be included, Eq.(4.3.15) is then modified to
1
2
[pi(x0)− p0]
=−
NV∑
k=1
1
2π
∫
l
[k]
v (s)
∫ 2π
0
∫ 2π
0
a(s)
Hb(s)
Lp(s)
κ
[pc(s)− pi(s)]G(x,x0)dθ0dθds
+
NV∑
k=1
1
2π
∫
l
[k]
v (s)
∫ 2π
0
∫ 2π
0
a(s)
Hb(s)
[pi(s)− p0]∇G(x,x0)n(x)dθ0dθds, (9.1.7)
in which NV stands for the number of the vessels within the entire tumour
vascular network.
Similar to the discretisation procedure described in Section 4.3.4, every
vessel within tumour vasculature is divided into small cylindrical elements
along its centre line, and all the physical variables are approximated to remain
constant within each element. The continuity condition is then imposed at
the middle of every element. As a result, Eq.(9.1.7) can be discretised and
calculated by BEM as
N¯E∑
j=1
{
δnj + 2B¯
[j]
n −
2L
[j]
p
κ
A¯[j]n
}
p
[j]
i
=−
N¯E∑
j=1
2L
[j]
p
κ
A¯[j]n p
[j]
c + p0

1 +
N¯E∑
j=1
2B¯[j]n

 , (9.1.8)
where N¯E is the number of discretised segments for the whole tumour vascular
network.
In the meantime, along the kth daughter vessel, for segment 2 ≤ n ≤
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NdkE − 1, Eq.(9.1.5) can be discretised and calculated by FDM as
N
dk
E∑
j=1
T dkjn pc
[j] = −16µLp
[n]
(an)
3 pi
[n], n = 2, 3, · · · , NdkE − 1, (9.1.9)
where NdkE is the number of elements on the kth daughter vessel, and
T dkjn =


2
(
Hb
[n]
)2
(∆sn +∆sn+1)∆sn
−
∆sn+1
(
Hb
[n]
)2
(∆sn +∆sn+1)∆sn
(
4a′n
an
+
Hc
[n]
Hb
[n]
)
j = n− 1,
(∆sn+1 −∆sn)
(
Hb
[n]
)2
∆sn∆sn+1
[
4a′n
an
+
Hc
[n]
Hb
[n]
]
−
2
(
Hb
[n]
)2
∆sn∆sn+1
− 16µLp
[n]
(an)
3 j = n,
2
(
H
[n]
b
)2
(∆sn +∆sn+1)∆sn+1
+
∆sn
(
H
[n]
b
)2
(∆sn +∆sn+1)∆sn+1
(
4a′n
an
+
H
[n]
c
H
[n]
b
)
j = n+ 1,
0 else.
(9.1.10)
The pressure continuity condition in Eq.(9.1.2) is used as the inlet boundary
condition for the flow inside each daughter vessel. Therefore, for segment n = 1
on the kth daughter vessel, Eq.(9.1.9) is reduced to
NkE∑
j=1
T dkj1 p
[j]
c = −
16µL
[1]
p
(a1)
3 p
[1]
i − T dkJ pJc , (9.1.11)
where
T dkj1 =


∆s2 −∆sJ
∆s
J
∆s2
(
4a′1
a1
+
H
[1]
c
H
[1]
b
)
−
2
(
H
[1]
b
)2
∆s
J
∆s2
− 16µL
[1]
p
(a1)
3 j = 1,
∆s
J
(∆s
J
+∆s2)∆s2
(
4a′1
a1
+
H
[1]
c
H
[1]
b
)
+
2
(
H
[1]
b
)2
(∆s
J
+∆s2)∆s2
j = 2,
0 else,
(9.1.12)
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and
T dk
J
= − ∆s2
(∆s
J
+∆s2)∆sJ
(
4a′1
a1
+
H
[1]
c
H
[1]
b
)
+
2
(
H
[1]
b
)2
(∆s
J
+∆s2)∆sJ
, (9.1.13)
in which ∆s
J
= s1−sJ, and sJ reflects the position of junction J. When outlet
pressure pv for the vascular flow is given at the venous point of every daughter
vessel, for segment n = NkE on the kth daughter vessel, Eq.(9.1.9) is reduced
to
NkE∑
j=1
T dk
jNkE
p[j]c = −
16µL
[NkE ]
p(
a
Nk
E
)3 p[NkE ]i − T dkv pv, (9.1.14)
where
T dk
jNkE
=


2
(
H
[NkE]
b
)2
(∆s
Nk
E
+∆sv)∆s
Nk
E
− ∆sv
(∆s
Nk
E
+∆sv)∆s
Nk
E

4a′NkE
a
Nk
E
+
H
[NkE]
c
H
[Nk
E
]
b

 j = NkE − 1,
∆sv −∆s
Nk
E
∆s
Nk
E
∆sv

4a′NkE
a
Nk
E
+
H
[NkE]
c
H
[Nk
E
]
b

− 2
(
H
[NkE]
b
)2
∆s
Nk
E
∆sv
− 16µL
[NkE]
p(
a
Nk
E
)3 j = NkE ,
0 else,
(9.1.15)
and
T dkv =
∆s
Nk
E
(∆s
Nk
E
+∆sv)∆sv

4a′NkE
a
Nk
E
+
H
[NkE ]
c
H
[NkE ]
b

 + 2
(
H
[NkE]
b
)2
(∆s
Nk
E
+∆sv)∆sv
. (9.1.16)
The governing equations for the flow inside the mother vessel can be discretised
in the same manner. However, the flux conservation condition in Eq.(9.1.3)
instead of the pressure is imposed at the junction. The flux condition is given
through the pressure derivatives in Eq.(9.1.6), and the three-point back and
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forward difference formulae are applied to replace the derivatives on the left-
and right-hand sides of that equation respectively. Eq.(9.1.6) then becomes
1∑
j=0
(
Tmj+2
)
p
[NmE −j]
c + T
m
1 p
J
c =
NkE∑
k=1
[
T dk1 p
J
c +
2∑
j=1
T dkj+1p
dk[j]
c
]
, (9.1.17)
where NmE is the number of elements generated along the mother vessel,


Tm1 = −
H
[NmE ]
b(
a
Nm
E
)4 2sJ − sNmE − sNmE −1(
s
J
− s
Nm
E
)(
s
J
− s
Nm
E
−1
) ,
Tm2 =
H
[NmE ]
b(
a
Nm
E
)4 sJ − sNmE −1(
s
J
− s
Nm
E
)(
2s
J
− s
Nm
E
− s
Nm
E
−1
) ,
Tm3 = −
H
[NmE ]
b(
a
Nm
E
)4 sJ − sNmE(
s
J
− s
Nm
E
−1
)(
2s
J
− s
Nm
E
− s
Nm
E
−1
) ,
(9.1.18)
and


T dk1 = −
Hdkb
[1](
adk1
)4 sdk1 + sdk2 − 2sJ(
sdk1 − sJ
)(
sdk2 − sJ
) ,
T dk2 =
Hdkb
[1](
adk1
)4 sdk2 − sJ(
sdk1 − sJ
)(
sdk1 + s
dk
2 − 2sJ
) ,
T dk3 = −
Hdkb
[1](
adk1
)4 sdk1 − sJ(
sdk2 − sJ
)(
sdk1 + s
dk
2 − 2sJ
) .
(9.1.19)
If inlet vascular flow pressure pa is given at the arterial point of the mother
vessel, for segment n = 1 on the mother vessel, the discretised equation is in the
same form of Eq.(9.1.11) but replacing pJc and sJ with pa and sa respectively.
The above set of equations can be solved through iteration. Similar to
the numerical procedure in Section 5.1, the detailed procedure for blood flow
through a vascular network is summarised as below:
1) Set up initial guess for interstitial pressure pi(s) on the exterior vascular
surface.
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2) Guess the vascular pressure pJc at the junction.
3) Evaluate the right-hand sides of Eqs.(9.1.9), (9.1.11) and (9.1.14).
4) Solve Eqs.(9.1.9), (9.1.11) and (9.1.14) for the pressures inside the daugh-
ter vessels.
5) Solve the equations similar to Eqs.(9.1.9) and (9.1.11) for the pressures
inside the mother vessel by applying the flux conservation condition in
Eq.(9.1.17) at the junction.
6) Use the solution of the pressures inside the mother vessel to get new pJc .
7) Repeat step 3 to step 6 until the pressures for the vascular flow have
converged.
8) Evaluate the right-hand side of Eq.(9.1.8).
9) Solve Eq.(9.1.8) for the interstitial pressures on the exterior vascular
surface.
10) Repeat step 2 to step 9 until the pressures both inside the vascular net-
work and on the outside vascular walls have converged.
Compared with the computation procedure for the case of a single vessel as
stated in Section 5.1, only steps 1, 3, 4, 9 and 10 mentioned above are previ-
ously involved.
To verify the mathematical model and the numerical procedure for the
case of tumour vasculature with branches, we artificially divide the single
straight vessel in the case which was investigated in the beginning of Section
5.2 into two separated parts. Each part of the vessel is solved independently,
and the conditions of pressure continuity and flux conservation are imposed
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Figure 9.2: Sketch of a single straight vessel splits into two connecting
straight vessels.
at the junction or the interface, as sketched in Fig.9.2. Adopting the physical
parameters of that test case, the pressures inside the vessel, the interstitial
pressures on the external vascular surface, and the extravasation flux obtained
by the one-whole-vessel simulation and by the two-separated-vessel simulation
are presented in Fig.9.3, when the mesh size is set as δsj = 0.2a and the rel-
ative round error as Er = 1 × 10−6 for these two simulations. Fig.9.3 shows
that the results are in excellent agreement, which indicates that our match-
ing conditions at the junction and the numerical procedure are rational. The
calculation time by the one-whole-vessel simulation is 142s, while the time by
the two-separated-vessel simulation is 160s. The clear difference of the simu-
lation time is due to that the numerical procedure in the two-separated-vessel
simulation is more complicated than that in the one-whole-vessel simulation.
According to the foregoing analysis in Section 5.2, the domain decom-
position method [Wu and Taylor (2003)] can be adopted to avoid the pro-
hibitiveness of computer CPU and memory when the size of the global fully
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Figure 9.3: Distributions of (a) vascular flow pressures and interstitial pres-
sures on the external vascular surface, (b) extravasation flux
along vessel. Solid line: results with one-vessel-simulation; sym-
bols: results with two-vessel-simulation.
populated matrix in BEM is too large. Mathematically, the basic idea of the
domain decomposition method is to separate the fully populated matrix into
sub-matrices with small sizes along its principal diagonal as
[
MxN¯EN¯EBEM
]
=


Mx11BEM Mx
12
BEM · · · Mx1sBEM
Mx21BEM Mx
22
BEM · · · Mx2sBEM
...
...
...
...
Mxk1BEM Mx
k2
BEM · · · MxkkBEM


. (9.1.20)
As a result, the original large-size set of discretised equations derived by
BEM, for example Eq.(9.1.8), is divided into some sets of discretised equations
with smaller size based on the sub-matrices MxiiBEM (i = 1, 2, · · · , k) along
the principal diagonal of the matrix on the right-hand side of Eq.(9.1.20).
These sets of equations can be solved through iteration. In this way, only part
of coefficients within the original global fully populated matrix in BEM are
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Table 9.1: Calculation time by two-separated-vessel simulation
Method Time(s)
size of MxiiBEM = 250× 250 i = 1, 2 4839
size of MxiiBEM = 125× 125 i = 1, 2, 3, 4 7190
one domain method 160
stored during the entire numerical simulation, which can help us to avoid the
prohibitiveness of personal computer CPU and memory. However, adopting
the domain decomposition method has to sacrifice simulation time, since there
is one more inner iteration to be added into the numerical procedure stated
above, and the unrecorded BEM coefficients are required to be calculated in
every step of this inner iteration. Table9.1 shows that there is a significant
increase of calculation time for the test case by the domain decomposition
method compared with the original one domain method.
9.2 Symmetrical dichotomous branching
Having verified the model, we take our study to the next step to consider the
cases as tumour vasculature with branches. Firstly, we investigate a case of
a symmetrical structure of vasculature when a straight mother vessel splits
into two straight daughter vessels with the same radius, and both two outside
angles at the junction are equal to each other, or β1 = β2 = β. This kind
of symmetrical dichotomous branching configuration is not only common in
normal tissues, but also can be found in tumour tissues. In this case, the
vascular network is permeable and embedded in a large solid tumour whose
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surface is far away from the network. All the vessel centre lines are placed on
one plane (oxy), and the afferent connecting point (arterial point) of mother
vessel m is located at origin o of reference frame o − xyz whose centre line is
along axis x, as illustrated in Fig.9.1. According to the patterns of tumour
vascular network summarised by Less et al. (1991), if the outside angles of two
daughter vessels are equal with each other, the radii of both daughter vessels
are one order lower than that of the mother vessel. Therefore, we can define
the geometrical sizes of the vascular network in the present case as followings:
lengths of all three vessels lmv = l
d1
v = l
d2
v = 0.5 cm, radius of mother vessel
am = 0.01 cm, radii of two daughter vessels ad1 = ad2 = 0.004 cm, and outside
angle β = 2π/3 at junction point J. Meanwhile, we set the tumour hydraulic
conductivity parameter as κ = 10−10 g−1cm3s, the tumour peripheral pressure
as p0 = 6.666 × 102 g cm−1s−2, the permeable parameters of all three vessels
as Lmp = L
d1
p = L
d2
p = 10
−9 g−1cm2s, the inlet vascular flow pressure in the
mother vessel as pa = 5.93283×104 g cm−1s−2, and the outlet venous pressures
for the flow in both daughter vessels as pd1v = p
d2
v = 1.19990× 104 g cm−1s−2.
According to the symmetry of the geometrical and physical data in this case, we
are able to predict that the flow patterns in two daughter vessels are identical
to each other, and the tumour interstitial flow field is symmetrical, as shown in
Figs.9.4 and 9.5 respectively. In Fig.9.4, we display the vascular flow pressures
and the interstitial pressures on the exterior vascular surface along all three
vessels together by placing the daughter vessels as the extension of the mother
vessel after the junction. The results in Fig.9.4a directly reflect the pressure
continuity condition for the vascular flow at junction point J as defined in
Eq.(9.1.2). This figure also shows that pressure pc(s) in both daughter vessels
decreases faster than that in the mother vessel. Generally speaking, the blood
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Figure 9.4: Distributions of (a) vascular flow pressures and (b) interstitial
pressures on the exterior vascular surface.
flow through a vascular network can be described as
Q =
∇pc
ZηZg
, (9.2.1)
in which Zη and Zg reflect the viscous and the geometrical resistances for the
vascular flow respectively. Viscous resistance Zη can be taken as a constant
since the blood viscosity is fixed throughout this work, while geometrical resis-
tance Zg varies according to the structure and geometrical sizes of the vascular
network. Zg depends on the geometrical sizes of vessels strongly, particularly
on vessel radius. For example, when the vasculature is represented by a single
straight vessel, Zg is in inverse proportion to the forth power of vessel radius
as described by the Poiseuille’s law in Eq.(9.1.1). In the present case, notic-
ing that the outlet venous pressures for the flow in both daughter vessels are
equal to each other, and taking into account the matching conditions for the
vascular flow at the junction defined in Eqs.(9.1.2) and (9.1.3), we can regard
the daughter vessels as two resistances which are connected in parallel, and
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the mother vessel and the daughter vessels as two resistances which are con-
nected in series at junction point J. As a consequence, the overall geometrical
resistance for the vascular flow can be written as
Zg = Z
m
g + Z
d
g , (9.2.2)
where Zmg is the geometrical resistance of mother vessel m, and
Zdg =
1
1
Z
d1
g
+ 1
Z
d2
g
, (9.2.3)
in which Zd1g and Z
d2
g represent the geometrical resistances of daughter vessels
d1 and d2 respectively. For our current case, since the geometrical sizes of the
two daughter vessels are identical to each other, we have
Zdg =
1
2
Zd1g . (9.2.4)
As the mother vessel and the daughter vessels are all straight, and they are
identical in length, we can conclude that Zmg is much lower than Z
d
g as the
radius of the mother vessel is larger than that of the daughter vessel. As a
result, the pressure gradient in the mother vessel is lower than that in the
daughter vessel.
Meanwhile, the pattern of the pressures inside vessels affects the inter-
stitial pressures on the exterior vascular surface significantly, as displayed in
Fig.9.4b. The results in this figure also show that the interstitial pressures
on the external vascular surface have some rapid variation near the junction.
Strictly speaking, for the interstitial pressures on the exterior vascular surface
near the junction, the present model may not be sufficiently accurate, since
there are sharp corners where the vessels meet. As a result, the normal vector
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Figure 9.5: Slides of 3D simulation results for (a) pressure contours and (b)
blood flow velocity streamlines on the vascular network located
plane.
of the vascular surface at junction point J is not continuous. Ideally, it may be
required to obtain a local solution for the interstitial flow around the junction
referring to the research work in the area of naval and ocean engineering as
illustrated by Faltinsen and Pettersen (1987). However, when our interest lies
in the global results, the present model is still highly relevant (Fig.9.5).
The symmetrical flow can be easily disturbed when there are some pertur-
bations on physical parameters, such as the unequal outlet venous pressures, or
the unequal vascular permeable coefficients of two daughter vessels. Permeabil-
ity is one of the particular features of tumour vasculature relative to the vessels
in normal tissues. As have been discussed in Section 6.3, the effects of vessel
permeability on vascular flow are insignificant. Consequently, when we adjust
permeability Ld2p of daughter vessel d2 while let the rest of physical parameters
remain unchanged, the pressure at the junction in the vascular network almost
remains constant, as shown in Fig.9.6. However, vessel permeability has strong
influence on the interstitial pressures on the external vascular surface and the
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extravasation flux. Along the increasing of Ld2p , interstitial pressure pi(s) on
the exterior surface of the entire vascular network is elevated, as shown in
Figs.9.7a, 9.7b and 9.7c. The distribution of extravasation flux along the vas-
cular network is complicated. For either mother vessel m or daughter vessel d1,
as their permeability does not vary, the extravasation flux along either of them
is decreased since pi(s) is elevated while pressure pc(s) inside vessels almost
remains unchanged, as presented in Figs.9.7a and 9.7b. On the other hand,
for daughter vessel d2, due to the increasing of vessel permeability L
d2
p , the
extravasation flux is increased despite the elevated pi(s), as shown in Fig.9.7c.
The results in Fig.9.8a indicate that the relative flux coefficient γ
Q
is improved
when Ld2p increases, where the definition of γQ has been modified to
γ
Q
=
Qa −
Nd∑
k=1
Qkv
Qa
. (9.2.5)
Consequently, the whole amount of the extravasation flux for the entire vascu-
lar network is improved when Ld2p is raised, since the flow through the vascular
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network is barely affected, as plotted in Fig.9.8b. Meanwhile, the asymmetrical
interstitial pressures on the external vascular surface and the uneven extrava-
sation flux caused by the unequal permeability of the two daughter vessels have
some clear effects on the flow in tumour interstitium. Fig.9.9 shows that near
the vascular network, the daughter vessel with higher permeability generates
higher interstitial pressures around it, which pushes blood flow to the daugh-
ter vessel with lower permeability. Nevertheless, away from the vasculature,
the shapes of the interstitial pressure contours tend to be circular. Therefore,
one can conclude that vessel permeability can affect the extravasation flux,
the relative flux coefficient, and the blood flow field within tumour interior at
some level. If part vessel permeability can be adjusted, the overall ability of
transvascular delivery of macromolecules with heavy weight and the effective-
ness of radiotherapy and chemotherapy could be improved by raising that part
of the vascular permeability.
The unequal outlet venous pressures for the flow in two daughter vessels
can also disturb the symmetrical flow field within tumour interstitium even
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Figure 9.9: Slides of 3D simulation results for (a, c) pressure contours and
(b, d) blood flow velocity streamlines on the vascular network
located plane.
though the vasculature is symmetrical. If we increase outlet venous pressure pd2v
for the flow in daughter vessel d2, but keep the other physical flow parameters
to remain constant, vascular flow pressure pJc at the junction is raised, and
interstitial pressure pi(s) on the external vascular surface is elevated, as shown
in Figs.9.10 and 9.11 respectively. In the meantime, the results in Fig.9.11
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indicate that the daughter vessel with higher outlet venous pressure generates
higher interstitial pressures around it compared with the interstitial pressures
near the daughter vessel with the lower outlet venous pressure. This affects the
distributions of the interstitial pressure and the flow fluid in tumour interior, as
presented in Fig.9.12. We might be able to obtain the similar flow phenomena
192
x/
y/
-0.5 0 0.5 1 1.5
-1
-0.5
0
0.5
1
a(100 )
∨ a
(10
0
)
∨
(a) pd1v /pˇ = 0.9, p
d2
v /pˇ = 0.65
x/
y/
-0.5 0 0.5 1 1.5
-1
-0.5
0
0.5
1
a(100 )
∨ a
(10
0
)
∨
(b) pd1v /pˇ = 0.9, p
d2
v /pˇ = 0.65
x/
y/
-0.5 0 0.5 1 1.5
-1
-0.5
0
0.5
1
a(100 )
∨ a
(10
0
)
∨
(c) pd1v /pˇ = 0.9, p
d2
v /pˇ = 2.15
x/
y/
-0.5 0 0.5 1 1.5
-1
-0.5
0
0.5
1
a(100 )
∨ a
(10
0
)
∨
(d) pd1v /pˇ = 0.9, p
d2
v /pˇ = 2.15
Figure 9.12: Slides of 3D simulation results for (a, c) pressure contours and
(b, d) blood flow velocity streamlines on the vascular network
located plane.
based on the results in Section 6.1.1 by regarding that the outlet vascular flow
pressure in mother vessel m, the inlet vascular flow pressure in daughter vessel
d1, and both inlet and outlet pressures for the flow in daughter vessel d2 are
increased. However, it is necessary to be noticed that the interstitial pressures
obtained here represent the fully coupling effects of all vessels within the entire
vascular network, not the simply added-up results when we artificially take
part of the vascular network to calculate each vessel individually. According
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to the foregoing analysis in Section 6.1.1, when the vasculature is represented
by a single vessel, the extravasation flux and the relative flux coefficient γ
Q
are
both improved if the outlet vascular flow pressure is elevated. The same trends
of the variations of the extravasation flux and the relative flux coefficient are
presented when we only increase the outlet venous pressure for the flow in
daughter vessel d2 (Fig.9.13). Then, if the tumour vasculature has multiple
outlet venous ends, it could be beneficial for the delivery of anti-cancer particles
with heavy weight through vascular walls in tumour and the effectiveness of
radiotherapy and chemotherapy when we can elevate one or more outlet venous
vascular flow pressures.
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9.3 Asymmetrical bifurcation
In order to support tumour growth, abnormal branching pattern is induced by
angiogenesis which is not usually found in normal tissues [Less et al. (1991)].
One of the special tumour vascular structures is an asymmetrical bifurcation.
Unlike the vascular configuration with symmetrical dichotomous branching in
normal tissues, Less et al. (1991) stated that some of the vascular bifurcations
in tumour are atypical. For such a kind of vascular bifurcation, the outside
angles between the daughter vessels and the mother vessel are unequal. Fur-
thermore, the radius of the daughter vessel with larger outside angle (normally
between 8π/9 and π) retains the same order as the radius of the mother vessel,
while the radius of the daughter vessel with smaller outside angle (normally
less than 8π/9) is one order lower than that of the mother vessel.
We set up a study case for tumour blood flow here, in which an asym-
metrically bifurcated vascular network with permeability is embedded in a
solid tumour to a large extent. Similar to the investigation case in Section
9.2, all the vessel centre lines are located on one plane (oxy), and the afferent
connecting point (inlet point) of mother vessel m is fixed at origin o whose
centre line is along axis x. The lengths of all vessels are identical, and set as
lmv = l
d1
v = l
d2
v = 0.5 cm. However, in the present case, the two outside angles
are not equal with each other, but assigned as β1 = 2π/3 and β2 = 17π/18
respectively. According to the patten of tumour vascular configuration stated
above, we let radii am = 0.01 cm, ad1 = 0.004 cm and ad2 = 0.008 cm for
mother vessel m, daughter vessels d1 and d2 respectively. There are two sig-
nificant differences of the vascular structure between the present study case
(Case BaS) and the case investigated in Section 9.2 (Case BS). One is that the
radius of daughter vessel d2 in Case BaS is enlarged significantly relative to
that in Case BS. The other is that the two outside angles are unequal to each
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other in the current case.
Based on the discussions in Sections 7.1 and 9.2, we notice that vessel
radius has strong effects on tumour blood flow, especially on vascular flow.
In our current study case (Case BaS), if the inlet vascular flow pressure in
the mother vessel is given as pma = 5.93283 × 104 g cm−1s−2, and the outlet
vascular flow pressures in both daughter vessels as pd1v = p
d2
v = pv = 1.19990×
104 g cm−1s−2, referring to the analogy described in Eqs.(9.2.1) to (9.2.3), we
can conclude that resistance Zd2g decreases when the radius of daughter vessel
d2 is enlarged while the radii of the other vessels within the vascular network
remain unchanged. This leads to the decreasing of the overall geometrical
resistance for the vascular flow. As a result, according to Eq.(9.2.1), the flux
flowing through the vascular network is increased in Case BaS relative to that
in Case BS since pressure difference pa − pv of the two cases is identical to
each other. Consequently, the pressure gradient along the mother vessel is
elevated since resistance Zmg remains constant, which indicates that vascular
flow pressure pJc at the junction is lowered as pa remains unchanged. Fig.9.14
presents the difference of the tumour blood flow between Case BaS and Case
BS when we let tumour hydraulic conductivity parameter κ = 10−10 g−1cm3s,
tumour peripheral pressure p0 = 6.666×102 g cm−1s−2, and vessel permeability
Lp = 10
−9 g−1cm2s. Fig.9.14a reflects the above analysis that the vascular flow
pressure at the junction in Case BaS is lower than that in Case BS. This also
leads to that the pressures in vessels are lower under Case BaS than those under
Case BS. Meanwhile, we notice that the pressures inside the two daughter
vessels in Case BaS are almost the same. This is due to that both the inlet and
the outlet vascular flow pressures in these two daughter vessels are respectively
identical to each other, and the variation of vessel radius has insignificant
effects on the pressures in vessel, as discussed in Section 7.1. The results in
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Figure 9.14: Distributions of (a) vascular flow pressures, (b) interstitial pres-
sures on the external vascular surface, (c) transmural pressure
differences, and (d) extravasation flux along the vascular net-
work.
Fig.9.14 show that, relative to the daughter vessel with smaller radius, the
daughter vessel with larger radius can generate higher interstitial pressures
on its external vascular surface (Fig.9.14b) and transport more extravasation
flux (Fig.9.14d), even though the transmural pressure difference is reduced
(Fig.9.14c). This is due to the broadened vascular surface area caused by the
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Figure 9.16: Distributions of interstitial pressures on the external vascular
surface. Delta symbols: daughter vessel d1; square symbols:
daughter vessel d2.
enlarged vessel radius. The flow phenomena are consistent with the results in
Section 7.1. We have to be aware that the results presented here are not the
simple additions of the simulation results obtained via three individual vessels.
The fully coupling effects between all the vessels within the whole vascular
network are included in this case. The results in Fig.9.15 show that the overall
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extravasation flux and the relative flux coefficient γ
Q
are lowered when the
radius of daughter vessel d2 is enlarged. These results have some difference
compared with the case in Section 7.1 when the vasculature is represented
by a single straight vessel, in which we have seen that enlarging vessel radius
reduces the relative flux coefficient γ
Q
, but improves the overall extravasation
flux.
The outside angles between mother vessel and daughter vessels reflect the
relative positions of vessels in vascular network. The variation of outside angle
has limited effects on the flow through vascular network since the discretised
differential equations for vascular flow remain unchanged, whereas it has clear
effects on the flow field in tumour interstitium. For Case BaS, when we let
β1 = 2π/3, 3π/4, 5π/6 orderly, while keep the other geometrical parameters
for the vascular structure to remain constant, the vascular flow pressures at
the junction almost remain unchanged, which are pJc/pˇ = 3.373263, p
J
c/pˇ =
3.373263 and pJc/pˇ = 3.373264 respectively. However, the interstitial pressures
on the exterior vascular surface are affected by the variation of β1, as plotted
in Fig.9.16. The results in Fig.9.17 show that the variation of β1 has clear
influence on the interstitial pressure contours and the flow field around the
vascular network in tumour interior. However, away from the vasculature, the
shapes of the interstitial pressure contours tend to be circular and the flow flux
over there would be uniform in all the directions.
9.4 Vasculature with three-dimensional centre
lines inside tumour
In our previous investigations, we let the vessel centre lines of the entire vas-
cular network locate on one plane. The major purpose of doing so is that
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Figure 9.17: Slides of 3D simulation results for (a, c, e) pressure contours
and (b, d, f) blood flow velocity streamlines on the vascular
network located plane.
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Figure 9.18: Sketch of the shape of a “tortuous” vessel.
it is convenient and illustrative for us to present the simulation results and
analyse the features of tumour blood flow. However, it is important to be
noticed that our mathematical model is applicable even when the centre lines
of tumour vessels are three-dimensional. In this part, we study two special
three-dimensional tumour vascular structures which are rarely found in nor-
mal tissues. One structure is a “tortuous” vessel, which means that when the
vessel is bent, it also rises with a uniform rate in the third dimension, as shown
in Fig.9.18. We set up a study case for tumour blood flow when a permeable
“tortuous” vessel is embedded in a solid tumour to a large extent. The vessel,
whose inlet point locates at origin o of reference frame o− xyz, is bent by 2π
and rises along axis z. The distance between the arterial and venous points
along axis z is lv/
√
2. According to the analysis in Section 8.2, vessel curvature
elevates the interstitial pressures on the external vascular surface, but reduces
the value of the relative flux coefficient γ
Q
. When the geometrical sizes and
physical parameters of the test case in Section 5.2 are adopted, Fig.9.19 plots
the distributions of the interstitial pressures along the exterior vascular surface
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surface.
for the present case and the case in Section 5.2. The relative flux coefficients
for the current case and for the test case in Section 5.2 are log10(γQ) = −3.4851
and log10(γQ) = −3.4811 respectively. These results reflect the foregoing dis-
cussions. Moreover, the complex shape of the vessel has significant effects on
the tumour interstitial flow, as presented in Fig.9.20.
Another unique structure of tumour vasculature is a vascular network
with trifurcation, which represents a mother vessel splits into three daughter
vessels. Less et al. (1991) stated that within the trifurcation of tumour vascular
network, the radius of the daughter vessel with the largest outside angle retains
the same order with the radius of the mother vessel, while the radii of the
other two daughter vessels are one order lower than that of the mother vessel.
We investigate a case for tumour blood flow, in which a permeable vascular
network with trifurcation is embedded in a solid tumour to a large extent. The
arterial point of the mother vessel is located at origin o of reference coordinate
system o − xyz whose centre line is along axis x. Daughter vessel d2 shares
the same centre line with the mother vessel (β2 = π), and daughter vessels d1
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Figure 9.20: Slides of 3D simulation results for (a, c, e) pressure contours and
(b, d, f) blood flow velocity streamlines in tumour interstitium.
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Figure 9.21: Slides of 3D simulation results for (a) pressure contours and (b)
blood flow velocity streamlines in tumour interstitium.
and d3 are on plane oyz and oxz with outside angles β1 = 2π/3 and β3 = 2π/3
respectively. Based on the patterns of tumour vascular network summarised
by Less et al. (1991), we set the geometrical sizes of the vascular network in
this case as followings: lmv = lv = l
d1
v = l
d2
v = l
d3
v = 0.5 cm, a
m = 0.01 cm,
ad1 = 0.004 cm, ad2 = 0.008 cm, and ad3 = 0.004 cm.
When the physical parameters for the flow in Case BaS are adopted,
the junction pressure inside the vascular network in the current case is lower
compared with that in Case BaS, which are pJc/pˇ = 3.3299 and p
J
c/pˇ = 3.3733
respectively. This is due to that the geometrical resistance for the daughter
vessel part in the present case is higher than that in Case BaS, while the
resistance for the mother vessel part are identical to each other under these
two cases. As a result, based on Eq.(9.2.1), the flux flowing through the
vascular network is reduced in the present case compared with that in Case
BaS since pressure difference pa−pv is the same in both cases, which leads to the
vascular flow pressure at the junction lowered in the current case. Meanwhile,
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Figure 9.22: Slides of 3D simulation results for (a, c, e) pressure contours and
(b, d, f) blood flow velocity streamlines in tumour interstitium.
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the complicated configuration of the vascular network with trifurcation has
clear effects on the flow field in tumour interstitium, as shown in Figs.9.21 and
9.22.
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Chapter 10
Approximation Model for
Tumour Vascular Flow
10.1 Approximation model for the blood flow
through a tumour vessel
In Chapter 4, we have developed a mathematical model for the blood flow
through a tumour vessel and the flow field in tumour interstitium based on
conservation of mass and momentum. In the meantime, as tumour vessels are
permeable, we have included the coupling effect between the vascular flow and
the interstitial flow by the Starling’s law which is also obtained from mass
conservation. We have applied this fully coupling model to investigate how
different kinds of physical parameters affect tumour blood flow when tumour
vasculature is represented by a single vessel in Chapters 6 to 8. According to
the obtained results, we noticed that the vascular flow pressures are almost
unaffected by the vessel permeability and the tumour hydraulic conductivity
coefficient, as shown in Figs.6.12a and 6.15a respectively. Mathematically, this
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indicates that the last term on the left-hand side of mass-conservation equation
(4.3.9), or
Hb(s)
dQc(s)
ds
+ 2πa(s)Lp(s) [pc(s)− pi(s)] = 0, (10.1.1)
is small in value compared with the first term on the left-hand of that equation
or Eq.(10.1.1). As a result, it is possible to develop an approximation model
through simplifying the above equation by ignoring the last term on its left-
hand side, which gives
Hb(s)
dQc(s)
ds
= 0. (10.1.2)
Once the position, shape and geometrical sizes of the vessel are given, we notice
that the approximation model in Eq.(10.1.2) is only relevant to vascular flow
pressure pc(s) (flux Qc). Consequently, if the above formulation is adopted
as the governing equation for the flow through tumour vessel, we are able to
obtain pc(s) directly by solving Eq.(10.1.2) analytically or through FDM. We
can then introduce pc(s) into Eq.(4.3.15) to calculate interstitial pressure pi(s)
on the external vascular surface. In this way, the whole numerical simulation
procedure of the approximation model is simplified into a one-step forward
process instead of the repeated iteration procedure of the fully coupling model
as stated in Section 5.1.
10.1.1 Analytical solution of Eq.(10.1.2)
As aforementioned in Sections 8.2 and 9.1, under the usual physical and phys-
iological conditions in a solid tumour, the blood flow through a tumour vessel
can be described by the Poiseuille’s law in Eq.(5.1.10) even if the vessel is not
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straight. Substituting Eq.(5.1.10) into Eq.(10.1.2), we obtain
H2b (s)
d2pc
ds2
+
dpc
ds
[
4H2b (s)
a(s)
da(s)
ds
+Hc(s)Hb(s)
]
= 0 (10.1.3)
which can be solved analytically. Let
dpc
ds
= fp, (10.1.4)
which gives
dfp
ds
=
d2pc
ds2
. (10.1.5)
Introducing Eqs.(10.1.4) and (10.1.5) into Eq.(10.1.3), and rearranging the
terms, we have
dfp
fp
= −
[
4
a(s)
da(s)
ds
+
Hc(s)
Hb(s)
]
ds. (10.1.6)
Noticing that Hc(s) = dHb(s)/ds as defined in Eq.(4.1.7), we obtain the solu-
tion of the above equation as
fp =
C1p
a4(s)Hb(s)
, (10.1.7)
in which C1p is a positive constant. Substituting Eq.(10.1.7) into Eq.(10.1.4),
we have the solution for pc(s) as
pc(s) = C
2
p + C
1
p
∫ s
0
1
a4(η)Hb(η)
dη, (10.1.8)
where C2p is a constant. If inlet and outlet vascular flow pressures pa and pv
are given, we have
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

pc = pa s = 0,
pc = pv s = lv(s).
(10.1.9)
Introducing Eq.(10.1.9) into Eq.(10.1.8), we obtain


C2p = pa,
C1p = − pa − pv∫
lv(s)
1
a4(η)Hb(η)
dη
. (10.1.10)
Substituting Eq.(10.1.10) into Eq.(10.1.8), and rearranging the terms, we get
pc(s) = pa − pa − pv∫
lv(s)
1
a4(η)Hb(η)
dη
∫ s
0
1
a4(η)Hb(η)
dη. (10.1.11)
The integrals in the above equation can be calculated numerically. When the
same discretised mesh as described in Section 4.3.4 are adopted, for segment
n = 1,
p[n]c = pa −
pa − pv
NE∑
i=1
δsi
(ai)
4H
[i]
b
{
δsn
2 (an)
4H
[n]
b
}
n = 1, (10.1.12)
and for segment 1 < n ≤ NE,
p[n]c = pa −
pa − pv
NE∑
i=1
δsi
(ai)
4H
[i]
b
{
n−1∑
i=1
δsi
(ai)
4H
[i]
b
+
δsn
2 (an)
4H
[n]
b
}
n = 2, 3, · · ·NE .
(10.1.13)
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Introducing pc(s) into Eq.(4.3.17) which is discretised from Eq.(4.3.15), we can
calculate interstitial pressure pi(s) on the exterior vascular surface straightfor-
wardly.
10.1.2 Validity of the approximation model
The approximation model is applied to calculate some of the study cases which
have been investigated in Sections 6.3, 6.2 and 8.2, and the results are presented
in Figs.10.1, 10.2 and 10.3 respectively, when the segment size is set as δsj =
0.2a and the relative round error as Er = 10−6. In Fig.10.1d, as Qa = Qv
under the approximation model, the definition of the relative flux coefficient
γ
Q
has been modified to
γ
Q
=
Q˘ex
Qa
=
∫
lv(s)
2πLp(s)a(s) [pc(s)− pi(s)] ds
Qa
. (10.1.14)
The definition in the above equation is equivalent to Eq.(5.0.4) for the fully
coupling model. These figures show that the simulation results obtained by the
approximation model are in good agreement with the results calculated by the
fully coupling model. This indicates that our primary assumption of ignoring
the last term on the left-hand side of Eq.(10.1.1) in the approximation model is
rational for the above study cases. For the study case in Fig.10.1a, the results
of simulation time by the approximation model and by the fully coupling model
are listed in Table10.1 under different sizes of discretised segment. Table10.1
shows that the smaller the size of discretised segment is, the more significant
the difference of the simulation time between these two models is. This is
mainly due to that the numerical procedure of the approximation model is a
one-step forward process, while the results pursued by the fully coupling model
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Figure 10.1: Comparison of the simulation results obtained by the fully cou-
pling model and by the approximation model for the study cases
in Section 6.3.
are through iteration. Generally speaking, the convergent rate of iteration
decreases when the segment size becomes smaller, which leads to the increasing
of the simulation time by the fully coupling model.
Before the approximation model is applied to further investigations, we
have to examine its validity in depth. The approximation model is established
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Figure 10.2: Comparison of the simulation results obtained by the fully cou-
pling model and by the approximation model for the study cases
in Section 6.2.
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Figure 10.3: Comparison of the simulation results obtained by the fully cou-
pling model and by the approximation model for the study cases
in Section 8.2, when an = 0.2, lv/Rc = 4π/3 (D = 647).
by ignoring the term with small value from the fully coupling model. Recalling
the governing equation for the vascular flow in the fully coupling model, which
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Table 10.1: Simulation time by the fully coupling model and approximation
model
Size of segment
Fully coupling model Approximation model
Time (s) Time (s)
δsj = 0.2a 142 131
δsj = 0.1a 662 635
δsj = 0.05a 2661 2538
is
H2b (s)
d2pc
ds2
+
[
4H2b (s)
a(s)
da(s)
ds
+Hc(s)Hb(s)
]
dpc
ds
− 16µLp(s)
a3(s)
[pc(s)− pi(s)] = 0,
(10.1.15)
we notice that the ignored term (Term Ig) is
16µLp(s)
a3(s)
[pc(s)− pi(s)] (10.1.16)
relative to Eq.(10.1.3) in the approximation model. As we have set that flow
dynamic viscosity µ is constant, the value of Term Ig is in direct proportion
to vessel permeability Lp(s) and transmural pressure difference pc(s) − pi(s),
but in inverse proportion to the cube of vessel radius a(s). It is worth to be
noticed that the value of Term Ig does not depend on Lp(s), pc(s) − pi(s) or
a(s) individually, because transmural pressure difference relies on vessel per-
meability and vessel radius according to the analysis in Sections 6.3 and 7.1.
However, though the variation of vessel radius can affect transmural pressure
difference pc(s)− pi(s), the effects are insignificant as discussed in Section 7.1.
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Figure 10.4: Distributions of (a) vascular flow pressures and (b) transmural
pressure difference.
Then, we are able to separate vessel radius a(s) for investigation. Since the
value of Term Ig is in inverse proportion to the cube of a(s), the variation
of a(s) can affect the value of Term Ig significantly. When the size of ves-
sel radius is small, the value of Term Ig can be large, which may make the
primary assumption of the approximation model invalid. We set up an in-
vestigation case for tumour blood flow, in which a single straight vessel with
length lv = 0.02 cm is embedded in a solid tumour to a large extent whose
hydraulic conductivity parameter is set as κ = 5 × 10−8 g−1cm3s and periph-
eral pressure as p0 = 6.666 × 102 g cm−1s−2. The vessel permeability is given
as Lp = 5 × 10−7 g−1cm2s, and the inlet and outlet vascular flow pressures
as pa = 1.58653 × 104 g cm−1s−2 and pv = 8.9326 × 103 g cm−1s−2 respec-
tively. The simulation results of the current case are presented in Figs.10.4,
10.5 and Table10.2, when the vessel radius varies from a(s) = 1× 10−3 cm to
a(s) = 3×10−3 cm. Since the radius is uniform along the vessel in the present
case, according to Eq.(10.1.3), pressure pc(s) inside the vessel declines linearly
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from pa to pv, as shown in Fig.10.4 by the solid line. However, the results in
Fig10.4a show that, when a(s) is small, pc(s) obtained by the fully coupling
model is not linear along the vessel. This is due to that the low value of a(s)
leads to the high value of ratio Lp/a
3. As a result, the value of Term Ig is no
longer small, since transmural pressure difference pc(s)−pi(s) does not tend to
zero, as displayed in Fig.10.4b. This indicates that, under such consequences,
the approximation model is not rational, and Term Ig cannot be ignored from
the fully coupling model. Along the increasing of vessel radius a(s), the value
of ratio Lp/a
3 decreases rapidly, which makes the value of Term Ig lowered sig-
nificantly. When the value of Term Ig is small enough, the results calculated
by the approximation model are in good agreement with the results obtained
by the fully coupling model, as shown in Fig.10.5 and Table10.2. For these
consequences, the approximation model is rational.
Another feature that can affect the value of ratio Lp/a
3 is vessel perme-
ability Lp(s), which consequently has effects on the value of Term Ig. The
effects of Lp(s) on the value of Term Ig is relatively complicated because it has
strong influence on interstitial pressure pi(s) on the exterior vascular surface,
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Table 10.2: The overall amount of the extravasation flux
Original model Approx model relative difference
a Lp/(a
3) Qnex Q˘
n
ex
∣∣∣Q˘nex −Qnex∣∣∣ /Qnex
0.0010 500.000 53.220 53.770 1.033%
0.0012 289.352 63.909 64.290 0.596%
0.0014 182.148 74.473 74.752 0.374%
0.0016 122.070 84.949 85.161 0.250%
0.0018 85.734 95.355 95.522 0.175%
0.0020 62.500 105.702 105.836 0.127%
0.0025 32.000 131.354 131.439 0.065%
0.0030 18.519 156.750 156.808 0.037%
which can then affect transmural pressure difference pc(s)− pi(s) significantly,
as aforementioned in Section 6.3. According to the above investigations, when
Lp/a
3 = 500 as Lp = 5 × 10−7 g−1cm2s and a = 0.001 cm, the approximation
model is not rational since the value of Term Ig is too large to be ignored.
However, if we keep the value of radio Lp/a
3 as Lp/a
3 = 500, while let vessel
radius a = 0.005 cm and vessel permeability Lp(s) = 6.25× 10−5 g−1cm2s, the
results obtained by the approximation model are in good agreement with the
results calculated by the fully coupling model, as shown in Fig.10.6. According
to the analysis in Section 6.3, when the value of vessel permeability is high,
interstitial pressure pi(s) on the external vascular surface could be elevated
even to be equal to vascular flow pressure pc(s), or pi(s) → pc(s). Under this
circumstance, transmural pressure difference pc(s)− pi(s) tends to zero, which
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Figure 10.6: Distributions of (a) vascular flow pressures and (b) transmural
pressure difference.
makes the value of Term Ig small enough to be ignored even though the value of
ratio Lp/a
3 is large (Lp/a
3 = 500). Consequently, the approximation model is
still rational under such a situation. Based on the foregoing discussions in Sec-
tion 6.2, when the value of tumour hydraulic conductivity coefficient κ is low,
transmural pressure difference pc(s)− pi(s) could also tend to zero. According
to the coupling effect relationship defined in Eq.(6.1.1), when the value of ratio
Lp/κ is high, pc(s) − pi(s) → 0 since interstitial pressure gradient ∂pi(s)/∂n
should be within some reasonable range when inlet vascular flow pressure pa,
outlet vascular flow pressure pv and tumour peripheral pressure p0 are given.
Under such a circumstance, the approximation model is still reasonable even
though the value of ratio Lp/a
3 is high. For the foregoing study case, if vessel
radius a = 0.001 cm remains constant while κ can be varied, we observe that
the results in Table10.3 reflect the above discussions. Therefore, the approx-
imation model is rational when either of the following two conditions is met:
1. the value of ratio Lp/a
3 is low; 2. if the value of ratio Lp/a
3 is not low, the
value of ratio Lp/κ should be high. Otherwise, tumour blood flow can only be
investigated by the fully coupling model. All the cases that have been investi-
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Table 10.3: The overall amount of the extravasation flux along vessel
Original model Approx model relative difference
Lp/κ Q
n
ex Q˘
n
ex
∣∣∣Q˘nex −Qnex∣∣∣ /Qnex
50 47.998 48.442 0.924%
100 42.759 43.108 0.816%
500 22.865 22.961 0.417%
1000 14.477 14.514 0.256%
5000 3.689 3.691 0.0615%
gated in the beginning of this section can be fallen into category 1, except the
case in Fig.10.1c, which belongs to condition 2.
10.2 Vasculature with branches
Having been clear with the range of rationality and availability of the approx-
imation model, we can further apply it to simulate tumour blood flow when
tumour vasculature contains complicated structures. To take the vascular
bifurcation which has been investigated in Section 9.1 as an example, the pres-
sures inside the mother vessel can be expressed in the form of Eqs.(10.1.12) and
(10.1.13) through replacing pv with vascular flow pressure p
J
c at the junction of
the vascular network, and the pressures inside each daughter vessel are in the
form of Eqs.(10.1.12) and (10.1.13) by replacing pa with p
J
c . Substituting the
expressions for the vascular flow pressures into the pressure gradient condition
at the junction which is defined in Eq.(9.1.6), we have
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Figure 10.7: Distributions of (a, c) vascular flow pressures and (b, d) inter-
stitial pressures on the external vascular surface for Case BS.
pma − pJc
NE∑
i=1
δsmi
(ami )
4Hmb
[i]
=
Nd∑
k=1
pJc − pdkv
N
dk
E∑
i=1
δsdki(
adki
)4
Hdkb
[i]
. (10.2.1)
Then, pJc can be obtained directly by solving the above linear equation, which
allows us to calculate pressure pc(s) in the vascular network according to
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Figure 10.8: Distributions of (a) vascular flow pressures and (b) interstitial
pressures on the external vascular surface for Case BaS.
Eqs.(10.1.12) and (10.1.13) straightforwardly. Introducing pc(s) into Eq.(9.1.7),
we are able to obtain interstitial pressure pi(s) on the exterior vascular sur-
face along the whole vasculature. Compared with the numerical procedure
which includes an inner loop to calculate pJc and an outer loop for pc(s) and
pi(s) in the fully coupling model as stated in Section 9.1, the whole calculation
procedure by the approximation model is a three-step process when tumour
vasculature has branches. According to Tables10.2 and 10.3, Case BS and Case
BaS in Chapter 9 can be solved by the approximation model. Figs.10.7 and
10.8 show that the simulation results obtained by the approximation model
are in good agreement with the results calculated by the fully coupling model.
The simulation time for Case BS by the approximation model is 1280s, while
it is 1393s by the fully coupling model. The difference of simulation time is
mainly due to the simplicity of the numerical procedure of the approximation
model.
The approximation model can be further applied to simulate tumour
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Figure 10.9: Sketch of the configuration of a 3D complex vascular network.
blood flow when tumour vasculature is a more complicated vascular network
with multiple generations of daughter vessels. Similar to the procedure which
was stated in the beginning of this section, we firstly compose a set of lin-
ear equations for vascular flow pressure pJc at all junctions within the entire
vascular network. We then calculate pJc by solving those linear equations,
and obtain the pressures inside vessels based on Eqs.(10.1.12) and (10.1.13).
After that, we can get the interstitial pressures on the exterior vascular sur-
face along the entire vascular network through Eq.(9.1.6). Fig.10.9 sketches
a study case, in which a complex vascular network with permeability Lp =
10−9 g−1cm2s is embedded in a solid tumour to a large extent whose hydraulic
conductivity parameter is set as κ = 10−10 g−1cm3s and peripheral pressure as
p0 = 6.666 × 102 g cm−1s−2. The vascular network starts with mother vessel
Vs1 splitting into three daughter vessels Vs2, Vs3, Vs4 at junction J1. Then
daughter vessel Vs2 separates into two granddaughter vessels Vs5 and Vs6
at junction J2, and daughter vessel Vs3 splits into two granddaughter vessels
Vs7 and Vs8 at junction J3. Furthermore, granddaughter vessels Vs7 and
Vs8 forms a self loop, which means that they meet with each other at the
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downstream ends of those two vessels, and connect with great-granddaughter
vessel Vs9 at junction J4. The shape and geometrical sizes of each vessel
within the vascular network are listed in Table10.4. Referring to Tables10.2
and 10.3, we are able to simulate this case by the approximation model.
The inlet condition for the vascular flow is pa = 5.93283 × 104 g cm−1s−2
at the arterial point of the mother vessel, and the outlet vascular flow con-
ditions are p4v = 1.19990 × 104 g cm−1s−2, p5v = 9.3325 × 103 g cm−1s−2,
p6v = 6.6661× 103 g cm−1s−2, p9v = 8.6659× 103 g cm−1s−2 at the venous ends
of vessels Vs4, Vs5, Vs6 and Vs9 respectively. We obtain that the junction
pressures inside the vascular network are pJ1c /pˇ = 39.29114, p
J2
c /pˇ = 26.76337,
pJ3c /pˇ = 30.52034 and p
J4
c /pˇ = 10.09251 for junctions J1, J2, J3 and J4 respec-
tively. Meanwhile, the three-dimensional simulation results for the pressure
contours and the flow velocity streamlines in tumour space are presented in
Fig.10.10.
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Table 10.4: Parametric equation for the vessel centre line and geometrical
sizes of every vessel within vascular network.
Vessel
Parametrical equations Length Radius
for the vessel centre line (cm) (cm)
Vs1


x(s) = s,
y(s) = 0.0,
z(s) = 0.0.
0.0 ≤ s ≤ 0.2 0.2 0.01
Vs2


x(s) = 0.2 + s/2,
y(s) =
√
3 s/2,
z(s) = 0.0.
0.0 ≤ s ≤ 0.2 0.2 0.004
Vs3


x(s) = 0.2 + s,
y(s) = 0.0,
z(s) = 0.0.
0.0 ≤ s ≤ 0.15 0.15 0.008
Vs4


x(s) = 0.2 + s/2,
y(s) = −s/2,
z(s) =
√
2 s/2.
0.0 ≤ s ≤ 0.5 0.5 0.003
Vs5


x(s) =
√
3/2 +
√
3 s cos(π/9)/2,
y(s) = 0.1 + s cos(π/9)/2,
z(s) = −s sin(π/9).
0.0 ≤ s ≤ 0.1 0.1 0.003
Vs6


x(s) =
√
3/2 + s,
y(s) = 0.1,
z(s) = 0.0.
0.0 ≤ s ≤ 0.05 0.05 0.0005
Vs7


x(s) = 0.35 + s,
y(s) = 0.0,
z(s) = 0.08 sin(sπ/0.25).
0.0 ≤ s ≤ 0.25 0.3045 0.0065
Vs8


x(s) = 0.35 + s,
y(s) = 0.0,
z(s) = −0.08 sin(sπ/0.25).
0.0 ≤ s ≤ 0.25 0.3045 0.0065
Vs9


x(s) = 0.6 + s,
y(s) = 0.0,
z(s) = 0.0.
0.0 ≤ s ≤ 0.15 0.15 0.01
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Figure 10.10: Slides of 3D simulation results for (a, c, e) pressure contours
and (b, d, f) flow velocity streamlines in tumour interstitium.
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Chapter 11
Summary and Discussions
Tumour blood flow is one of the most important factors that can affect tu-
mour growth and cancer therapies. It can be investigated efficiently by com-
putational fluid dynamics through modelling tumour blood flow by numerical
simulations. In this thesis, a three-dimensional mathematical model has been
developed to investigate the blood flow through a vascular network with per-
meability which is embedded in a solid tumour. In this model, the vascular net-
work can be three-dimensional in space and with generations of branches. The
complex three-dimensional configuration of tumour vasculature is described by
the parametric equation in terms of the vessel centre lines. The cross section
of each vessel in the vascular network is assumed to be circular, and the length
scale in the transverse direction of the vessel is smaller than that in the lon-
gitudinal direction. As a result, the flow inside a tumour vessel is dominated
by the pressure gradient along its centre line. The mass- and momentum-
conservation equations are derived in the local cylindrical coordinate system
located on a certain vessel cross section, whose longitudinal axis is along the
tangential direction of the vessel centre line at that section. Since the vascular
flow is dominated by the leading component in the longitudinal direction of
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the vessel, its governing equation becomes an ordinary differential equation,
which is converted into one with respect to the parameter of the parametric
equation for the vessel centre line. For the vasculature with complex structure,
for example a mother vessel splitting into two or more daughter vessels at a
junction point, the conditions of pressure continuity and mass conservation are
imposed at every junction of the vascular network.
Due to the permeability of tumour vasculature, blood is transmitted from
vessels into tumour interstitium. The mathematical relationship for extravasa-
tion flux is described by the Starling’s law, which indicates that the transvas-
cular flux depends on the vessel permeability and the transmural pressure
difference. Based on mass conservation, the flux exceeded from a tumour ves-
sel into interstitium must be equal to the gradient of the flux flowing through
the vessel. Combining this relationship with the governing equation for the
vascular flow, a one-dimensional differential equation for the flow inside the
vessel is obtained, in which the source term contains tumour interstitial pres-
sure. This coupling effect is also included in the governing equation for the
blood flow in tumour interstitium. Together with the conditions of pressure
continuity and mass conservation at junctions, the governing equations for the
flow through entire vascular network are derived.
As tumour interstitium is regarded as porous media, the blood flow in
it is described by the Darcy’s law, which indicates that the fluid velocity is
in direct proportion to the gradient of interstitial pressure. Substituting the
Darcy’s law into flow continuity equation, the interstitial pressure satisfies the
Laplace equation as the tumour tissue hydraulic conductivity is assumed to be
constant. The boundary condition for the interstitial flow is derived based on
continuity of flow velocity on the vascular surface. Taking this boundary condi-
tion into account, the Laplace equation is transformed into a boundary-integral
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equation when the Green’s function is used. This offers anther equation link-
ing the pressures inside and outside vessels, or the coupling effect. Together
with the governing equations for the vascular flow, the mathematical model is
completed.
The mathematical model is discretised and solved numerically. There
are a number of complications for the numerical procedure. In particular,
though the flow inside each vessel has been rationally approximated by the
component in the longitudinal direction of the vessel, the interstitial flow on
the external vascular surface has other components because its direction is
unconstrained. The circumferential average of the interstitial pressure on the
exterior vascular surface is adopted to avoid the mismatch between the internal
and external vascular pressures. As a result, the original three-dimensional
boundary-integral equation is reduced to a one-dimensional integral equation
with respect to the parameter of the parametrical equation for the vessel centre
line. Moreover, when the vessel shape becomes complex, for example a curved
vessel, the governing differential equation for the flow through the vessel could
become complicated in terms of the expression of the parametrical equation
for the vessel centre line. In the meantime, since the vessel cross sections
are no longer parallel with each other, the integral equation derived from the
Laplace equation is also significantly modified. The discretised differential and
integral equations are solved by finite difference method and boundary element
method respectively. The developed model and methodology have first been
tested for a single straight vessel. Results are compared with published data,
and excellent agreement has been found. The efficiency of the methodology
has been analysed.
As the rationality of our mathematical model has been approved, it is ap-
plied to study how different types of physical parameters and irregular tumour
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vascular structures affect tumour blood flow in context with the transvascular
delivery of anti-cancer agents with heavy weight in a solid tumour and the
effectiveness of chemotherapy and radiotherapy for cancer. Our simulation re-
sults indicate that, when we can elevate one or more venous pressures of the
vascular network to reduce the difference between the inlet and outlet vascular
flow pressures and to enlarge the difference between the outlet vascular flow
pressures and the tumour peripheral pressure, it would be beneficial for the
delivery of anti-cancer agents with heavy weight throughout the vascular sur-
face and the effectiveness of radiotherapy and chemotherapy. If the vascular
permeability or part of it can be raised, the overall ability of transvascular
delivery of anti-cancer macromolecules with large size and effectiveness of ra-
diotherapy and chemotherapy can be improved, while the efficiency would be
compromised when the permeability is higher than some level. Increasing the
tumour tissue hydraulic conductivity is another option to improve the ability
of transporting anti-cancer agents out of the vessels into tumour interior and
the effectiveness of chemotherapy and radiotherapy, but the efficiency would
be lowered when the value of the tumour tissue hydraulic conductivity is high.
The variation of vessel radius has different effects on tumour blood flow under
different types of vascular flow conditions. When the perfused flux and the in-
let pressure for the vascular flow are given, an increase of tumour vessel radius
can improve the efficacy of transporting anti-cancer agents with heavy weight
through vascular surface into tumour interstitium and the effectiveness of the
chemotherapy and radiotherapy. However, if the perfused flux and the outlet
pressure for the vascular flow are fixed, dilated tumour vessel has negative ef-
fects on transvascular delivery of the macromolecules with large size in tumour
or the effectiveness of the chemotherapy and radiotherapy. On the other hand,
if we can control the inlet and outlet pressures for the vascular flow, enlarging
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tumour vessel can be beneficial for transporting the anti-cancer agents with
heavy weight through vascular surface into tumour interior, but the effective-
ness of cancer therapies has to be sacrificed. Moreover, our model is applied to
undertake some initial investigations on tumour blood flow when a compliant
permeable vessel is embedded in a solid tumour. Our results show that, under
the same physical and geometrical conditions, the vessel with compliance can
generate more extravasation flux relative to the rigid one.
Meanwhile, the interstitial flow field has been investigated by our model.
The interstitial flow near the vessels is affected significantly by the physical
parameters and the abnormal complex configuration of tumour vasculature.
For example, if a tumour vessel is bent with some curvature, the shapes of
interstitial pressure contours vary rapidly near the vessel. The interstitial flow
velocity streamlines show that the interstitial blood flow on the concave side
of the vessel is less active than the flow on the convex side. This can cause
the uneven supply of anti-cancer agents within tumour interstitium. Far away
from tumour vasculature, the shapes of interstitial pressure contours tend to
be circular and the flux over there is uniform in all directions.
Based on the patterns of the vascular flow, an approximation model is
developed by ignoring the term with small value in the fully coupling model.
Compared with the fully coupling model, the approximation model neglects
the coupling effect between the internal and external vascular pressures in the
differential equations for the vascular flow, which simplifies the calculation
procedure. The approximation model is valid only if the rational conditions
are met. The computation efficiency of the approximation model is higher than
the fully coupling model, especially when the structure of vascular network is
complicated. Further to this, if the accurate results are required, the solution
obtained by the approximation model can be adopted as the initial guess for the
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fully coupling model, which should be able to reduce the number of iteration
in the fully coupling model.
The present model is derived based on conservation of mass and momen-
tum, which does reflect the true physics of the blood flow through a permeable
vascular network embedded in a solid tumour to a large extent. There are
nevertheless some approximations within this model, such as the longitudinal
flow assumption for the vascular flow and the Darcy’s law for the interstitial
flow. Also the one-dimensional model for the interstitial flow along the exter-
nal vascular surface is questionable for the local results near the junctions of
tumour vascular network. All of these require further research and investiga-
tions. It is therefore unrealistic to expect that the present work has immediate
clinical applications, but it nevertheless is one step forward towards the goal
of improving the delivery of anti-cancer agents with heavy weight into solid
tumours.
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Appendix A
Computation of the Complete
Elliptic Integrals of the First
and Second Kind
The complete elliptic integrals of the first and second kind are defined as
F (mˆ) =
2
π
∫ π/2
0
(1− mˆ sin2 ξ)−1/2dξ, (A.0.1)
and
E(mˆ) =
2
π
∫ π/2
0
(1− mˆ sin2 ξ)1/2dξ, (A.0.2)
respectively, where
√
mˆ is the module of the elliptic integrals.
When 0 ≤ √mˆ < 1, an efficient method to calculate F (mˆ) and E(mˆ) is
through the recursive formulae [Pozrikidis (1997)], which are
F (mˆ) = (1 + Kˆ1)(1 + Kˆ2)(1 + Kˆ3) · · · , (A.0.3)
232
and
E(mˆ) = F
(
1− mˆ
2
Pˆ
)
, (A.0.4)
where
Kˆ0 = mˆ, Kˆj =
1− (1− Kˆ2j−1)
1
2
1 + (1− Kˆ2j−1)
1
2
j ≥ 1, (A.0.5)
and
Pˆ = 1 +
Kˆ1
2
[
1 +
Kˆ2
2
(
1 +
Kˆ3
2
(· · · ) · · ·
)]
. (A.0.6)
Abramowitz and Stegun (1972) provided the alternative polynomial ap-
proximations to calculate F (mˆ) and E(mˆ), as stated in Section 4.3.4.
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